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Background: Multidisciplinary team (MDT) meetings have been endorsed by the Department of Health as
the core model for managing chronic diseases. However, the evidence for their effectiveness is mixed and
the degree to which they have been absorbed into clinical practice varies widely across conditions and
settings. We aimed to identify the key characteristics of chronic disease MDT meetings that are associated
with decision implementation, a measure of effectiveness, and to derive a set of feasible modifications to
MDT meetings to improve decision-making.
Methods: We undertook a mixed-methods prospective observational study of 12 MDTs in the London and
North Thames area, covering cancer, heart failure, mental health and memory clinic teams. Data were
collected by observation of 370 MDT meetings, completion of the Team Climate Inventory (TCI) by
161 MDT members, interviews with 53 MDT members and 20 patients, and review of 2654 patients’
medical records. We examined the influence of patient-related factors (disease, age, sex, deprivation
indicator, whether or not their preferences and other clinical/health behaviours were mentioned) and MDT
features (team climate and skill mix) on the implementation of MDT treatment plans. Interview and
observation data were thematically analysed and integrated to explore possible explanations for the
quantitative findings, and to identify areas of diverse beliefs and practice across MDT meetings.
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Based on these data, we used a modified formal consensus technique involving expert stakeholders to
derive a set of indications of good practice for effective MDT meetings.
Results: The adjusted odds of implementation were reduced by 25% for each additional professional
group represented [95% confidence interval (CI) 0.66 to 0.87], though there was some evidence of a
differential effect by type of disease. Implementation was more likely in MDTs with clear goals and
processes and a good team climate (adjusted odds of implementation increased by 7%; 95% CI 1% to
13% for a 0.1-unit increase in TCI score). Implementation varied by disease category (with the lowest
adjusted odds of implementation in mental health teams) and by patient deprivation (adjusted odds of
implementation for patients in the most compared with least deprived areas were 0.60, 95% CI 0.39 to
0.91). We ascertained 16 key themes within five domains where there was substantial diversity in beliefs
and practices across MDT meetings. These related to the purpose, structure, processes and content of
MDT meetings, as well as to the role of the patient. We identified 68 potential recommendations for
improving the effectiveness of MDT meetings. Of these, 21 engendered both strong agreement (median
≥ 7) and low variation in the extent of agreement (mean absolute deviation from the median of < 1.11)
among the expert consensus panel. These related to the purpose of the meetings (e.g. that agreeing
treatment plans should take precedence over other objectives); meeting processes (e.g. that MDT decision
implementation should be audited annually); content of the discussion (e.g. that information on
comorbidities and past medical history should be routinely available); and the role of the patient
(e.g. concerning the most appropriate time to discuss treatment options). Panellists from all specialties
agreed that these recommendations were both desirable and feasible. We were unable to achieve
consensus for 17 statements. In part, this was a result of disease-specific differences including the need to
be prescriptive about MDT membership, with local flexibility deemed appropriate for heart failure and
uniformity supported for cancer. In other cases, our data suggest that some processes (e.g. discussion of
unrelated research topics) should be locally agreed, depending on the preferences of individual teams.
Conclusions: Substantial diversity exists in the purpose, structure, processes and content of MDT
meetings. Greater multidisciplinarity is not necessarily associated with more effective decision-making and
MDT decisions (as measured by decision implementation). Decisions were less likely to be implemented for
patients living in more deprived areas. We identified 21 indications of good practice for improving the
effectiveness of MDT meetings, which expert stakeholders from a range of chronic disease specialties
agree are both desirable and feasible. These are important because MDT meetings are resource-intensive
and they should deliver value to the NHS and patients. Priorities for future work include research
to examine whether or not the 21 indications of good practice identified in this study will lead to better
decision-making; for example, incorporating the indications into a modified MDT and experimentally
evaluating its effectiveness in a pragmatic randomised controlled trial. Other areas for further research
include exploring the value of multidisciplinarity in MDT meetings and the reasons for low implementation
in community mental health teams. There is also scope to examine the underlying determinants of the
inequalities demonstrated in this study, for example by exploring patient preferences in more depth.
Finally, future work could examine the association between MDT decision implementation and
improvements in patient outcomes.
Funding: The National Institute for Health Research Health Services and Delivery Research programme.
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Glossary
There is much debate regarding the term that is used to describe those under the care of mental health
services, with a range of terms including ‘service user’, ‘client’ and ‘survivor’ being advocated (Simmons P,
Hawley CJ, Gale TM, Sivakumaran T. Service user, patient, client, user or survivor: describing recipients of
mental health services. Psychiatrist 2010;34:20–3). For the sake of consistency in comparing a range of
teams we use the term ‘patient’. However, we recognise that some prefer other terms.
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Plain English summary
Our study investigated multidisciplinary team (MDT) meetings for chronic illnesses: cancer, dementia,heart failure and mental illnesses. These teams are widely used across the NHS. They comprise
different professionals, for example doctors, nurses, social workers and psychologists, and meet weekly to
discuss their patients and make treatment plans. The teams work in a wide variety of different ways, not
all of which may be helpful for making high-quality decisions for patients. We wanted to identify the
factors that influence effective decision-making in these teams (by which we mean decisions being
carried out).
We found that 78% of treatment plans were implemented overall, though this varied across teams: mental
health teams were less likely to have implemented the agreed plan than cancer, heart failure and memory
clinic teams. By observing 370 meetings we identified factors that help explain this. Teams with many
different types of professionals present at the meeting were less likely to carry out the treatment plans
agreed by the team. It was also crucial to have a good team atmosphere, and clear goals and processes.
We found that patients living in more deprived areas were less likely to get the treatment recommended
by the team. This was not explained by whether or not patients’ preferences or their other illnesses had
been discussed.
We also found that individual teams had varying aims and organisational structure, and discussed different
information when making decisions. Based on these differences, we asked a group of experts to recommend
improvements to MDT meetings, which could help all teams regardless of whether they care for cancer, heart
failure or mental health patients. They agreed on 21 indications for good practice, including that there should
be yearly audits to check that MDT meetings are achieving their goals, and that the most appropriate time to
discuss treatment options with patients is after the meeting, when information about treatment options is
more complete.
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Scientific summary
Background
Multidisciplinary team (MDT) meetings have been endorsed by the Department of Health as the core
model for managing chronic diseases. The proliferation of MDT meetings in health care has occurred
against a background of increasingly specialised medical practice, more complex medical knowledge,
continuing clinical uncertainty and the promotion of the patient’s role in their own care. In this
environment, it is believed that MDT meetings ensure higher-quality decision-making and improved
outcomes. However, the evidence underpinning the development of MDT meetings is not strong and
the degree to which they have been absorbed into clinical practice varies widely across conditions
and settings. In the light of this uncertainty, there have been calls for empirical research on MDT
meeting decision-making in routine practice to understand how and under what conditions MDT meetings
produce effective decisions.
We conducted a large mixed-methods study of MDTs for a range of chronic diseases to examine and
explore determinants of effective decision-making (defined as decision implementation) and areas of
diversity across MDT meetings (study 1). We applied a transparent and explicit consensus development
method to develop a list of indications of good practice, based on our results, to improve MDT meeting
effectiveness (study 2).
Aims
i. To identify the key characteristics of chronic disease MDT meetings that are associated with decision
implementation (whether or not treatment decisions recommended by the team were carried out).
ii. To derive a set of feasible modifications to the MDT meetings to improve effective MDT
decision-making for patients with chronic diseases.
Objectives
i. To undertake an observational study of chronic disease MDT meetings to identify factors which
influence their effectiveness in terms of decision implementation (study 1).
ii. To explore the influence of patient preferences and comorbidity on any socioeconomic variations in
implementation found (study 1).
iii. To explore areas of diversity in beliefs and practices across MDT meetings (study 1).
iv. To use the results from study 1 in a structured formal consensus technique to derive a set of feasible
modifications to improve MDT meeting effectiveness (study 2).
Study 1
Data collection
We undertook a mixed-methods prospective cohort study of MDT meetings in 12 chronic disease MDTs in
the London and north Thames area, England. We examined one skin cancer, one gynaecological cancer,
two haematological cancer, two heart failure, two psychiatry of old age (memory clinic) and four
community mental health MDTs (including one early intervention service for psychosis).
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Quantitative and qualitative data were collected by observation and audiotaping of 370 MDT meetings,
a questionnaire on ‘team climate’ completed by 161 MDT members, interviews with 53 MDT members,
interviews with 20 patients and review of 2654 patient medical records. Two patient and public
involvement representatives provided in-depth advice throughout the study, from design to dissemination.
Observations
The weekly MDT meetings of 12 teams were observed and audiotaped over 18–55 weeks. For each
patient discussed, we collected quantitative data on decisions made, diagnosis and whether or not health
behaviours (smoking, drinking, physical inactivity), other clinical factors (including comorbidities and
medical and family history) and patient treatment preferences were mentioned.
In addition, qualitative field notes were taken on MDT features (e.g. attendee job titles, presence of an
MDT co-ordinator), context (e.g. reference to national policy/guidance and local resource issues) and
process (e.g. levels of participation, the role of the chairperson and clarity and documentation
of decisions).
Multidisciplinary team member questionnaire
Core MDT members completed the Team Climate Inventory (TCI) during the final month of observation,
which assessed members’ perceptions across the four domains of ‘team vision’, ‘participative safety’
(i.e. a facilitative atmosphere for involvement), ‘task orientation’ (e.g. with respect to individual and team
accountability) and ‘support for innovation’. A low TCI score reflects perception of poor team climate.
We added two items to the TCI. The first asked respondents to rate their agreement with the statement
‘I believe that the [team name] MDT meetings are an effective use of my time’ on a scale of 1 to 5.
The second was an open question: ‘Is there anything you would change about these meetings?’
Interviews
We conducted semistructured interviews with 53 MDT members and 20 patients/carers. Members were
recruited from all the MDTs observed, purposively sampled to include core professional groups and both
frequent and infrequent attendees. Patient/carers were recruited across all four disease types from the
MDTs under observation, and purposively sampled in terms of sex, age and ethnicity.
Review of medical records
Quantitative data on decision implementation, reasons for non-implementation and patients’
sociodemographic and diagnostic details were collected from medical records. Decision implementation
was assessed 3 months after the MDT meeting, unless the MDT explicitly noted that implementation
should be later (e.g. ‘follow up in 6 months’).
Quantitative analysis
The influence of MDT and patient-related factors on treatment plan implementation was investigated
using random-effects logistic regression models, allowing for clustering by MDT. We also descriptively
analysed responses to the statement ‘I believe that the [team name] MDT meetings are an effective use
of my time’.
Qualitative analysis
Interview transcripts and field notes were thematically analysed using a combination of inductive and
deductive coding. Findings from the different qualitative data sets were integrated to explore possible
explanations for the quantitative findings, and to identify areas of diverse beliefs and practice across
MDT meetings.
Results
Of the 3184 patient discussions observed, 2654 culminated in a treatment plan. There was considerable
variation among the 12 teams in the number of patients discussed at each meeting, with the mean
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ranging from 4 to 49. The median number of meeting attendees ranged from 5 to 17, and the median
number of professional disciplines represented ranged from two to six.
Characteristics of chronic disease multidisciplinary team meetings that are
associated with treatment plan implementation
Implementation varied by disease category, and was highest in gynaecological cancer (84%) and lowest in
mental health (70%). High-implementing teams tended to have clear goals, and members shared the
view that the main purpose of the MDT meeting was to make treatment recommendations for patients.
In contrast, in lower-implementing teams, members identified a range of diverse objectives and some
stated that meetings lacked clarity of purpose. Lack of implementation was commonly due to patient or
family choice, and to difficulties in engaging patients with the service.
Implementation also varied according to patients’ socioeconomic circumstances; the adjusted odds of
implementation were reduced by 40% for patients in the most deprived areas compared with those
in the least deprived areas [odds ratio 0.60, 95% confidence interval (CI) 0.39 to 0.91]. This could not be
explained by consideration of patient preference, comorbidities or other health related factors in team
meetings. We found no association between discussion of patient preferences or comorbidities and
treatment plan implementation.
We found that the adjusted odds of implementation were reduced by 25% for each additional
professional group represented at the meeting (odds ratio 0.75, 95% CI 0.66 to 0.87). This trend was
mostly accounted for by mental health and memory teams. In these teams, when meetings were attended
by more professional groups there was a tendency for more diverse issues to be raised in an ad hoc
manner, with abrupt changes of subject.
Implementation was also more likely in MDTs with a good team climate (adjusted odds of implementation
increased by 7%; 95% CI 1% to 13% for a 0.1-unit increase in TCI score).
Areas of diversity in beliefs and practices across multidisciplinary
team meetings
There was considerable variation among the 12 teams in terms of meeting characteristics. We identified
16 key themes within five domains where there was substantial diversity in beliefs and practices across
MDT meetings. This diversity was apparent both within and across specialities. Variation related to the
purpose, functions, structure and processes of the MDT meetings, as well as the role of the patient and
content of discussions.
The purpose and functions of multidisciplinary team meetings
Overall there was considerable variation between teams in the purpose and functions of MDT meetings.
These included decision-making, information-sharing, peer support and education. There was evidence
of teaching in some teams, but not all, and there was wide variation between MDT meetings in how
frequently recruitment to clinical trials was considered.
The structure of multidisciplinary team meetings
Attendance and participation in discussions also varied considerably, with evidence of status hierarchies
and medical dominance in some specialties. There was also wide variation in how MDT meetings were
organised. All cancer teams had dedicated MDT co-ordinators, while, in heart failure, memory and
mental health, administrative duties were undertaken by managers, health-care professionals and
general administrators.
Multidisciplinary team meeting processes
There was variation in the chairing arrangements. Most meetings were formally chaired by a member of
the team, several teams had a rotating chairperson system and in some teams there was no predefined
chairing system and different senior members took the lead on different occasions. Teams also differed in
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how they selected patients to be discussed and in how cases were presented. The process, completeness
and accuracy of documentation also varied widely across teams. This ranged from typing decisions directly
into patients’ electronic records to handwritten records that were not subsequently filed in patients’ notes.
Content of discussion in multidisciplinary team meetings
There was variation across teams in how frequently they referred to scientific evidence and research, and
in whether or not patient psychosocial issues were discussed. There was also variation across teams in the
extent to which patient comorbidities and patient preferences were mentioned during case discussions.
Overall, MDT members and patients considered discussion of comorbidities and patient preferences to be
important; however, this information was not always available in advance of the meeting, and some MDT
members believed that it was more appropriate to discuss patient preferences after the meeting when
treatment options had been evaluated.
The role of the patient in multidisciplinary team meetings
We found that not all patients were aware that their cases were being discussed at MDT meetings. In line
with previous research, most patients and staff believed it would be impractical for patients to attend the
meetings. Patients varied in their preferences regarding the format and content of the information they
would like fed back to them after the meeting.
Study 2
Methods
In study 2, we applied a modified formal consensus technique to derive a set of indications of good
practice for improving the effectiveness of MDT meetings for patients with chronic diseases. We used the
qualitative and quantitative findings from study 1 to generate potential recommendations to be discussed
and rated by an expert panel.
We recruited an expert panel of health-care professionals, policy-makers and patient representatives
with experience of MDTs in each of the disease types under study: cancer, heart failure and mental
health (including memory clinics). The formal consensus technique was based on the RAND/UCLA
appropriateness method, a technique developed by the RAND corporation and clinicians at the University
of California, Los Angeles. It involved two stages:
Round 1: postal questionnaire
We developed a questionnaire which was divided into 16 sections. Each section summarised relevant
policy and guidance, published research literature, and our quantitative (where appropriate) and qualitative
findings. This was followed by a series of statements regarding potential ways that MDTs could be
modified on the basis of the information provided. Each statement was accompanied by a Likert scale
(1–9). Panellists received and returned this questionnaire via post.
Round 2: expert panel discussion and second-round ratings
The ratings from round 1 were used to develop a personalised version of the questionnaire for each panel
member. For each item, it showed the participant’s own round 1 response and the distribution of
responses for all panellists. We convened a consensus development meeting where panellists reviewed,
discussed and rerated the statements. The meeting was audiotaped and field notes were taken.
In analysing the round 2 ratings, we examined:
l the strength of agreement with each recommendation and
l the variation in extent of agreement among panellists.
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The final list of indications of good practice included those for which there was both strong agreement
and low variation in extent of agreement.
We transcribed the meeting in full and conducted a thematic analysis, coding the panellists’ comments to
identify the range of views about each item discussed and to examine possible explanations for differences
in ratings.
Results
The synthesis of the qualitative and quantitative findings from study 1 produced 68 potential
recommendations for improving the effectiveness of MDT meetings.
At the end of the consensus development process, there were 21 statements for which there was both
strong agreement (median ≥ 7) and low variation in the extent of agreement (MADM score of < 1.11)
among the expert panel. These indications for good practice related to the purpose of the meetings,
meeting processes, the content of the discussion and the role of the patient, as detailed below.
Indications of good practice: improving the effectiveness of multidisciplinary
team meetings for patients with chronic diseases
The purpose and functions of multidisciplinary team meetings
1. The primary objective of MDT meetings should be to agree treatment plans for patients. Other
functions are important but they should not take precedence.
2. MDT discussions should result in a documented treatment plan for each patient discussed.
3. MDT meeting objectives should include locally (as well as nationally) determined goals.
4. The objectives of MDT meetings should be explicitly agreed, reviewed and documented by each team.
5. Explaining the function of the MDT meeting should be a formal part of induction for new staff.
6. There should be a formal mechanism for discussing recruitment to trials in MDT meetings (e.g. having
clinical trials as an agenda item).
Multidisciplinary team meeting processes
7. All new patients should be discussed in an MDT meeting even if a clear protocol exists.
8. All chairpersons should be trained in chairing skills.
9. Teams should agree what information should be presented for patients brought for discussion in an
MDT meeting.
10. All new team members should be told what information they are expected to present on patients they
bring for discussion in an MDT meeting.
11. The objectives of the MDT meeting should be reviewed yearly.
12. Once a team has established a set of objectives for the meeting, the MDT should be audited against
these goals (e.g. every 2 years).
13. All action points should be recorded electronically.
14. Implementation of MDT decisions should be audited annually.
15. Where an MDT meeting decision is changed, the reason for changing this should always
be documented.
16. There should be a named implementer documented with each decision.
Content of discussion in multidisciplinary team meetings
17. Comorbidities should be routinely discussed at MDT meetings.
18. Patients’ past medical history should routinely be available at the MDT meeting.
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The role of the patient in multidisciplinary team meetings
19. The MDT should actively seek all possible treatment options, and discuss these with the patient after
the meeting.
20. Patients should be given verbal feedback about the outcome of the MDT meeting.
21. Where it would be potentially inappropriate to share the content of an MDT discussion with the
patient (e.g. where it may lead to unnecessary anxiety or disengagement from services), the decision
not to give feedback should be formally agreed and noted at the meeting by the team.
Panellists from all specialties agreed that these were desirable and feasible.
The panel as a whole was uncertain about 17 statements. However, every one of these was rated ‘agree’
or ‘disagree’ by at least one disease group. For example, whereas the need to be prescriptive about MDT
membership was supported for cancer MDTs, local flexibility was deemed appropriate for heart failure
MDTs. Similarly, mental health panellists considered it imperative for someone with personal knowledge of
a patient to be present when a patient is discussed by the MDT, but this was believed to be unnecessary in
cancer and heart failure MDT meetings.
There were 13 recommendations that the panellists disagreed with. Most disagreements centred on the
role of the patient in MDT decision-making. For example, panellists argued that it was unfeasible to always
obtain patients’ treatment preferences before discussing their case. They also pointed to practical and
cognitive barriers to asking patients before the MDT about how much they wished to be involved in
decision-making.
Conclusions
As the largest study of its kind, and the first to examine and compare MDT meetings for different chronic
diseases, this study enabled identification of factors associated with good outcomes that are generalisable
across health care. We found that 78% of treatment plans were implemented overall, though this varied
across teams from 65% to 94%. Greater multidisciplinarity was not necessarily associated with more
effective decision-making. Implementation was more likely in MDTs with clear goals and processes and a
good team climate. Finally, despite policy initiatives to reduce inequalities, we found that MDT decisions
were less likely to be implemented for patients living in more deprived areas.
The use of a diverse range of qualitative and quantitative data has allowed an unprecedented breadth and
depth of data to be explored. This allowed us, first, to identify key characteristics of chronic disease MDT
meetings that are associated with decision implementation, and, second, to identify 21 feasible and
desirable indications for good practice to improve the effectiveness of MDT meetings using a formal
consensus development technique involving key stakeholders.
No single team from the 12 teams that we observed in study 1 met all of the recommendations agreed on
by the expert panel. Our findings illustrate that there is scope for learning between specialties and the
potential to make a significant number of recommendations that are applicable in the varied contexts
within which MDTs operate. This is important because MDT meetings are resource-intensive, and their
value to the NHS and patients should be maximised.
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Summary of key findings
l We found that greater multidisciplinarity is not necessarily associated with more effective
decision-making (defined as MDT decision implementation). Rather it is mediated by having a clear
purpose, agreed processes and a team atmosphere that facilitates inclusion and improvement.
l Overall, 78% of MDT decisions across the 12 chronic disease MDTs studied were implemented.
l Community mental health teams implemented fewer decisions than did other teams (70%). Staff in
these teams reported a wide array of functions of MDT meetings in addition to decision-making;
however, some reported that meetings lacked clarity of purpose.
l Teams differed widely in relation to the format and structure of meetings, documentation and audit
procedures, the choice of patients for discussion, the content of discussions and the use of technology.
l Some teams were characterised by a strong medical dominance in terms of attendance and
participation. While these teams typically made and implemented high numbers of treatment plans,
those plans were less likely to have incorporated the full range of disciplinary and
professional perspectives.
l Patients from more deprived areas were less likely to have their treatment plans implemented and this
occurred despite the routine reference to treatment guidelines by cancer teams. Consideration of
patient preference, comorbidities or other health-related factors did not seem to explain this, and we
were unable to account for these findings.
l Stakeholders with expertise in cancer, mental health and heart failure agreed on 21 indications of good
practice, which were applicable to all the chronic diseases considered. They included indications
relating to the purpose of the meetings (e.g. that agreeing treatment plans should take precedence
over other objectives); meeting processes (e.g. that MDT decision implementation should be audited
annually); content of the discussion (e.g. that information on comorbidities and past medical history
should be routinely available); and the role of the patient (e.g. concerning the most appropriate time to
discuss treatment options). Panellists from all specialties agreed that these recommendations were both
desirable and feasible.
l No single team from the 12 teams that we observed in study 1 met all of the recommendations agreed
on by the expert panel. Our findings illustrate that there is scope for learning between specialties and
the potential to make a significant number of recommendations that are applicable in the varied
contexts within which MDTs operate.
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Chapter overview The structure of the report
This project consists of two studies. Study 1 examines the determinants of effective decision-making andareas of diversity across MDT meetings. Study 2 uses a consensus development method to develop a
list of indications of good practice for MDT meetings. In this report each of the studies is introduced,
presented and discussed in turn. Study 1 encompasses Chapters 1–5, study 2 is reported in Chapter 6,
and Chapter 7 brings together the findings from the two studies and highlights issues warranting
further investigation.
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Chapter 1 Study 1: examining the determinants of
multidisciplinary team meeting effectiveness and
identifying areas of diversity
Background
Multidisciplinary team (MDT) meetings are central to the management of chronic disease and they have
become widely established across the NHS1–4 and internationally.5 The proliferation of MDT meetings in
health care has occurred against a background of increasingly specialised medical practice, more complex
medical knowledge, continuing clinical uncertainty and the promotion of the patient’s role in their own
care. In this environment, it is believed that MDT meetings ensure higher quality decision-making and
improved outcomes,6–8 for example by providing a better assessment of treatment strategies and
safeguarding against errors.9
However, the evidence underpinning the establishment of MDT meetings is limited and mixed, and the
degree to which they have been absorbed into clinical practice varies widely across conditions and
settings.10–12 One recent trial found multidisciplinary care is associated with improved survival for patients
with breast cancer.13 However, another trial comparing multidisciplinary memory clinics with general
practitioner care found no evidence of improved effectiveness.14 Several recent systematic reviews of MDTs
working in cancer, mental health and other disciplines have concluded that there is insufficient evidence to
determine their effectiveness.15–17 In the light of this ambiguity, there have been calls for empirical research
on MDT meeting decision-making in routine practice to understand how and under what conditions MDT
meetings produce effective decisions.11
Team features and group processes
Research into the critical factors which have the greatest impact on team effectiveness has established
the importance of certain features including clear leadership,18,19 clearly defined goals with measurable
outcomes19 and team reflection.20,21 Some studies have found team ‘climate’, defined as shared
perceptions of policies, practices and procedures,22 to be associated with improved performance;23
however, others have found no association.24 Taylor and Ramirez25 surveyed cancer MDT members,
assessing the extent to which they agreed with an extensive list of statements regarding team features
potentially important for effective MDT working. They identified several domains that were considered
important, including the physical environment, meeting administration, leadership and professional
development. However, virtually all respondents agreed with the majority of the statements, making it
difficult to prioritise particular issues, and the narrow distribution of responses makes it uncertain whether
they are an accurate representation of views or the result of a design effect. Furthermore, their findings
may not be generalisable to non-cancer MDTs.
Team structure and group processes are also likely to influence the effectiveness of teamwork. Professional
boundaries and hierarchies have the potential to undermine the benefits of multidisciplinarity.21,26 Previous
research has demonstrated that team diversity can create communication barriers arising from differences
in knowledge, skills, ability, professional identity21 and status.27 The unidisciplinary nature of professional
education may hinder collaboration as professional groups struggle to assert the primacy of their own
theories of illness.28,29 A recent survey of community mental health teams (CMHTs) across 67 mental health
trusts found that CMHT members felt satisfied with multidisciplinary working, but that there were still
cases of ‘silo working’ and concerns about the ‘dilution’ of core professional skills.30
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Hierarchical differentiation and the inability of some MDT members to freely communicate may undermine
decision-making. A recent systematic review of cancer MDT meetings found that MDT decisions are
typically driven by doctors, with limited input from nurses. However, where there was active involvement
of nurses, this improved perceptions of team performance.17 Howard and Holmshaw31 found that a lack of
engagement in MDT discussions and a lack of ownership and follow-up of discussed plans hindered
effective teamworking.
Context
Context is the environment or setting in which the MDT meeting is located. This incorporates social,
economic, political and cultural influences.32 Organisational research has demonstrated the influence of
context on team behaviour and performance.33 However, a recent systematic review found that the
majority of studies investigating health-care team effectiveness have not addressed the impact of the
context in which teams operate.34 Health-care management research has drawn a distinction between the
outer (national, sectoral or health-care issue-based) and the inner (local) context, which includes both
‘hard’ features such as the degree of structural complexity and ‘soft’ features such as culture.35 Team
climate (described in the previous section, Team features and group processes) may be considered an
aspect of the local ‘soft’ context. Models of ‘receptive contexts for change’ have suggested that
improvement in health care is most likely to occur where relationships are good, learning, teamwork
and a patient focus are emphasised, and the larger system and environment are favourable.36
Comparative assessments of a range of MDT meetings are needed to explore how contexts vary and how
MDT meetings respond to both national and local influences. Although MDT working has been endorsed
at a high level for chronic disease management,2 each of the disease types under study in this report is
underpinned by different policies and guidance, which contain varying levels of detail.
Cancer multidisciplinary teams
Specialist multidisciplinary teams in cancer were initially introduced in response to the Calman–Hine Report
published in 1995.37 This was followed in 2000 by the NHS Cancer Plan,38 which documented the progress
made in establishing specialist teams for the most common cancers (breast, colorectal and lung) and
recommended the extension of MDTs for other cancer types. Specifically, the NHS Cancer Plan committed
to ensuring that all patients were reviewed by tumour-specific cancer MDTs from 2001.38 Additional
resources were made available, and there was significant commitment at both national and local levels to
support these reforms.
By the time the Cancer Reform Strategy was published in 2007, approximately 1500 cancer MDTs had
been established in England.39 The strategy confirmed that MDT working was to remain the core model
for cancer service delivery. This was reiterated when the coalition government published its national policy
document for cancer in 2011, which concluded that MDTs should remain the cornerstone of cancer care,
in recognition of support for the model from the National Institute for Health and Care Excellence (NICE)
and clinicians.40
In addition to these national policies, tumour-specific guidance has been published by NICE41 and the
National Cancer Action Team (NCAT).1,42,43 The NCAT guidelines set out measures relating to the
composition of teams, attendance at MDT meetings and the frequency of meetings, in addition to stating
which patients should be discussed and the need for documentation of MDT decisions. Since 2001, MDTs
have been audited annually to ensure they fulfil these requirements.10
Community mental health teams
In contrast, although MDTs are long established in mental health, their development has been much more
‘bottom up’, more locally varied44 and less well defined than in cancer. Multidisciplinary teams providing
mental health services for adults based outside hospitals began to emerge in the 1970s, bringing together
social workers from local authorities and NHS clinicians in ‘community mental health centres’.45 These were
criticised, however, for having a lack of clear service objectives, and for providing limited services.46
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The National Service Framework for Mental Health (NSF), published in 1999, provided significant funds to
reorganise and improve the quality of mental health services to address the wide geographical variations
in provision.47 However, there are still concerns that mental health services are underfunded.48 The NSF
promoted the use of more specialist teams, including Crisis Resolution and Home Treatment teams as well
as teams for those experiencing a first episode of psychosis (Early Intervention Services). Generic CMHTs
have retained an important role, however, continuing to care for the majority of mentally ill people in the
community and functioning as a key source of referrals to these more specialist teams.49
In contrast with the detailed tumour-specific guidance for cancer MDTs, there is little guidance on the
structure and processes that teams should follow for MDT meetings within community mental health.
Recommendations that do exist state that assessments and reviews of patients should be routinely
discussed by the whole team in a timetabled weekly meeting where actions are agreed and changes in
treatment are discussed, and that these weekly meetings should include the consultant psychiatrist.
There is also some guidance about the different professions that should be members of the team,
but the guidance explicitly avoids being ‘too prescriptive’ in order to allow local flexibility.49 Recently,
however, the Care Quality Commission has committed to developing definitions of ‘what good looks like’
in mental health and is currently developing an assessment framework of indicators to facilitate quality
inspections.50 It remains to be seen whether or not this will lead to more specific guidance on
multidisciplinary working.
Heart failure multidisciplinary teams
The detailed guidance for cancer MDTs is also in marked contrast to heart failure MDTs, where they
appear to have evolved in response to local needs. In 2003, NICE recommended that heart failure care
should be delivered by a multidisciplinary team.51 The August 2010 NICE update reiterated the pivotal role
of the multidisciplinary team in the continuing management of the heart failure patient.52 This specified
that patients should be referred to the specialist multidisciplinary heart failure team for initial diagnosis of
heart failure; management of severe heart failure; heart failure that does not respond to treatment; and
heart failure that can no longer be managed effectively in the home setting.
In addition to this national guidance, the NICE commissioning guide, Services for People with Chronic
Heart Failure,53 provided a number of best-practice service models for integrated care. It proposed that
regular MDT discussion of patients should involve review of people with chronic heart failure covering
outcomes, current care plans and possible improvements as well as potential discharge or onward
referrals.53 However, there is no further detail on processes or structures for heart failure MDT meetings.
Memory clinics
In 2001, the National Service Framework for Older People was published, which recommended that all
specialist mental health services for older people include memory clinics.54 Memory clinics specialise in the
diagnosis and treatment of people with memory impairment, delivered by a core multiprofessional team.55
However, existing evidence demonstrates that there are major variations in practice between teams.56
Guidance on formal team meetings to make diagnosis or treatment decisions is limited, with
recommendations on developing a service specification for memory clinics stating that only care providers
should draft a care plan for dementia patients ‘in consultation with other relevant disciplines’.57
Summary
This overview of the different national policies that underpin MDT working highlights the degree of
variation in the context within which different MDTs operate. While NHS policy for cancer, and to a more
limited extent in mental health, provides guidance on MDT meetings, in other specialties the format is
locally determined. It is unknown whether such flexibility is appropriate or undermines the productivity
of meetings.
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Patient-related factors
The impact of patient-related factors upon MDT meeting decisions also requires examination. Although
reducing health-care inequalities is a key aim of government policy,58 there remains evidence of
inequalities in health-care use according to socioeconomic circumstances, age, ethnic group and sex,
having adjusted for clinical need.59–61 In heart failure, some studies have found socioeconomic variations in
the use of services such as angiography and heart surgery.62–64 In mental health, there is mixed evidence of
an association between socioeconomic circumstances and contact with psychiatric services, with some
finding associations between socioeconomic variables, such as low income, low education and
unemployment, and contact with psychiatric services65 and other studies finding no such association.66–68
One of the main aims of the NHS Cancer Plan for England was to tackle inequalities in cancer survival for
people from deprived or less affluent backgrounds.38 Whereas some studies have reported no difference in
treatment by socioeconomic circumstances,69 others have demonstrated evidence of lower rates of surgical
treatment for patients in more deprived areas70,71 as well as differences in the use of chemotherapy72
and radiotherapy.73,74
If patients’ sociodemographic characteristics influence MDT effectiveness, then explanations such as the
influence of patient preferences and comorbidities should be sought. The involvement of patients in
decision-making is now widely advocated75 and guidelines state that patient preferences should be taken
into account when managing their care.40,50,76–78 The influence of patient-centred factors such as patient
preference and comorbidity on MDT decision-making has been shown to be partly dependent on variation
in the presence and participation of particular professional groups (e.g. specialist nurses).79,80 There is also
some evidence to suggest that MDT decisions that take account of patient preferences are more likely to
be implemented.81,82 There is, therefore, a need to explore how best to obtain and consider patient
preferences in MDT meeting decision-making.
Measuring effectiveness
There is debate in the literature concerning the most appropriate outcome for evaluating the effectiveness
of MDTs. Measures used include health-care use, patient and team member satisfaction, and well-being,
as well as various health outcomes. Each measure has limitations; for example, for patient satisfaction, it is
difficult for patients to separate satisfaction with a clinical intervention from the benefits of teamwork.8
The underlying rationale for MDT meetings is to produce higher-quality decisions that lead to improved
health outcomes. However, health improvement is affected by factors other than the quality of care.
These factors include subsequent onset of unrelated morbidity, change in patient’s personal circumstances,
extent to which patients adhere to treatment and efficiency of care provision.8,83 Furthermore, intended
health outcomes may not be evident for a year or more. Finally, many outcomes are specific to particular
illnesses, making it impractical to compare MDTs for different conditions. It is for these reasons that other
researchers have robustly defended the use of process measures over outcomes, provided that the process
measure clearly lies on the pathway to health improvement.84
However, the identification of an indicator of high-quality decisions is also difficult. While some decisions
can be compared with best practice guidelines, the latter rarely specify recommended courses of action
for every management decision made for a patient. Moreover, guidelines rarely consider how decisions
should be modified for patients with comorbidities or other factors (such as their social circumstances or
preferences) which will influence decision-making. Finally, guidelines are not available for all the conditions
considered in MDT meetings. We identified decision implementation as a useful process measure of
effectiveness because it lies on the pathway to health improvement and reflects effective team
decision-making that has taken account of relevant clinical and non-clinical information. For example,
MDT meeting decisions may not be implemented because of a lack of meaningful patient involvement,
failure to consider comorbidities, lack of agreement with the decision among those who have to
implement it, and incomplete clinical information available.85,86 Furthermore, decision implementation can
be measured and compared across MDTs for different conditions. Investigation of a diverse range of MDT
meetings may enable identification of factors associated with effective decision-making that are
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generalisable across health care. For these reasons, the measure of MDT meeting effectiveness used in this
research is decision implementation, and when the term ‘MDT meeting effectiveness’ is used in this report
it refers to decision implementation.
Given the widespread presence of MDTs, the opportunity costs for the NHS of unwarranted variations in
team membership and processes and the consequences for patients of inequitable care, we undertook a
prospective cohort study of chronic disease MDT meetings across the North Thames area (North London,
Essex and Hertfordshire).
Study 1 examined the effect of a range of team and patient features on decision implementation.
We collected quantitative and qualitative data, including clinical and sociodemographic data, through
non-participant observation of MDT meetings, review of patients’ medical records and interviews
with professionals and patients.
In study 2, we drew on these quantitative and qualitative findings and used formal consensus methods to
derive a series of generalisable recommendations for modifying the structure and process of MDT meetings
to improve the quality of decision-making.
Purpose of the research
Main research question
How can we improve the effectiveness of decision-making in MDT meetings for patients with
chronic diseases?
Aims
i. To identify the key characteristics of chronic disease MDT meetings that are associated with
decision implementation.
ii. To derive a set of feasible modifications to MDT meetings to improve effective MDT decision-making for
patients with chronic diseases.
Objectives
i. To undertake an observational study of chronic disease MDT meetings to identify factors which
influence their effectiveness in terms of decision implementation (study 1).
ii. To explore the influence of patient preferences and comorbidity on any socioeconomic variations in
implementation found (study 1).
iii. To explore areas of diversity in beliefs and practices across MDT meetings (study 1).
iv. To use the results from study 1 in an explicit structured formal consensus technique to derive a set of
feasible modifications to improve MDT meeting effectiveness (study 2).
Chapter summary
In this chapter we have outlined the background to the study and described the relevance to MDT team
effectiveness of the national and local contexts within which MDTs operate, of their distinctive features
and group processes, and of patient characteristics. We have discussed the complexity of measuring
effectiveness in this context, and outlined our rationale for investigating treatment plan implementation.
Finally, we outlined the aims and objectives of the study. In Chapters 2 and 3, we discuss the methods
through which these aims and objectives were addressed.
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Chapter 2 Study 1 methods
We undertook a prospective cohort mixed-methods (quantitative and qualitative) study of MDTmeetings in 12 adult chronic disease MDTs across North Thames between December 2010 and
December 2012. We examined one skin cancer, one gynaecological cancer, two haematological cancer,
two heart failure, two psychiatry of old age (memory clinic) and four community mental health MDTs
(including one early intervention service for psychosis).
Ethics and research governance permissions
This study was approved by East London Research Ethics Committee (10/H0704/68) and the National
Information Governance Board (NIGB) for Health and Social Care [Ethics and Confidentiality Committee
(ECC) 6-05 (h)/2010]. The NIGB ECC provided permission, under Section 251 of the NHS Act 2006,87 to
process patient identifiable information without consent. We gained permissions from the relevant
research and development (R&D) departments to collect data following submission of site-specific
information forms (using the Integrated Research Application System) at each of the NHS organisations
that participated in the study.
Recruitment of multidisciplinary teams
We aimed to include a diverse range of teams and chronic conditions to allow examination of key issues
about MDT decision-making and implementation. We sought to include teams which varied in terms of
health-care context, professional mix of team, conditions which affected patients from different parts of
the adult life range, and fatal versus lifelong conditions. When deciding which and how many chronic
diseases to include, we also had to take a pragmatic approach to ensure feasibility, because the data
collection phase involved extended periods of observation at multiple sites.
Teams which might have been interested in participating in the study were identified by our clinical
coapplicants. The principal investigator (PI) wrote to the lead clinician of each MDT inviting them to take
part. This was followed by a discussion with each MDT lead to clarify any issues or concerns.
Following this, the research team visited each MDT meeting to introduce the study. We provided
participant information sheets and obtained members’ signed consent to observe, record data from and
audiotape MDT meetings (see Appendix 1). Other professionals occasionally attend MDT meetings on an
‘ad hoc’ basis, so we also displayed a printed notice at the entrance to the meeting room during every
meeting we recorded. This explained the nature of the observation and provided the researcher’s contact
details. We made it clear that if individuals did not wish to take part in the study we would delete their
contributions from any transcripts. Nobody requested this.
We initially aimed to recruit 10 teams. This was based on estimates made by our clinical coapplicants of
the number of patients discussed in each specialty. In practice, we found considerable differences in
the number of patients discussed at each MDT (even within the same specialty), so we had to vary the
observation period in each team to maximise data collection in those teams which discussed fewer patients
(Table 1). In addition, one mental health team disbanded during the observation period. We therefore
asked one of our coapplicants (with a background in mental health) to identify other suitable mental
health MDTs. We subsequently recruited an additional two mental health teams (in order to increase our
capability of achieving the required sample size), taking the total number of teams in the study to 12.
Three field researchers observed a total of 394 meetings (including two meetings for each of the 12 teams
where the data collection tools were piloted) and collected quantitative and qualitative data from
370 meetings.
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We also planned to include semiurban and metropolitan teams but, in the event, only one MDT from
outside London accepted our invitation to participate.
Quantitative methods
We collected both quantitative and qualitative data. In the rest of this section (Quantitative methods) and
the next (Qualitative methods) we first describe how we collected and then analysed the quantitative data,
and then describe how we collected and analysed the qualitative data.
Quantitative data collection
Non-participant observation
Non-participant observation included collection of both quantitative and qualitative data. The quantitative
data collected are described here (see below under Qualitative methods for a description of the
qualitative data).
In collaboration with our clinical coapplicants and patient advisors we designed a standard proforma
to collect quantitative data on each patient discussed. This included information on patient features
(e.g. presenting problems, comorbidities, medical and social history) mentioned during the discussion.
The clinically active members of the research team identified the most important and common
comorbidities and other health behaviour risk factors which could have an impact on the MDT decision
and/or whether or not it was subsequently implemented. Examples of data collected are provided in Box 1.
The proforma also included a space for free text on additional clinical or social factors mentioned during
a discussion but not already included in the standard proforma. We also used this proforma to record
discussion features (e.g. whether or not patient preferences were mentioned, whether or not the presenter
was questioned), and decision features (e.g. decision, whether responsibility for implementing the decision
was given to a named individual or not, and whether the agreed decision was written down or verbally
summarised) (see Appendix 2).
TABLE 1 Summary of observation period and number of meetings observed
Team Observation period (months) Number of meetings observed
Gynaecological cancer 5 18
Haematological cancer 1 13 38
Haematological cancer 2 12 36
Skin cancer 11 31
Mental health 1 5 15
Mental health 2 8 20
Mental health 3 17 55
Mental health 4 8 23
Heart failure 1 13 42
Heart failure 2 9 24
Memory clinic 1 12 43
Memory clinic 2 9 25
Total 370
Pilots (two per team) 24
Total 394
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Patient preference included any preference indicated by a patient, even if it was not directly related to the
decision ultimately made, for example general mention of the fact that a patient was reluctant to
see doctors.
A decision was defined as a resolution about patient management, either with or without discussion
(e.g. a decision based on local protocols) between MDT members. This did not include:
l mention of a decision that had been made outside the MDT
l when team members provided feedback or updates regarding a case but no decisions were made
l when a patient was listed for discussion on an agenda but the discussion was deferred until the
following week because key information or people needed to make a decision were absent.
We completed the proforma during observation of each team’s weekly MDT meetings. We also
audiotaped each meeting and collected data on meeting attendance (number of attendees and their
professional category). Following the meeting, a researcher listened to the audio recording to double-check
that the information had been recorded accurately.
Follow-up of medical records
We reviewed patients’ medical records to ascertain sociodemographic information, whether or not their
MDT decisions had been implemented, and reasons for non-implementation where applicable (Table 2).
This involved accessing electronic patient records, paper records, or both, at the hospital or clinic where
the MDT meeting took place. On some occasions, files had been moved to other sites for storage. In these
instances, we either requested that the specific records be returned to the MDT site or we obtained
permission to review the records at the site where they were stored. We followed up each individual
decision observed, and we recorded all information directly into an IBM Statistical Product and Service
Solutions (SPSS) database, version 20 (IBM Corporation, Armonk, NY, USA).
These data were collected at least 3 months after each MDT decision was made. The Department of
Health national targets for cancer services state that MDT decisions should be implemented within 31 days
of patients receiving their diagnosis of cancer.58 For the other conditions studied, although there is no
national standard, MDTs commonly aim to have the investigations complete and the patients and carers
offered an appointment for discussion of diagnosis and plan 6 weeks after being seen. Hence, 3 months
after the MDT was deemed a reasonable time to check for MDT decision implementation, even allowing
for unavoidable delays in beginning treatment. For longer-term decisions, where it was explicit that a
decision would not be implemented within 3 months (e.g. follow up in 4 months), we followed up after
the requisite time period.
BOX 1 Examples of comorbidities and other factors which may have an impact on MDT decisions and their
implementation (coded as ‘health behaviours/other clinical factors’)
l Comorbidities including other chronic diseases, for instance anaemia, diabetes and transient conditions
(e.g. broken leg, bladder infection, flu).
l Medical history (e.g. history of breast cancer, history of substance misuse).
l Health behaviours (smoking, drinking, physical inactivity).
l Obesity.
l Terms that indicate comorbidity without being given a diagnostic name (e.g. back problems,
memory problems).
l Allergies, hypersensitivity to medication/side effects.
l Learning disabilities.
l Behavioural problems.
l Family history (e.g. BRCA gene).
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Examples of partially implemented decisions included ‘cancel existing appointment and write to patient
confirming no diagnosis of cancer’, where the records showed ‘wrote to patient but still saw in clinic to
discharge’, or ‘biopsy of left sided nodules’ where the records showed ‘biopsy attempted but had to be
abandoned after patient lost consciousness’. The research team met to review all cases that were recorded
as ‘partially implemented’ to ensure the category was used consistently across the data set.
Team Climate Inventory
During the final month of observation, core team members (as defined by the lead clinician or based
on a team list, where this existed) were invited to complete the Team Climate Inventory (TCI), which is a
44-item questionnaire. This validated measure88–90 assesses members’ perceptions of team processes in
four domains: team vision, participative safety (i.e. a facilitative atmosphere for involvement), task
orientation and support for innovation. Responses for each item on the TCI are given on a 5-point Likert
TABLE 2 Information gathered from medical records
Type of information Data collected
Patient details Information recorded
Date of birth
Ethnicity
Postcode (used to derive indicator of deprivation)
Recorded diagnosis
Decision details Response options
Decision implementation Implemented
Partially implemented
Not implemented
Not documented
Patient not identifiable
Records not available
Reasons for non-implementation recorded in notes Patient choice
Carer/family choice
Patient and family/carer choice
Comorbidity present but not mentioned at MDT meeting
Comorbidity deteriorated post MDT meeting
New comorbidity arose post MDT meeting
No reason recorded
Clinician notes decision not implemented
Patient died
Other
Patient did not attend
Change in circumstances
Condition not met
Was implementation rescheduled? Rescheduled by patient
Rescheduled by staff
Not applicable
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scale, with a rating of 1 indicating strong disagreement with the statement, and a rating of 5 indicating
strong agreement.91 Lower TCI scores reflect poorer perceptions of team climate.
Additional questions
In addition to the TCI items, we added two items to the TCI questionnaire. The first asked respondents to
rate their agreement with the statement ‘I believe that the [team name] MDT meetings are an effective use
of my time’ on a scale of 1 to 5. The second was an open question: ‘Is there anything you would change
about these meetings?’
Planned sample size
We calculated the sample size using the conservative assumption (based on published research and clinical
experience) that 18% of decisions would not be implemented.92 Using Peduzzi’s rule of 10, we required
80 non-implemented decisions to estimate eight coefficients in our regression model; this would require
approximately 440 patients.93 To allow for clustering by MDT, the sample size was inflated using estimates
of the intracluster correlation coefficient (ICC) and the average cluster size.94 Directly relevant estimates for
the ICC were not available, but published models associating the ICC and outcome prevalence for a range
of outcomes in community and health services settings suggested an ICC of between 0.01 and 0.05.95
Thus, we assumed an ICC of 0.025 and that across MDTs the average number of patients with relevant
decisions during the study would be approximately 230. Based on this information we aimed to include
3000 patients with a decision from the 12 MDTs.
The sample size calculation, based on decision implementation, assumed one decision for each patient.
Some patients had more than one decision per meeting. We grouped these decisions into a ‘treatment
plan’. This is described below under Summary measures.
Summary measures
The data were categorised for analysis using the following summary measures.
Treatment plan
We limited our analyses to the first presentation of each patient at an MDT meeting within our observation
period. Discussion of a patient often resulted in more than one decision being made which cannot be
assumed to be independent. We therefore grouped decisions into a ‘treatment plan’. This is consistent
with cancer guidance, which refers to treatment plans rather than individual decisions.42
In the majority of cases (88%) implementation of the treatment plan was consistent, that is either all or no
component decisions of treatment plans were implemented. In cases where some decisions in the plan
were implemented and others were not, we classified a treatment plan as implemented if more than 50%
of the component decisions were implemented. This definition was agreed to be reasonable by our study
team but was investigated further in sensitivity analyses (see Appendix 3).
Team Climate Inventory
The overall team TCI score was obtained by averaging the scores of team members. Team members with
missing responses for more than 25% of items in one of the four dimensions of the TCI were excluded.
There is no advice given about an acceptable team completion rate for the TCI. Previous studies using the
TCI have ranged from including teams where at least 30% of members responded96 to including any
teams where at least two members responded.97 For this study we included all team responses in the
main analysis.
We averaged the scores of team members in response to the statement ‘I believe that the [team name]
MDT meetings are an effective use of my time’ and summarised responses to the additional open question
about things they would change for use in the qualitative analysis.
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Skill mix (Adjusted Teachman’s Index and number of professional categories)
There is no consensus on the best measure of skill mix or team diversity.98 We therefore considered both
the number of professional categories represented and the more complex Adjusted Teachman’s Index
(ATI). This index captures both the number of professional categories represented and the evenness of
representation within each of these categories. A higher value reflects a more even spread across a greater
number of categories.98 By including both measures we could assess whether or not the more complex
index added any predictive value over a count of professional categories. These were classified as
diagnostic doctor, surgeon, doctor, MDT co-ordinator, nurse, researcher, social worker, allied health
professional and psychologist (Table 3). Both core and occasional members were included. Observers such
as students were excluded.
Index of Multiple Deprivation
We used the Index of Multiple Deprivation (IMD) 2010 as an indicator of patient’s socioeconomic
circumstances.99 This index is a widely used area-based measure that combines seven domains into a single
deprivation score for each small geographical area (i.e. each ‘lower layer super output area’, which covers
about 1500 people) in England. The domains comprise income; employment; health and disability;
education; skills and training; barriers to housing and services; and crime and living environment.99
We grouped IMD scores into quintiles, where quintile 1 encompassed the least deprived and quintile 5
the most deprived areas. The postcode address of patients was linked to the lower layer super output area
and hence to the corresponding deprivation quintile.
Health behaviours/other clinical factors
We combined data on comorbidities (physical and mental health), health behaviour risk factors, medical
history and family history into a binary variable which we referred to as ‘health behaviours/other clinical
factors’ (see Box 1).
Primary statistical analysis
Data were collected on all patients discussed, although only those about whom at least one decision was
made were included in the primary quantitative analysis, which aimed to identify factors predicting
MDT decision implementation. The factors we investigated were patient characteristics (age, sex and
socioeconomic circumstances) and MDT and decision characteristics (team climate, disease type, skill mix,
discussion of patient preferences and health behaviours/other clinical factors).
TABLE 3 Inclusion criteria for professional categories
Professional category Inclusion criteria
Allied health professional Includes occupational therapists, support workers and Age Concern representatives
Diagnostic doctor Includes radiologists, pathologists, consultants in nuclear medicine, clinical scientists
MDT co-ordinator Includes individuals whose role focuses on facilitating the smooth running of the
meeting (MDT co-ordinator may not be their official job title). They may have limited
clinical input, prepare notes for patients discussed and take minutes
Nurse Includes clinical nurse specialists, community psychiatric nurses, palliative care nurses
and visiting crisis team nurses
Doctor Includes junior doctors, consultants and staff grade doctors (medical students were excluded)
Psychologist Includes assistant psychologists and clinical psychologists
Social worker Includes junior and senior social workers
Surgeon Includes subspecialist trainees, specialist registrars and consultants
Researcher Includes clinical research fellows, research nurses, clinical trials practitioners and clinical
trials co-ordinators
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For the primary analysis, the implementation response categories were collapsed into a predefined binary
outcome where partially implemented was combined with implemented. We also combined decisions
where implementation was not documented with those decisions which were not implemented. This was
because, on the basis of our clinical experience, non-implementation is commonly not explicitly recorded in
patients’ records.
The influence of MDT and patient-related factors on treatment plan implementation was investigated
using random-effects logistic regression models, allowing for clustering by MDT. We fitted unadjusted
models for each factor of interest. We then undertook the following predefined selection process to obtain
a final adjusted model. Initially we fitted two separate models. Model 1 included patient characteristics
(age, sex and IMD quintile) and model 2 considered MDT and decision related characteristics (TCI score,
disease type, ATI score, number of professional groups, mention of patient preferences and health
behaviours/other clinical factors). Factors identified as having potential importance from these models
(p< 0.3)100 were then fitted in the final model (model 3).
The suitability of models was investigated, including considering normality of the random effect, goodness
of fit (using a Hosmer–Lemeshow test) and evidence of overfitting (using bootstrapping).100 We examined
the pattern and extent of missing data and considered its potential impact on our results. We also carried
out a set of sensitivity analyses to investigate some assumptions made in our main analysis. We refitted
model 3 including adjustment for the number of decisions making up the first treatment plan. The impact
of using the first recorded treatment plan in analysis was examined by refitting the model based on a
randomly chosen treatment plan for each patient. We also refitted model 3 collapsing the five IMD
quintiles into two groups (IMD 1–3 and IMD 4–5) in order to produce an eight-coefficient model
(as specified in our sample size calculation).
We undertook exploratory investigations to further understand the associations observed in our model and
whether these differed by disease type. We extended model 3 to examine interaction terms between the
number of professional groups and disease type, and between IMD and guideline-driven cancer compared
with non-cancer MDTs.
Quality assurance: clinician validation
The field researchers were not clinicians, but there were several quality assurance procedures in place to
safeguard against this potential limitation. Clinical members of the research team (the PI and several of the
study coapplicants) were involved throughout data collection and analysis, and were available to respond
to any specific queries the field workers had throughout the project (e.g. relating to specialist terminology).
In addition, the clinical members of the research team ensured accurate recording of the primary outcome,
decision implementation. During the follow-up period, a clinician from each specialty (SG for heart failure,
AL for cancer and GL for dementia and mental health) reviewed a random selection of approximately
20 treatment plans from each of the specialities, and examined the medical records to independently
ascertain whether or not the decision had been implemented. Any discrepancies between the outcome
recorded by the field researcher and the clinician were discussed with the wider research team.
Discrepancies were rare and the process gave us confidence in the accuracy of data collection. We also
sought advice from the clinical coapplicants on any other clinical queries that had arisen throughout the
medical record follow-up.
Qualitative methods
The qualitative aspect of the study served two purposes: firstly, to provide insights into possible
explanations for the quantitative findings, and, secondly, to identify areas where there were diverse beliefs
or practices with respect to MDT meetings.
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To achieve this we collected qualitative data using three data collection methods:
l non-participant observation of MDT meetings
l interviews with MDT members
l interviews with patients.
The steps taken to collect and analyse the qualitative data are described below.
Non-participant observation
In addition to the quantitative data collected during non-participant observation of MDT meetings, we also
developed a qualitative observation coding sheet to obtain a detailed understanding of the meeting
context and processes.
Developing the qualitative observation coding sheet
The observation coding sheet (see Appendix 4) was based on an adaptation of an inputs–process–outcome
model.33,34,101,102 It included sections on the meeting environment, mention of national or local policies,
features of the team and task, levels of participation, and mediators of team processes and outcomes.
This provided a framework to map out the potential factors influencing implementation of MDT decisions.
Data collection
Although we attended a total of 394 meetings, the purpose of the first two meetings we attended at each
team was to test the data collection instruments and to enable the team to get used to the presence of
the researcher. We took observational field notes at 370 MDT meetings. These notes focused on
significant events and interactions observed by the researcher. Within 24 hours of each meeting, the
researcher categorised these field notes according to the observation-coding sheet. The researcher also
listened to the audio recording of each meeting, adding further notes and noting the timing of key events
on the recording for future reference.
Interviews
We conducted semistructured interviews with MDT professionals and with patients to gain an
understanding of MDT meetings from different perspectives.
Developing the interview topic guides
Draft topic guides for the MDT professional and patient interviews were developed based on reviews of
the literature and the research aims. These were revised based on emerging issues identified during
non-participant observation and suggestions from the study steering group.
The MDT professional interview topic guide included open-ended prompts about the purpose of the
MDT, areas of diverse beliefs or practices, and what participants saw as their role in the meeting
(see Appendix 5). This was piloted with a clinical coapplicant and amended on the basis of their feedback.
The patient topic guide covered issues such as whether or not patients were aware of the MDT meeting
and what issues they believed should be considered when the MDT was making decisions about their care.
This topic guide was piloted with two patient representatives and amended on the basis of their comments
(see Appendix 6).
Recruitment of multidisciplinary team professionals
We purposively selected interviewees to ensure diversity in terms of professional group, seniority and level
of participation in MDT meetings (based on the observation data).
Interviewees were approached after observation for each team was completed. This was done either in
person or by e-mail, and individuals were provided with an information sheet and consent form. While we
STUDY 1 METHODS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
16
suggested that the interview would take approximately 1 hour, some clinicians requested shorter
interviews (e.g. 30 minutes) to fit in with their schedules.
The interviews were all conducted at the place of work of the participants and were audiotaped.
Researchers wrote reflective field notes following each interview, including comments on setting, the main
issues discussed and new perspectives on the research questions prompted by the interview.
Recruitment of patients
We aimed to interview patients or carers across all four disease types and to maximise diversity in terms
of sex, age and ethnicity. Patients were recruited from the MDTs under observation. The inclusion and
exclusion criteria for these are detailed in Box 2. To increase the likelihood that interviewees would still be
under the care of the team, the 30 patients who had been most recently discussed by each team at the
end of the observation period were selected. From this group, we gave the relevant lead clinician or team
manager a list of the patients we sought to invite for interview. We asked clinicians to highlight any cases
where they thought the interview would present a risk to the patient or to the interviewer. These patients
were not approached for interview.
The relevant key worker was then asked to contact the selected patients, provide them with a study
information sheet and consent form, and seek permission for the researchers to contact patients directly
to discuss the study further. Patients who agreed to be contacted were telephoned by a member of
the research team to confirm participation, address any questions they had and arrange the interview.
Interviews took place in either the hospital/clinic or the patient’s home and were audiotaped. As with the
professional interviews, researchers wrote reflective field notes directly after each interview.
Qualitative analysis
We devised a strategy for qualitative data analysis to enable us to manage the large volume of data
generated. The analysis was an iterative process, using a combination of both inductive and deductive
coding and ethnographic methods such as constant comparison and coding frame revisions. Analytic
conferences of the field researchers and the wider research team were used to scrutinise and revise codes
and themes and to encourage reflexivity.
BOX 2 Inclusion and exclusion criteria for recruiting patients to interview
Summary of inclusion criteria
Diversity of age, sex and ethnicity.
Under the care of the team.
Summary of exclusion criteria
Non-English speaker.
Clinician deems a risk to interviewer.
Clinician deems too vulnerable for interview.
Not living in England.
Declines to be interviewed.
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Analysis of non-participant observation data
This was undertaken in two stages, as described below:
Stage one: initial coding and selective transcription
Verbatim transcription of MDT meetings was not practical given the large number of participants at some
meetings, overlapping talk and variable audio quality depending on the layout of the meeting rooms.
Instead, we used selective transcription to document relevant parts of the meetings.103
In the first instance we inductively coded the observation coding sheets (i.e. our field notes) for the first
16 meetings (excluding the initial 2-week ‘test’ period for each team) of each of the teams observed
(with the exception of one team, which disbanded after 15 weeks of observation). We used NVivo 9 (QSR
International, Warrington, UK) to organise the data. Each observation was labelled with a basic descriptive
code, and recurring and salient issues were compiled into an initial coding framework. Exceptions were
noted within the relevant codes and some codes were relevant to only specific teams or specialties.
This coding framework was then used to identify and selectively transcribe at least two discussions
illustrating each code. This ‘data reduction’ technique allowed us to manage the huge volume of data
collected, while still reviewing the excerpts in the context in which they occurred by listening to the
audio recordings.
These selective transcripts were imported into the NVivo database alongside the observation coding sheets
and were read, reread and further coded using the initial coding framework. Thus, codes included data
from both observation notes and transcripts. The coding framework was revised iteratively and additional
codes were added where new issues that were relevant to the research questions arose. Code definitions
were discussed by the team and revisited regularly throughout the analysis to ensure they were being
applied consistently. The list of observation code definitions is provided in Appendix 7. This pool of codes
was drawn upon throughout the analysis, as appropriate to the question at hand. For example, for the
qualitative investigation of the primary quantitative findings, relevant codes were grouped as shown
in Appendix 8.
Stage two: analytic conferences
Conducting qualitative research as a team is recognised to have a number of potential benefits, such as
increasing rigour by providing an opportunity to challenge and clarify conflicting understandings and
encouraging a richer conceptual analysis.104 We drew upon the expertise and experience of project team
members to devise a strategy for the analysis of the qualitative data that would be both reflexive and
rigorous. This involved using analytic conferences to discuss the analysis and interpretation of the findings.
Analytic conferences were attended by the researchers who conducted the observation and senior
members of the team with clinical and research experience. For each of the 12 MDTs, the researcher
who completed stage one of the observation analysis provided each member of the analytic team
(CN, IW, PX, AL, AC) with an audio recording of a different meeting from the same team. Each team member
listened to their allocated audio recording, making notes of potential codes, exemplary quotes and deviant
cases. Following this, the team met to discuss and review the appropriateness of the codes allocated.
Once this process had been completed for half the teams, an analytic conference was dedicated to refining
and integrating the codes across the data set, merging synonymous codes and splitting compound codes
to form a coherent framework. Analytic conferences were also held for the remaining six teams to monitor
the consistent application of the framework.
Analysis of interviews
All interviews were transcribed verbatim and analysed thematically using NVivo 9. Transcripts were
anonymised and identifying details (such as names and specific job titles) were removed where necessary
to preserve anonymity.
STUDY 1 METHODS
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The initial analysis of professional interviews was conducted independently of the patient interviews.
In order to manage the large volume of data, and to build on our observation analysis (as described
above), we adopted a hybrid inductive and deductive approach to analysing the interview data.
The deductive themes were based on our research objectives and our preliminary qualitative analysis of the
observation data. These are listed in Box 3. We applied these in the first instance to collate the data
relevant to each theme. We then inductively analysed the data to generate subthemes. This allowed us to
explore relevant issues identified in the data more fully. Tables 4 and 5 provide illustrative examples of
these levels of analysis for the professional and patient interview analyses respectively.
TABLE 4 Professional interview analysis: example of deductive theme, inductive subthemes and codes
Deductive theme Inductive subthemes Codes
Added value of MDT in
relation to decision-making
Improving decision-making Consistency of decision-making (acting as a ‘check’)
Having access to all the information to inform decision-making
Context within which
MDT decision-making
is most helpful
When the ‘right’ people attend
When there is good leadership/management
When people make meaningful, significant contributions
Difference as strength Sharing professional knowledge and expertise
Providing a different perspective
Reproduced from Determinants of treatment plan implementation in multidisciplinary team meetings for patients with
chronic diseases: a mixed-methods study, Raine R, Xanthopoulou P, Wallace I, Nic a’ Bháird C, Lanceley A, Clarke A, et al.
[Published online ahead of print June 9 2014], 2014, with permission from BMJ Publishing Group Ltd.105
BOX 3 Deductive themes for the MDT professional and patient interview analyses
MDT professional interviews: deductive themes
Added value of the MDT meeting, in relation to (1) decision-making, (2) other formal and informal functions of
the MDT meeting.
Areas for improvement/weaknesses/problems of the MDT meeting, in relation to (1) decision-making, (2) other
formal and informal functions of the MDT meeting.
Patient preferences and decision-making.
Comorbidities and decision-making.
MDT patient interviews: deductive themes
Patient preferences.
What should and should not be considered when making a decision in the MDT meeting.
Most appropriate methods for implementing patient preference.
Feedback (what kind of feedback patients received and would want in the future).
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Analytic integration and triangulation across data sources
The term ‘triangulation’ has been ascribed several meanings. Two of the most common uses are the
corroboration approach (assessing whether or not accounts derived from different data sets are consistent)
and complementarity approach (using different methods to assess different aspects of the same issue to
gain a more complete picture).106,107 We adopted a complementarity approach106 using multiple methods
to gain a more comprehensive, multidimensional understanding of a complex issue.107 We integrated our
three qualitative data sources with two specific objectives in mind: firstly, to provide insights into possible
explanations for the results from the quantitative analysis, and, secondly, to identify areas of diverse beliefs
or practices in MDT meetings.
1. To provide insights into possible explanations for the quantitative findings
This analysis drew upon each of the different methods (non-participant observation and semistructured
interviews) to explore possible explanations for variation in treatment plan implementation.
We undertook a deductive analysis of both the observation and interview data, where each finding
from the logistic regression formed the basis of a deductive theme (see Appendix 8 for an illustration of
how the observation codes were grouped according to the quantitative variables examined). We drew
on the entire pool of inductive codes, grouping them according to their relevance to each deductive
theme, as illustrated by Table 6. This allowed us to identify the relevant transcripts and field notes to
illuminate possible reasons for each finding. Additional analytic conferences were held to facilitate
these analyses.
2. To identify areas of diverse beliefs or practices in MDT meetings
In order to identify themes for study 2, we distinguished issues around which there were differences in
beliefs or practices, either within or across teams. This was achieved by synthesising findings from the
three qualitative data sources to produce overarching ‘metathemes’ relating to these differences and
issues of contention.
TABLE 5 Patient interview analysis: example of deductive theme, inductive subthemes and codes
Deductive theme Inductive subthemes Codes
What feedback do patients want? Content of feedback Symptoms/test results
Options
Decisions
Other
Life expectancy
Impact on life: side effects
Feedback format No paperwork/a phone call
No feedback wanted Feedback would not change anything
Best for others to decide
Too much information can be confusing
Might not be able to understand
Need for basic information in order to recover
Control over feedback Asking for information that you want to know
Feedback dependent on the person/situation
Feedback wanted Full feedback of all the options
Information about the MDT discussion
STUDY 1 METHODS
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Throughout the analysis, we drew on the ‘following a thread’ technique108 where key themes and
topics identified in the initial analyses of each data source were further explored in the other data sets.
Since we gathered the observational data before the interview data were collected, we were able to
follow up ‘promising’ findings when analysing the other data sets, as well as in the questions we asked
interviewees. This allowed us to collect richer interview data on ‘promising’ codes than would have
been possible by integrating the findings in the analytic stages alone.
Once we had undertaken preliminary analyses of the three qualitative data sources, we convened an
analytic synthesis meeting attended by the chief investigator (RR), the three field researchers (CN, IW, PX),
two senior clinical members of the research team (AL, AC) and two patient representatives (DA, MH).
At this meeting, we reviewed the outputs from each of the preliminary analyses (observational codes,
professional interview themes and patient interview themes) and, taking the comprehensive data set as a
whole, we identified all the issues around which there were different opinions or practices (which we
called metathemes, e.g. differing opinions about the role of the patient and differing chairing practices).
We then collated the relevant themes, codes and quotes from all sources related to each of these issues.
Quality assurance
Non-participant observation
Observation notes and selective transcripts of the meeting discussions were coded and analysed in a
constant comparative manner, with repeated inspection of each data source between three researchers,
and at regular analytic conferences with other members of the research team. We used multiple coding to
address the issues of subjectivity sometimes levelled at the process of qualitative data analysis.109 As new
codes were introduced, they were assigned a working definition to ensure they were used consistently
by the different researchers. These definitions were debated and revised repeatedly throughout the
process. The analytic conferences allowed the researchers to check whether or not codes were being
applied according to the definition, and that definitions were iteratively revised where appropriate. The
analytic conferences also facilitated group reflexivity and safeguarded against individual bias by providing
opportunities to make each researcher’s assumptions explicit and open to challenge.110 Together with
regular meetings between the field researchers, the chief investigator and other members of the team,
these formed a kind of auditing that was ‘built into the research process to repeat and affirm
researchers’ observations’.111
Professional and patient interviews
In order to establish consistency of coding for the interview data, two researchers initially independently
coded 20% of the transcripts. Following this, the researchers met to discuss any incongruence, going
through each transcript line by line to check for differences in terms of both sections coded and the
specific code applied in each case. Differences were resolved by discussing the differing interpretations,
TABLE 6 Example of deductive and inductive codes used to explore quantitative findings
Quantitative finding
(deductive theme)
Examples of relevant
observation codes
(inductive codes)
Examples of relevant
interview codes
(inductive codes) Example quote
No evidence of a relationship
between treatment plan
implementation and
discussion of health
behaviours/other
clinical factors
Comorbidities Comorbidities inconsistently
considered
‘I think we discuss it
[comorbidities] when it’s
important . . . yes we do
bring in physical problems
as well which we need to
if necessary’ (memory clinic
allied health professional,
interview)
Holistic discussion
of patients
Not enough consideration
given to comorbidities
Dominance of
clinical information
Comorbidities not known
because of poor assessment
Missing information Too much detail
on comorbidities
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identifying any misunderstandings and refining code definitions as necessary. A third researcher was
present to give an independent perspective if the two coders failed to reach agreement.
Steering group meetings
Throughout the study, we convened four steering group meetings (between July 2011 and March 2013),
which provided a mechanism for peer review and guidance (see Appendix 9 for collaborators and steering
group members).
In these meetings, as well as providing general support and advice (e.g. with recruitment), the steering
group members discussed methodological issues, reviewed the definitions of variables and outcomes and
the interview topic guides, and helped to develop data-auditing strategies, hence providing further
quality assurance.
Patient and public involvement
We had two active patient and public involvement (PPI) representatives on our project steering group
(MH and DA, coauthors on this report), who were actively involved throughout. They attended steering
group meetings and provided in-depth and valuable contributions to our study design and analysis. In
particular, they reviewed and amended the information sheets for the patient interviews, to ensure these
were clear and informative. They also collaborated in the design of the patient interview topic guide and
helped to organise pilot interviews to test and refine them. In addition, they reviewed the anonymised
patient interview transcripts and participated fully in the analytic conference where these were discussed.
The collaboration of patient representatives in this research was integral to both its design and delivery.
We found that having continuous rather than sporadic PPI engagement was invaluable, because their
in-depth knowledge of the background and progress of the study meant that they could respond quickly
when their patient perspective on particular aspects of the study was needed.
Chapter summary
We began this chapter by outlining the ethics and recruitment procedures undertaken. We then described
the data collection and analysis methods for the quantitative components (i.e. non-participant observation
of meetings and medical record review) and the qualitative components (i.e. non-participant observation of
meetings, interviews with patients and professionals) of the research. Finally we explained how we
integrated these data to address the study aims. Chapters 3 and 4 present the quantitative and
qualitative results.
STUDY 1 METHODS
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Chapter 3 Study 1 quantitative results
A shorter version of the results presented in Chapters 3 and 4 has been published in Raine et al.105
Team characteristics
We observed 370 MDT meetings during which 3184 patients were discussed. Characteristics of the
12 teams and their meetings are summarised in Table 7. There was considerable variability among the
12 teams in the number of patients discussed at each meeting. The average for each team ranged from
4 to 49 patients. The average meeting size across the 12 MDTs ranged between 5 and 28 members, with
one to seven professional groups represented (an overall median of four). Of the patients discussed, 83%
had a least one treatment plan made, but this proportion was notably lower for the mental health teams.
Team Climate Inventory and additional questions
Of the 211 TCIs issued, 161 were returned, giving a response rate of 76%, ranging from 50%
(mental health team that disbanded) to 100% (skin cancer).
Across all teams, 155 members responded to the additional question, with almost all agreeing to a great
or very great extent with the statement, ‘I believe that the [team name] MDT meetings are an effective use
of my time’ (Figure 1).
Treatment plan implementation
Overall, 2654 patients had a treatment plan. The number of decisions making up the plan ranged between
1 and 11 (Figure 2) with an average of 1.6 decisions per plan.
Of the patients with treatment plans, 2512 (94.6%) had adequate implementation data recorded for
implementation status to be classified, and 1967 (78.3%) of these had implemented plans. Treatment
plan implementation is summarised by patient, MDT and discussion characteristics in Table 8. By disease
type, implementation was highest in the gynaecological cancer team and lowest in the CMHTs, although
implementation also varied by team. There was a trend for non-implementation with increasing
patient deprivation.
Adjusted associations (Table 9) showed no evidence of a relationship between treatment plan
implementation and patient’s age or sex, or with discussion of patient preferences or health behaviours/
other clinical factors. ATI and number of professional groups were highly correlated (correlation coefficient
0.8) but did not appear to have an association when fitted together (model 2). When included individually
in the model, however, each showed a relationship such that an increase in team diversity or number of
professional groups was associated with a reduced odds of treatment plan implementation.
Factors with an association (p< 0.3) in models 1 and 2 were fitted together in the final model (model 3).
The adjusted odds of implementation increased by 7% (95% CI 1% to 13%) for a 0.1-unit TCI score
increase (indicating improved team climate). In contrast, the adjusted odds of implementation were
reduced by 25% for each additional professional group represented, and were lower for patients living in
more deprived IMD quintiles. Adjusted odds of implementation also varied by disease type.
DOI: 10.3310/hsdr02370 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 37
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Raine et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
23
TA
B
LE
7
Te
am
an
d
m
ee
ti
n
g
ch
ar
ac
te
ri
st
ic
s
M
D
T
ch
ar
ac
te
ri
st
ic
s
H
ae
m
at
o
lo
g
ic
al
ca
n
ce
r
G
yn
ae
co
lo
g
ic
al
ca
n
ce
r
Sk
in
ca
n
ce
r
M
em
o
ry
cl
in
ic
M
en
ta
l
h
ea
lt
h
H
ea
rt
fa
ilu
re
Te
am
1
Te
am
2
Te
am
1
Te
am
2
Te
am
1
Te
am
2
Te
am
3
Te
am
4
Te
am
1
Te
am
2
TC
Is
co
re
4.
32
3.
79
3.
49
4.
11
4.
10
3.
89
4.
01
3.
31
3.
64
4.
01
4.
00
3.
75
N
u
m
b
er
o
f
m
ee
ti
n
g
s
38
36
18
31
43
25
15
20
55
23
42
24
N
um
be
r
of
pa
tie
nt
s
di
sc
us
se
d
pe
r
m
ee
tin
g:
m
ea
n
(S
D
)
14
.5
(4
.1
)
14
.2
(4
.8
)
34
.5
(5
.0
)
21
.7
(5
.6
)
11
.2
(5
.4
)
4.
3
(1
.3
)
29
.1
(1
1.
5)
14
.6
(4
.4
)
14
.0
(4
.9
)
49
.3
(1
2.
1)
8.
0
(2
.3
)
6.
0
(2
.2
)
A
TI
:
m
ea
n
(S
D
)
1.
38
(0
.1
4)
1.
29
(0
.1
0)
1.
70
(0
.1
2)
1.
52
(0
.1
2)
1.
75
(0
.1
4)
0.
86
(0
.3
3)
1.
26
(0
.1
7)
1.
34
(0
.1
4)
1.
34
(0
.1
3)
1.
47
(0
.0
8)
1.
36
(0
.1
3)
0.
89
(0
.1
4)
N
um
be
r
of
pr
of
es
si
on
al
ca
te
go
rie
s
re
pr
es
en
te
d:
m
ed
ia
n
(2
5t
h
–
75
th
pe
rc
en
til
e)
5
(4
–
5)
5
(5
–
5)
6
(6
–
6)
6
(5
–
6)
5
(5
–
6)
3
(2
–
3)
3
(3
–
4)
4
(3
–
4)
4
(3
–
4)
4
(4
–
4)
4
(4
–
5)
2
(2
–
2)
N
um
be
r
of
M
D
T
m
em
be
rs
at
th
e
m
ee
tin
g:
a
m
ea
n
(S
D
)
11
.7
9
(1
.6
5)
28
.2
5
(4
.4
3)
18
.2
8
(2
.8
9)
17
.4
8
(2
.6
6)
9.
23
(1
.6
0)
6.
92
(1
.7
5)
7.
73
(2
.6
0)
8.
35
(2
.1
3)
9.
09
(2
.2
1)
9.
70
(1
.9
4)
15
.0
2
(2
.9
6)
5.
38
(1
.5
8)
N
u
m
b
er
o
f
p
at
ie
n
ts
d
is
cu
ss
ed
d
u
ri
n
g
o
b
se
rv
at
io
n
p
er
io
d
(a
t
le
as
t
o
n
ce
)
39
0
37
1
32
4
38
4
40
3
10
6
23
1
13
4
31
4
16
9
22
5
13
3
Pa
tie
nt
s
w
ith
at
le
as
t
on
e
tr
ea
tm
en
t
pl
an
:
nu
m
be
r
(%
)
33
0
(8
5)
32
1
(8
7)
28
1
(8
7)
33
5
(8
7)
35
6
(8
8)
10
6
(1
00
)
14
5
(6
3)
71 (5
3)
25
1
(8
0)
13
1
(7
6)
19
7
(8
8)
13
0
(9
8)
a
C
or
e
te
am
m
em
be
rs
.
Re
pr
od
uc
ed
fr
om
D
et
er
m
in
an
ts
of
tr
ea
tm
en
t
pl
an
im
pl
em
en
ta
tio
n
in
m
ul
tid
is
ci
pl
in
ar
y
te
am
m
ee
tin
gs
fo
r
pa
tie
nt
s
w
ith
ch
ro
ni
c
di
se
as
es
:
a
m
ix
ed
-m
et
ho
ds
st
ud
y,
Ra
in
e
R,
X
an
th
op
ou
lo
u
P,
W
al
la
ce
I,
N
ic
a’
Bh
ái
rd
C
,
La
nc
el
ey
A
,
C
la
rk
e
A
,
et
al
.
[P
ub
lis
he
d
on
lin
e
ah
ea
d
of
pr
in
t
Ju
ne
9
20
14
],
20
14
,
w
ith
pe
rm
is
si
on
fr
om
BM
J
Pu
bl
is
hi
ng
G
ro
up
Lt
d.
1
0
5
STUDY 1 QUANTITATIVE RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
24
70
60
50
40
30
20
10
0
N
u
m
b
er
 o
f 
re
sp
o
n
se
s
1
To a very little extent To a little extent To some extent To a great extent To a very great extent
2
27
61
64
Extent of agreement
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TABLE 8 Frequency (%) of treatment plan implementation by patient, MDT and discussion characteristics
Characteristic Treatment plan implemented, n (%)
Age (years) (n = 2504)
20–39 355 (73)
40–59 488 (79)
60–79 739 (81)
80+ 381 (80)
Sex
Male 945 (78)
Female 1022 (79)
IMD quintile (n = 2431)
Least deprived 197 (85)
2 331 (82)
3 395 (82)
4 541 (76)
Most deprived 442 (73)
TCIa,b
< 4 (median score) 853 (78)
≥ 4 1114 (79)
Type of diseasea
Haematological cancer 502 (81)
Gynaecological cancer 228 (84)
Skin cancer 229 (78)
Memory clinic 362 (81)
Mental health 403 (70)
Heart failure 243 (80)
Teama
Haematological cancer 1 276 (85)
Haematological cancer 2 226 (76)
Gynaecological cancer 228 (84)
Skin cancer 229 (78)
Memory clinic 1 263 (76)
Memory clinic 2 99 (94)
Mental health 1 106 (77)
Mental health 2 42 (65)
Mental health 3 163 (68)
Mental health 4 92 (70)
Heart failure 1 148 (81)
Heart failure 2 95 (79)
STUDY 1 QUANTITATIVE RESULTS
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TABLE 8 Frequency (%) of treatment plan implementation by patient, MDT and discussion
characteristics (continued )
Characteristic Treatment plan implemented, n (%)
ATIc
< 1.2 349 (82)
1.2–1.4 538 (76)
1.4–1.6 591 (78)
> 1.6 489 (78)
Number of professional groupsc
1–3 312 (81)
4–5 1199 (77)
6–7 456 (79)
Patient preferences considered
Yes 361 (75)
No 1606 (79)
Health behaviours/other clinical factors mentioned
Yes 1069 (79)
No 898 (77)
Total 1967 (78)
n= 2512; 142 patients had missing information about decision implementation such that their treatment plan
implementation could not be classified.
a Measures recorded for each team.
b Average team response rate= 76%.
c Measures recorded for individual meetings.
Reproduced from Determinants of treatment plan implementation in multidisciplinary team meetings for patients with
chronic diseases: a mixed-methods study, Raine R, Xanthopoulou P, Wallace I, Nic a’ Bháird C, Lanceley A, Clarke A, et al.
[Published online ahead of print June 9 2014], 2014, with permission from BMJ Publishing Group Ltd.105
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We had sufficient data on 2512 (92%) patients to include them in the final model. Data were missing for
age (2%), IMD quintile (6%) and treatment plan implementation (5%), mainly because of missing patient
notes. The only characteristic associated with ‘missingness’ was MDT disease type. Given the small
proportion of missing values, we did not consider it necessary to account for this in our analysis.
Sensitivity analyses for model 3 included adjusting for the number of decisions making up the first treatment
plan (which varied between 1 and 11 decisions); examining the impact of using the first recorded treatment
plan in analysis by refitting the model based on a randomly chosen treatment plan for each patient; collapsing
the five IMD quintiles to two groups (IMD 1–3 and IMD4–5) to produce an eight-coefficient model; and altering
the definition of an implemented treatment plan such that implementation is when > 80% of component
decisions are implemented. None of these analyses substantially changed our conclusions (see Appendix 3).
We further explored the observed trend between implementation and number of professional groups to
examine whether this was dependent on disease type. Tabulations suggested that this association was
mainly apparent in memory clinic and mental health teams, and an interaction term added to model 3
indicated some evidence of a differential effect by type of disease (p= 0.06) (Table 10). We also considered
whether the relationship between IMD and implementation differed for cancer and non-cancer specialties.
This interaction term was not significant (interaction p= 0.13) (Table 11).
TABLE 10 Proportion of first treatment plans implemented by disease type and number of professional categories
represented at the meeting, number (%)
Disease type
Number of professional categories represented
1 2 3 4 5 6 7
Haematological cancer 60 (85%) 442 (81%)
Gynaecological cancer 42 (86%) 151 (82%) 35 (90%)
Skin 96 (76%) 133 (79%)
Memory clinic 3 (100%) 37 (97%) 34 (94%) 73 (87%) 78 (76%) 137 (74%)
Mental health 146 (76%) 257 (67%)
Heart failure 84 (79%) 8 (72%) 110 (81%) 41 (80%)
Total 3 (100%) 121 (84%) 188 (79%) 500 (74%) 699 (80%) 421 (78%) 35 (90%)
Extending model 3 to include interaction for number of professional categories and disease type, p-value
for interaction= 0.06.
TABLE 11 Proportion of first treatment plans implemented by disease type and IMD quintile, number (%)
Disease type
IMD quintile
1 (least deprived) 2 3 4 5 (most deprived)
Haematological cancer 62 (86) 127 (80) 144 (85) 93 (78) 59 (76)
Gynaecological cancer 32 (94) 43 (84) 49 (85) 59 (82) 42 (78)
Skin cancer 30 (77) 45 (74) 67 (87) 57 (75) 23 (72)
All cancer 124 (86) 215 (79) 260 (85) 209 (78) 124 (76)
Memory clinic 40 (89) 69 (90) 64 (74) 119 (81) 63 (75)
Mental health 0 (0) 4 (80) 15 (63) 159 (71) 208 (70)
Heart failure 33 (85) 43 (83) 56 (88) 54 (75) 47 (77)
All non-cancer 73 (84) 116 (87) 135 (78) 332 (75) 318 (72)
Total 197 (84) 331 (82) 395 (83) 541 (76) 442 (73)
Extending model 3 to include interaction between IMD and cancer/non-cancer, p-value for interaction= 0.13.
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The reasons for non-implementation of treatment plans are summarised in Table 12 by disease type.
Although 15% of non-implementations were recorded as for patient, family or carer reasons, ‘other’
reasons for non-implementation were most commonly recorded. The ‘other’ reasons were diverse, and
included cases where the decision was implemented outside the 3-month follow-up period or when new
information or test results emerged after the MDT meeting, for example where it was subsequently
decided that a referral had been inappropriate or that a patient should have been referred to a team in
a different catchment area. Patient-led reasons were recorded most frequently in CMHTs (e.g. because
of patient non-attendance) while patient death was reported most frequently for heart failure MDTs.
We also collapsed the five IMD quintiles to two groups (IMD 1–3 and IMD 4–5) and found that
reasons for non-implementation were similar, although patient death was a more frequent reason for
non-implementation in the least deprived group while patient non-attendance and changes in
circumstances were recorded less for this group (Table 13).
TABLE 12 Reasons for non-implementation for decisions in the first treatment plan, number (%)a
Reason for non-
implementation of
treatment decision
Gynaecological
cancer (n= 40)
Haematological
cancer (n= 109)
Skin
cancer
(n= 48)
Community
mental
health
(n= 102)
Heart
failure
(n= 25)
Memory
clinic
(n= 31)
Total
(n= 355)
Patient/carer/
family choice
7 (18) 12 (11) 10 (21) 16 (16) 3 (12) 6 (19) 54 (15)
Change
in circumstancesb
5 (13) 12 (11) 0 19 (19) 4 (16) 0 40 (11)
Patient did not attend 2 (5) 6 (6) 3 (6) 25 (25) 0 0 36 (10)
Decision was
conditional and
condition was
not met
6 (15) 6 (6) 5 (10) 4 (4) 0 0 21 (6)
Patient died 3 (8) 7 (6) 1 (2) 0 8 (32) 0 19 (5)
Comorbidity arising
post MDT meeting or
deteriorated post
MDT meeting
2 (5) 3 (3) 1 (2) 0 0 0 6 (2)
Comorbidity
not discussed
2 (5) 4 (4) 1 (2) 0 0 0 7 (2)
Otherc 4 (10) 36 (33) 17 (35) 29 (28) 4 (16) 8 (26) 98 (28)
Non-implementation
recorded but reason
not given
9 (22) 23 (21) 10 (21) 9 (9) 6 (24) 17 (55) 75 (21)
a For 306 decisions there was no record of whether or not the decision was implemented. In the analysis these were
considered as non-implemented decisions.
b For example, patient left the care of the team.
c For example, new information or test results emerged after the MDT meeting; incorrect or missing information at the
MDT meeting; decision was implemented outside of the 3-month follow-up period.
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Chapter summary
In this chapter we have quantitatively described characteristics of the teams studied and presented the
results of the primary quantitative analysis, assessing factors associated with decision implementation.
We also described some of the reasons for non-implementation. Chapter 4 presents the qualitative results.
This includes a qualitative description of team characteristics, a qualitative exploration of the quantitative
findings, and a qualitative analysis investigating areas of diversity in beliefs and practices relating to
MDT meetings.
TABLE 13 Reasons for non-implementation (where available) for decisions that make up the first treatment
plan in cases where the treatment plan was not implemented by IMD quintile in two groups, number (%)
(n= 347, IMD quintile missing for some)
Why was the decision not implemented?
Least deprived
(IMD quintile 1–3)
(n= 143)
Most deprived
(IMD quintile 4 or 5)
(n= 204)
Patient/carer/family choice 20 (14) 33 (16)
Change in circumstances 11 (8) 29 (14)
Patient did not attend 10 (7) 26 (13)
Decision was conditional and condition was not met 7 (5) 14 (7)
Patient died 13 (9) 4 (2)
Comorbidity arising post MDT meeting or
deteriorated post MDT meeting
3 (2) 3 (1)
Comorbidity not discussed 3 (2) 4 (2)
Other 37 (26) 58 (28)
Non-implementation recorded but reason not given 39 (27) 33 (16)
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Chapter 4 Study 1 qualitative results
A shorter version of the results presented in Chapters 3 and 4 has been published in Raine et al.105
As described in the methods chapter, the qualitative data served two functions. Firstly, we drew
upon the pool of qualitative codes across the three data sets to provide explanations for the main
quantitative findings (a deductive analysis where the quantitative findings were the main themes).
Secondly, we conducted a thematic analysis (by synthesising the three qualitative data sources) to explore
areas where there were diverse beliefs or practices with respect to MDT meetings. These results provided
data for study 2.
Data sources
Non-participant observation
We observed 370 meetings in four cancer teams, four mental health teams, two memory clinic teams and
two heart failure teams. Of these, we performed an in-depth analysis of 192 meetings that took place
during the first 4 months of observations of each team.
Semistructured interview
We conducted 53 semistructured interviews with MDT professionals and with 20 patients (carers were also
present and contributed to seven of these). The characteristics of MDT member interviewees in terms of
their profession and specialty are shown in Table 14. The characteristics of patients interviewed are shown
in Table 15.
TABLE 14 Number of professional interviews by professional group and disease specialty
Profession Cancer Heart failure Memory clinic Mental health Total
Allied health professional 0 0 1 2 3
Diagnostic doctor 3 0 0 0 3
MDT co-ordinator 0 0 1 0 1
Nurse 4 4 0 5 13
Doctor 8 2 3 3 16
Psychologist 1 0 4 1 6
Social worker 0 0 0 8 8
Surgeon 3 0 0 0 3
Totals 19 6 9 19 53
TABLE 15 Number of patient/carer interviews by disease type
Disease type Males Females Total
Cancer 4 3 7
Heart failure 5 1 6
Memory clinic 3 2 5
Mental health 1 1 2
Total 13 7 20
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Overview of the multidisciplinary team meetings and
their context
Here we present a brief analysis of our observation and interview data to provide an overall description of
the teams, and the contexts within which they operated.
In terms of meeting characteristics, overall there was considerable variation between teams, in the size
of the teams, the number of patients discussed (as mentioned in Chapter 3) the length of the MDT
meetings, the chairing arrangements and the administrative support provided (Table 16).
The context within which each of the 12 teams operated, and attendance and structural characteristics,
are described below.
TABLE 16 Meeting characteristics of the 12 MDTs
Team
Number of
patients
discussed
Approximate
duration of
meeting
(hours)
Number of
professional
categories in
attendance
(min.–max.)
Number
of core
team
members Chairperson
Administrative
support
for meeting
Cancer 1 35 2.5 5–7 28 Doctor MDT
co-ordinator
Cancer 2 15 1 4–5 17 Doctor MDT
co-ordinator
Cancer 3 14 1 5 45 Doctor MDT
co-ordinator
Cancer 4 22 1.5 5–6 21 Doctor MDT
co-ordinator
CMHT 1 29 2.5 3–4 12 Social worker None
CMHT 2 15 1 3–4 12 Rotating chairperson Administrator
records minutes
CMHT 3 14 1 3–4 15 Rotating chairperson Administrator
records minutes
CMHT 4 49 2.5 4 16 Social worker None
Heart
failure 1
8 1.5 4–5 30 Doctor None
Heart
failure 2
6 2 2 8 No formal
chairperson – varied
throughout discussion
None
Memory
clinic 1
11 1 4–6 15 Doctor or nurse Provided by
team manager
Memory
clinic 2
4 1.5 1–4 13 No formal
chairperson – varied
throughout discussion
None
max., maximum; min., minimum.
Reproduced from Determinants of treatment plan implementation in multidisciplinary team meetings for patients with
chronic diseases: a mixed-methods study, Raine R, Xanthopoulou P, Wallace I, Nic a’ Bháird C, Lanceley A, Clarke A, et al.
[Published online ahead of print June 9 2014], 2014, with permission from BMJ Publishing Group Ltd.105
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Cancer teams
Context
All four cancer teams worked closely according to local and national policies and guidelines, which were
mentioned frequently in meetings. Thus, references were often made to NICE guidelines and professional
guidelines for pathology or radiology reporting, as well as to local discharge policies and team operational
policies. It was also apparent that teams were expected to collect and report specific data regularly, for
example diagnostic information for Cancer Registries.
National waiting time targets and breach dates were a recurring issue for two of the cancer teams.
This added to a sense of constant pressure: ‘we are under scrutiny at the moment’ (cancer surgeon,
observation) and ‘we are asking for more [theatre] lists left, right and centre’ (cancer surgeon, observation).
Occasionally, in these teams there was also mention of bed shortages, but these comments were made in
passing and the discussion did not dwell on these issues. Some members of the MDT believed these
pressures were unsustainable, while others did not necessarily think they were a problem. The quotes
below illustrate that these differences were apparent even within the same team:
I think we’ve got more clinicians, we’re seeing more patients, we’ve got more patients with complex
issues and I would question, it, it feels fragile because I feel that, it feels like you’re in a bubble that’s
about to burst. How much more can, how, how much more can you take?
Cancer nurse, interview
In general . . . people are very happy to just have extra patients in clinic.
Cancer doctor, interview
Meeting environment
All the cancer MDT meetings were held weekly in dedicated hospital meeting rooms. These were set up
in a lecture-style format, with rows of chairs facing projector screens at the front, which were used to
display pathology and radiology images. This was in keeping with the hierarchical nature of the
meetings and there was a tendency for consultants to sit towards the front of the room, with junior
doctors, nurses and other members of the team further back. All cancer teams used information
technology (IT), either to present and access patient information, or to link up with clinicians on
different sites.
Attendance and structure
The cancer MDTs were the most heavily attended teams we observed. National guidelines for each tumour
type list ‘core’ professions that must be present at MDT meetings, including specialist surgeons (where
applicable), oncologists, imaging specialists, pathologists, clinical nurse specialists and MDT co-ordinators.
Teams documented attendance at each meeting to demonstrate adherence to the national guidelines.
However, in practice, in some teams not all clinicians attended for the duration of the meeting. Further
detail about the specific disciplines and structure of the meeting by team are included in Appendix 10.
In two of the teams in particular, there were regular interruptions and members would talk over each
other, or in small groups, on occasions taking phone calls during the meeting to discuss other issues.
Decision-making processes
The focus of all the cancer team meetings was on making treatment decisions for patients and there was a
fairly standard format to the way that cases were presented. This involved an initial brief presentation of
a patient by a consultant or specialist registrar, depending on who had seen the patient. Very occasionally
a clinical nurse specialist would present a case, but this would be an exception rather than the norm.
The results of investigations were presented by radiologists and pathologists. In addition, some of the
teams accessed patient information either electronically or using paper records during the meeting to
clarify issues relating to, for example, comorbidities or previous test results. Presentation of cases and
DOI: 10.3310/hsdr02370 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 37
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Raine et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
35
discussions were generally structured, with a focus on medical issues. Presentations rarely included
reference to patient preferences or social factors.
It was common for decisions to relate to clinical treatment options, for example specific chemotherapy
regimens or surgical procedures (depending on the specialty). Most other decisions related to carrying out
further investigations or tests (e.g. bone marrow biopsy, chest radiograph, skeletal survey), liaising with or
referring to another team, decisions to watch and wait, or to discharge or admit. These decisions were
generally quite clearly summarised and then documented so even those who had not attended the
meeting were able to see what decision the MDT had made for a specific patient.
Across all cancer teams, and in line with national guidance, all new cancer patients were discussed at the
MDT meeting. Where the team did not have the necessary information to make a decision, for example
where the pathology results were not yet available, cases were deferred until the following week. Where a
patient required urgent treatment and could not wait until the next meeting, a decision would be made
outside the meeting, but this was usually then ratified the following week.
Heart failure teams
Context
The two heart failure teams operated in very different contexts from each other. Although there were
occasional references to NICE guidelines for diagnosis and treatment in both teams, there was no sense of
a clear national policy to provide a framework for the MDT meeting itself (in contrast with the
cancer teams).
Although there was an awareness of resourcing issues, as demonstrated for example by reference to
procedures being ‘expensive’, ‘cost-effective’ or ‘cheap’, there was less of a sense of financial pressure
than in some other teams:
I know we’ve got lots of money to throw at these things, but is that really going to change how we
manage him?
Heart failure doctor, observation
Meeting environment
Both heart failure MDT meetings were held weekly on an acute hospital site and used a computer and
projector to present and access patient information.
For team 1, the meeting room was set up in a lecture-style format, with rows of chairs facing the projector
screens at the front:
It’s got everything we need there and the room’s big enough for the meeting.
Heart failure nurse, interview
Although both heart failure teams were medically dominated, the larger team was also hierarchical in
physical terms, with consultants sitting at the front of the room and nurses and others towards the back.
Team 2 was much smaller, with members sitting in a large room around a table, in no particular order.
Attendance and structure
Attendance, structure and processes of the two meetings were very different from each other. Team 1 had
formal structures and processes, with a wide range of different professionals attending regularly and
punctually (further detail about the specific disciplines and structure of the meeting by team is included in
Appendix 10). This team was more similar to the cancer teams described above, both in size and in having
an agreed patient list used during the meeting, structured presentations, and documented decisions which
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were later added to patient notes. Team 2 was a newly established team, and was much smaller
(usually five attendees), with a less formal structure. There were regular interruptions, with members often
taking phone calls, arriving late and leaving early. Meetings were also sometimes cancelled because
consultants were not able to attend.
Decision-making processes
Both teams presented patient information electronically for everyone in the room to see, and presentations
were heavily dominated by a focus on imaging. In team 1, cases were presented by a junior doctor and in
team 2 they were presented by a nurse or a specialist registrar. The format of presentations in team 1
was similar for all patients (information permitting), including symptoms/reasons for the patient being
discussed, previous medical history, comorbidities, current drug regimens, blood test results and, finally, a
slide at the end with proposals for a treatment plan. Consultants and specialist registrars tended to
contribute spontaneously while the imaging was being presented. Following this, decisions were usually
made by the consultant cardiologists, with the specialist heart failure nurses occasionally contributing or
being invited to comment on particular issues such as social circumstances. In team 2, the presentation of
patients varied. In some cases, presentations were brief and limited to short, specific questions. In other
cases, the patient history and test results were presented before a decision was made.
The type of decisions made in both heart failure teams tended to relate to medication or surgery, liaison or
referral to other teams, including palliative care, further reviews or investigations, or discharge.
Not all patients were discussed in heart failure meetings, and those that were tended to be complex cases,
or those where a member of the team had a specific query to be addressed. This meant that there were
fewer patients discussed than in the cancer team meetings, even though some meetings ran for a similar
length of time.
Memory clinic teams
Context
The two memory clinic MDTs were relatively small teams. In terms of context, it was apparent that both
teams were operating under local and national policies and guidelines, but there was no clear national
policy to provide a framework for the MDT meeting itself. When these teams did refer to policies or
guidelines, these mainly related to diagnostic criteria (i.e. World Health Organization International
Classification of Diseases) or treatment protocols:
We have a very clear protocol about prescribing antipsychotics and that behavioural routes should be
tried first.
Memory clinic nurse, observation
Caseload and capacity issues were a common theme:
It’s ridiculous! . . . 15 [new referrals] is really bad news because we haven’t got the people here to see
them . . . as we’re in complete crisis I’ll take four [new referrals] . . . all hands on deck!
Memory clinic doctor, observation
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Meeting environment
Both teams catered to community-based patients, though the meetings took place on hospital sites. Team
members sat around a table and discussions were relaxed and friendly. In team 1, there were sometimes
problems with the room, such as inappropriate heating and inadequate space:
It actually gets really hot in there in the winter cause the radiator is very fierce so from a heating point
of view it can become uncomfortable at times.
Memory clinic team manager, interview
Occasionally it’s a little bit cramped.
Memory clinic doctor, interview
Team 2 did not use any IT during the meeting and relied on paper patient records and individual members’
notes. Team 1 recorded decisions directly into patient records using a laptop.
Attendance and structure
Team 1 had regular attendance by all members and there were very few disruptions to the meeting. In
contrast, attendance in team 2 was irregular and members would arrive late or leave early. The consultants
would often take phone calls during the meeting.
There were also notable differences between the teams in terms of their purpose and structure. Team 2
had a very specific purpose, which was to diagnose patients. The meeting was medically dominated in
terms of both attendance and participation. Discussions were often very long, and there was not always
time to discuss all cases that had been brought to the meeting.
Team 1 had a broader remit, managing and treating patients as well as determining their diagnosis.
Reflecting this broader function, this team had more disciplines attending and more multiprofessional
participation (further detail about the specific disciplines and structure of the meeting by team is included
in Appendix 10). Discussions were clearly structured and all cases brought to the meeting were discussed.
Decision-making processes
Patients were generally presented by the member of the team who was working with them, after which
other team members would ask questions and there was an opportunity for discussion. In both teams,
there was extensive discussion about patient characteristics and the needs of family and/or carers.
Consultant psychiatrists usually made the decisions although others had the opportunity to contribute.
In team 1, it was common for the consultant psychiatrist to have made decisions about their own patients
before the MDT meeting, and these were then fed back to the team. This was not usually the case for
other team members although occasionally some members would present a plan they had already
implemented, with other team members suggesting additional actions.
Decisions in team 1 related to diagnosis, further assessments or investigations, medication, reviews or
follow-up appointments, discharge and contact with other services in the community including GPs.
Decisions also concerned practical or social issues, for example organising a smoke alarm to be fitted or
giving advice about state benefits. In contrast, decisions made by team 2 were clearly focused on making a
diagnosis, and patients were subsequently discharged back to the GP or followed up in clinic. Occasionally,
decisions were made about further investigations or recruitment to trials but this was much less common.
Decisions were clearly recorded and summarised in both memory teams.
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Mental health teams
Context
All four mental health teams were undergoing major organisational restructuring. During the observation
period, team 1 disbanded and teams 2 and 3 were preparing for major changes. Generic CMHTs were
being abolished in favour of triage teams that would redirect referrals into specialist teams dealing with
specific kinds of mental illness (e.g. psychosis, personality disorders). As part of the restructuring, staff were
being transferred to different teams, many had to re-interview for their jobs and redundancies
were expected.
This context had a major influence on the attitudes and morale of staff, and many felt it was negatively
impacting on the quality of care:
There’s some redundancies and people re-applying for their jobs, and uncertainty, and breakdown of
teams, and merging of teams, and people going . . . that has affected morale and it’s also, I think, had
an impact. I think some of our structures within the team and the direction has loosened a little . . .
tightness of discharge criteria, regularity of meetings . . . all of these things have sort of been eroded a
bit you know.
Mental health doctor, interview
People are far less able to engage and reflect on the way that they’re making decisions and empathise
with people . . . if they’re in a state of fear. I am absolutely sure it has a direct influence [on care].
Mental health social worker, interview
Team members frequently discussed resource constraints such as restricted treatment options due to
service closures, a lack of appointment slots and difficulty finding a physical space to hold appointments. It
was apparent that members of the teams had to make difficult choices balancing ‘the clinical ideal versus
the financial reality’ (mental health psychologist, observation). Two of the mental health teams had no
psychologist, and reference was made to a waiting list of 18 months for referral to primary care
psychology (further detail about the specific disciplines and structure of the meeting by team is included
in Appendix 10).
Meeting environment
The meeting rooms were just large enough to accommodate the team and members would sit in a
circle around a table. Meetings were described as having a relatively ‘relaxed and open atmosphere’
(mental health social worker, interview) and discussions were inclusive, with all attendees contributing
each week. Case presentations were relatively informal and unstructured. Only team 4 used a computer
(to take minutes).
Attendance and structure
The whole team usually attended, with occasional visitors such as researchers, students or members from
related teams (forensic, home treatment or crisis services). Meetings were structured into sections which
varied slightly by team. All teams had sections for feeding back on new assessments and raising ongoing
cases of concern. Other sections, found in some teams but not all, included recent/planned Mental Health
Act assessments, clients under Home Treatment Services, clients under Crisis Services, and new referrals.
Generally, the chairperson announced each section and members volunteered if they had anything
relevant to report. The meeting served a range of functions (see The purpose and functions of MDT
meetings) and discussions did not always result in a specific treatment plan for each patient.
Decision-making processes
The CMHT meetings focused on members of the team feeding back about recent appointments and
challenges or noteworthy incidents such as patients’ relapsing or having crises. Discussions were not
usually framed in terms of specific queries or deciding between different options, and did not always result
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in a treatment plan. Rather, members of the team often provided a range of suggestions and advice to the
patient’s key worker without explicitly agreeing a particular course of action.
Sometimes team members explicitly sought advice about particular options (‘I wondered if he’d be a
candidate for cognitive behavioural therapy, I don’t know what anybody else thinks?’, mental health social
worker, observation), while on other occasions they would describe a general problem (‘I don’t know what
to do. I’m stuck’, mental health social worker, observation) and the team would use the discussion to
generate ideas.
Where decisions were made, they often related to arranging further appointments with patients and
attempts to resolve ongoing issues, for example trying to persuade patients to take medication
or to attend their appointments. There were also decisions about social issues, including arranging
accommodation or checking a patient’s asylum status as well as liaising with other services in primary
and community care such as forensic, housing, and drug and alcohol services.
Of the four teams, CMHT 1 used the weekly MDT meeting to share the contents of new referral letters
and allocate them to a key worker (also known as a care co-ordinator). In CMHTs 2, 3 and 4, cases were
allocated by the team manager. In CMHT 4, a patient list was distributed at the beginning of the meeting
listing all patients under the care of the team, organised by key worker. The team would read through the
names and the relevant key worker would comment, sometimes briefly, on each patient. In the other
teams (CMHT 1, 2 and 3), members were prompted to feed back on new assessments but there were
no patient lists and it was up to individual team members to raise patients about whom they had
particular concerns.
In addition to the weekly MDT meetings, CMHTs 2 and 3 had brief morning handover meetings to make
everyone aware of any crises or emergencies that needed to be attended to.
Qualitative exploration of the quantitative results
The main findings from the quantitative analysis formed the basis for the following five deductive themes,
which we explored further using our qualitative data:
1. theme 1: influence of disease specialty on implementation
2. theme 2: influence of multidisciplinarity on implementation
3. theme 3: influence of team climate on implementation
4. theme 4: influence of socioeconomic characteristics on implementation
5. theme 5: roles that patient preference, health behaviours and other clinical factors may have in
explaining the socioeconomic variations in implementation.
Theme 1: influence of disease specialty on implementation
Our quantitative analysis demonstrated significant differences in implementation rates across specialties.
However, we also found considerable variation within specialties (e.g. memory clinic 1 implemented 76%
of the decisions made, while memory clinic 2 implemented 94%). The qualitative data indicated that
this may be because the two memory clinics tended to carry out different functions:
I think the main function . . . it’s discussion about clinical cases and making decisions about clinical
cases. Be that assessment, intervention, you know, that would be the main role, and I think there are
other roles, like information giving, teaching, sharing, support role, for other practitioners. I think, but
mainly it’s clinical discussion, you know, around cases, and planning around what you’re going to do
with the case.
Memory clinic 1 psychologist, interview
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It [the main aim of the meeting] tends to be making a diagnosis for the client. It is like a
diagnostic clinic.
Memory clinic 2 psychologist, interview
High-implementing teams, regardless of disease specialty, more frequently referred to diagnostic or
treatment protocols and national guidelines. In the cancer MDTs, for example, all new patients were
discussed, many of whom were treated according to standard protocols. This contributed to a higher
throughput of patients and higher implementation rates than for those non-cancer teams which focused
on discussing only complex cases where the appropriate treatment plan was less clear:
We have protocols for melanoma here, so that’s easy. The same with squamous cell and basal cell
carcinoma there are national guidelines about optimal treatment. And so often the decision is obvious.
Cancer doctor, interview
High-implementing teams also had clear goals, and members shared the view that the main purpose
of the MDT meeting was to make treatment recommendations for patients. In contrast, in
lower-implementing teams, members identified a range of diverse objectives and some stated that there
was a lack of clarity of purpose:
I am never quite sure what the purpose of the meetings are . . . It was the thing that was done and
therefore I did not have any say on whether it was done or not done.
Mental health nurse, interview
All four cancer teams adhered closely to national guidelines, so they had the dedicated administrative
support members considered to be essential for meeting preparation and facilitation:
[The MDT co-ordinator] she’s brilliant. She really is. She holds the meeting together very well I think
. . . She’s really, really important. Like she’s not medical in the slightest, but she knows where the
patients are, when they should be treated.
Cancer nurse, interview
High-implementing teams also tended to have permanent and authoritative chairpersons who maintained
a focus on decisions, which were clearly recorded.
I think it is the best-run meeting I have attended . . . the person who runs it, he runs it very well in the
sense that he is very strict in starting the meeting on time, going through cases promptly.
Cancer diagnostic doctor, interview
In teams with rotating chairpersons, there was some concern that meetings were often left without a
confident leader to direct and manage discussions. Occasionally time was spent at the start of the meeting
trying to establish whose turn it was to chair that week:
I think one of the weaknesses is everyone chairing and therefore everyone being lumbered two or
three times a year . . . seniors chairing the meeting, that makes a little bit more sense, because then
that person can deliver their control of the group a bit more . . . [it] was the idea of having everyone as
equals but not everyone was as equals.
Mental health nurse, interview
High-implementing teams also assembled lists of patients for discussion in advance of the meeting. This
stimulated case presenters to consider the management options they wished to discuss before, rather than
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during, the meeting and led to more explicit decisions. The other MDTs included either none or some of
these features, and this varied by team rather than by disease type.
Theme 2: influence of multidisciplinarity on implementation
Contrary to policy-makers’ expectations that multidisciplinarity increases the quality of decisions and thus
the likelihood of implementation, the quantitative analysis found that there were increased odds of
implementation when there were fewer professional groups in attendance. However, this trend was not
consistent across teams and was mostly accounted for by mental health and memory teams. In these
teams, when meetings were attended by more professional groups there was a tendency for very diverse
issues to be raised in an ad hoc manner, with abrupt changes of subject. For example, the discussion
might move from medication to housing problems to employment issues, without a clear summary
of what was decided in relation to each issue. There was a lack of focus on specific questions and
documentation was inconsistent. Thus, if a key worker was unclear about which of the suggestions
had been ultimately agreed, there was rarely a comprehensive record of the discussion to refer to.
In addition, some MDT members found decision-making more difficult when a range of professionals were
attending and teams struggled to bring the diverse viewpoints into alignment to agree a plan:
Sometimes I used to think too many cooks . . . you could have too many opinions.
Mental health social worker, interview
Sometimes it feels a bit like they feel like they’re in two camps [social work and nursing] . . . social
workers very much do try to defend, you know a person’s right to be mad. I mean the nurse view is
‘you’re not well so we need to get you on the path and let’s make the decisions you would make’ . . .
well social workers, they come from a different point of view.
Mental health nurse, interview
Across all teams, participants emphasised the value of disciplinary diversity and considered multidisciplinary
participation a key benefit of MDT meetings:
All of those people bring different things into that mix.
Cancer doctor, interview
In practice, however, there was considerable variation in the degree of multidisciplinary input into
discussions. Some complained that meetings were overly dominated by the medical profession in terms of
both the numbers of each discipline represented and the power dynamics involved:
It’s rarely a multidisciplinary meeting. It is in many ways, it often consists of a surgeon talking to
the radiologist.
Cancer doctor, interview
It is quite medically dominant. There can be one psychologist and assistant and then a lot of doctors, it
can be a very strong medical dominance in terms of what is more likely to be the outcome.
Memory clinic psychologist, interview
Even where disciplines were represented in the team, some felt it was difficult for them to be effective if
they were largely outnumbered:
Doing it on your own is very hard. I think MDTs don’t work where you’ve got overwhelming numbers
of one set of professional and just one of another.
Mental health social worker, interview
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Several non-medical MDT members commented that they did not feel a sense of ownership at the
meeting and did not always feel able to contribute freely about patient management or the design of
the meeting:
The room is full, there are other people in there . . . however they don’t have a voice. I notice that
nobody else speaks. It’s just the consultants that are around the table that discuss among themselves
. . . nobody else has any involvement.
Heart failure nurse, interview
In some teams there was a physical divide with consultants sitting at the front and nurses at the back:
The discussion is very much focussed on the people who are sitting at the front and information is
invited from other people if it’s required . . . sometimes does make it difficult to hear and/or be
involved in a discussion.
Cancer nurse, interview
However, some of the doctors found it frustrating that the other professionals did not involve
themselves more:
I’m always amazed how very able staff can be so passive . . . it would be nice if the non-medical
people were a little bit more volunteering, didn’t have to draw out, but I’ve given up trying to
expect that.
Heart failure doctor, interview
The principle of multidisciplinary input, therefore, was highly valued by professionals across all disease
specialties. However, there was dissatisfaction about the way that it played out in practice.
Theme 3: influence of team climate on implementation
The team meeting was considered important for many aspects of team functioning. Health professionals
emphasised that team meetings served a range of social functions in addition to decision-making,
including opportunities for peer support, team-building and bonding:
I probably go there because it’s valuable for education, for team building, for giving a sense of
responsibility, for influencing other people’s approach to things, for building up team culture, that’s
the reasons I go.
Heart failure doctor, interview
The MDT meeting was also perceived to be important for understanding the roles of other team members:
An opportunity for I think all the staff to be aware of the sort of work that other members of the
team do and I think that’s you know, sort of all helps with sort of cohesiveness of the team and also
you know awareness.
Memory clinic doctor, interview
In this way, MDT meetings were a forum where team climate was cultivated, providing an opportunity to
develop the team’s culture, share learning and develop clear understandings of one another’s roles.
These positive aspects of the meeting were considered key to the general effectiveness of the team.
Theme 4: influence of socioeconomic characteristics on implementation
The odds of implementation was lower for more socioeconomically disadvantaged patients. Socioeconomic
information was only occasionally mentioned in cancer and heart failure teams. In contrast, it was routinely
discussed in memory clinic and mental health teams: ‘he lives with his wife no financial concerns at all’
(memory clinic doctor, observation).
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Has been claiming on and off for seventeen years of his life . . . he’s trapped really I think with his kind
of ideology and the reality that’s he’s on housing benefit. He’s on DLA [disability living allowance] and
he’s on, he couldn’t remember if it’s income support or incapacity erm, and he’s on these benefits so
and he’s taking up our time and resources as a team . . . he’s very bright so he’s in no denial about
that, the reality of that he’s receiving them. And he can’t seem to manage without them. You know,
he can’t hold down a job.
Mental health social worker, observation
Although socioeconomic circumstances were discussed within the context of services provided by mental
health and memory clinic teams, it was unclear how, if at all, these influenced decision-making
or implementation.
Theme 5: roles that patient preference, health behaviours and other clinical
factors may have in explaining the socioeconomic variations in implementation
We explored the roles that patient preference, health behaviours and other clinical factors may have in
explaining the socioeconomic variations in implementation that we found in the quantitative analyses.
However, although there was marked team variation in discussion of these factors, most members
considered that the extent to which ‘health behaviours and other clinical factors’ were discussed
was appropriate:
I think we discuss it when it’s important . . . yes we do bring in physical problems as well which we
need to if necessary.
Memory clinic allied health professional, interview
However, it was acknowledged that information on comorbidities was not always available when making
decisions in the MDT meeting:
There may be some instances where we don’t know enough about the comorbidities to make the
decision and have come back to clinic and found that actually the patient’s not fit for a
particular treatment.
Cancer doctor, interview
There were mixed views from patients, with many indicating that they were happy for clinicians to use
their judgement when presenting their cases, and that there was nothing specific about them that they
would want mentioned. Others felt strongly that their comorbidities were crucial to their quality of life and
therefore should be discussed:
What is the point in mending a man’s heart, well not mending it but keeping it going on a really nice
basis, and lungs, if every day he has got wind up to his ear holes, he can’t eat and he feels awful.
It just seems bad, it seems wrong.
Heart failure patient, interview
With regard to patient preferences, some clinicians argued that these should be central to MDT
decision-making:
If you don’t take patients’ views into account that does create a lot of problems for the team in the
long run, so I think it’s important for both the patient and the team, so that’s become a big part of
your decision-making.
Memory clinic doctor, interview
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Others preferred to elicit patient preferences after the MDT, when treatment options could be shared with
patients. This was attributed partly to the fact that patient preferences can change over time, but also to
the importance of being fully informed before discussing treatment options with a patient in clinic:
One of the values of the MDT meeting is to allow the clinician to actually go into a consultation [after
the meeting] with a patient and tell them what the options are, tell them how the decision has been
reached and what the advantages and disadvantages are, and I think that that’s more useful to a
patient than actually giving patients a list of options beforehand . . . and then having the MDT meeting
decide that half those options are off the table anyway.
Cancer doctor, interview
In summary, although patients from more deprived areas are less likely to have their treatment plans
implemented, consideration of patient preference, comorbidities or other health-related factors did not
seem to explain this.
Additional information in regards to discussion of comorbidities is presented in Content of discussion in
multidisciplinary team meetings, theme 11. Further discussion of patient preferences in MDT discussions is
explored in Content of discussion in multidisciplinary team meetings, theme 13.
Qualitative investigation of areas of diversity in beliefs
and practices
Our synthesis of the observation, professional and patient interview data resulted in 16 metathemes
relating to areas of diverse beliefs or practices in MDT meetings (Box 4) (see Chapter 2, Summary
measures, for a description of this analysis). Each of the 16 metathemes is discussed below.
The purpose and functions of multidisciplinary team meetings
Theme 1: the purpose of multidisciplinary team meetings
Our analysis demonstrated that MDT meetings served a variety of functions, including decision-making,
information-sharing, peer support and education. When asked what the primary function of the MDT
meeting was, interviewees provided a wide range of responses, although there were some similarities
across specialties (Table 17). While ‘agreeing treatment plans’/‘decision-making’ and ‘diagnosis’ were cited
by cancer, mental health and memory clinic teams, the heart failure and mental health teams also reported
that ‘ensuring quality’ was a primary function.
For cancer teams, the responses centred around decision-making regarding treatment, diagnosis and
eligibility of patients to participate in research: ‘the overt aim is to review all the patients and their
treatment decisions’ (cancer psychologist, interview).
In contrast, mental health interviewees highlighted broader communication functions such as liaising with
peers, advice and peer support, and providing feedback to ensure continuity of care:
It’s a useful thing, well, in all sorts of ways, it’s information-sharing, it’s an opportunity for the team to
actually meet as a group and know each other and know what everyone’s doing in a way. It’s a, it’s
quite a containing function . . . it can be quite a supportive thing for members of the team as well . . .
a nurturing thing, an educational thing, people can learn from what others say.
Mental health doctor, interview
The wide range of explicit and implicit functions was also clear from the observation data. For example,
meetings in all specialties were also sometimes used to carry out management functions (e.g. reminding
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TABLE 17 The primary purpose of the meetings (MDT members’ responses)
Cancer Memory clinic Mental health Heart failure
Agreeing treatment plans Agreeing treatment plans Decision-making Improving care
through consensus
Meeting audit requirements Validation of earlier decisions Ensuring quality and
consistency
Ensuring quality
Holistic multidisciplinary review Liaising with peers Liaising with peers Coordinating different
specialties
Diagnosis Diagnosis Information-sharing Information-gathering
Checking trial eligibility Seeking advice Seeking advice
Team cohesiveness Raising concerns and
providing support
Feedback on ongoing work
(sharing responsibility)
BOX 4 Areas of diverse beliefs or practice in MDT meetings
The purpose and functions of multidisciplinary team meetings
l Theme 1: the purpose of MDT meetings.
l Theme 2: teaching and peer-to-peer learning as a function of MDT meetings.
l Theme 3: recruitment to trials in MDT meetings.
The structure of multidisciplinary team meetings
l Theme 4: attendance and participation in the MDT meeting.
l Theme 5: administrative support and the role of the MDT co-ordinator.
Multidisciplinary team meeting processes
l Theme 6: chairing the MDT meeting.
l Theme 7: agreeing which patients should be discussed in MDT meetings.
l Theme 8: preparing and presenting cases for discussion.
l Theme 9: recording and reviewing MDT decisions.
Content of discussion in multidisciplinary team meetings
l Theme 10: the role of research and evidence in MDT meetings.
l Theme 11: discussing comorbidities at MDT meetings.
l Theme 12: discussing patients holistically.
l Theme 13: incorporating patient preferences about treatment into MDT discussions.
The role of the patient in multidisciplinary team meetings
l Theme 14: patient awareness of MDT meetings.
l Theme 15: patient attendance at MDT meetings.
l Theme 16: providing feedback to patients on the outcome of MDT discussions.
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staff of administrative deadlines, training opportunities, etc.), and some mental health teams regularly used
the meeting to discuss the ongoing service restructuring.
The time dedicated to decision-making as opposed to other functions varied across teams and specialties.
The more treatment decision-focused meetings tended to have a structured format designed to support
decision-making. This included a precirculated agenda listing patients for discussion, prepared case
presentations and standard forms for documenting each patient’s treatment plan. Teams with more
wide-ranging functions tended to raise patients in a less structured manner, taking turns to discuss clients
of concern, usually without prepared presentations or paperwork and with details documented in
free-form minutes.
Though almost all mental health professionals endorsed the team meetings as valuable, some believed
their purpose needed to be revisited:
I think with things that evolve organically, I think we, probably don’t step back and think as readily as
we should about what’s the purpose that it solves . . . we probably haven’t actually talked about the
function of the team meeting probably for about 3 years at least.
Mental health doctor, interview
Go back to the basics and revisit [the objectives] . . . if you interview some people here they might say,
‘Well, I don’t see the purpose of them’. I see the importance in them but it’s just to refresh.
Mental health nurse, interview
In contrast to the desire for a more clearly defined purpose in mental health, some members of other
teams reported that they would like to use the meeting in a more flexible way, with more time for
feedback and peer support: ‘that’s another thing that could be improved is feedback [about outcomes of
previous decisions]’ (heart failure doctor, interview).
I think that sometimes the team don’t talk about the impact of what’s it’s like to work with difficult
clients in our MDT . . . I do hear people say in our team meeting, you know, ‘I’m really frustrated
because the wife never does what I say’, but I don’t think we always have enough time to think with
them about how could they manage their response to that.
Memory clinic psychologist, interview
Theme 2: teaching and peer-to-peer learning as a function of
multidisciplinary team meetings
Teaching
There was evidence of teaching in some teams, but not all. This was not specific to teams of the same disease
type: teaching was a feature in most cancer teams, but not all, and in one heart failure team but not the
other. For some, teaching was argued to be an opportunity to make meetings more inclusive and stimulating:
If they tried to genuinely include everyone, made it a teaching session as well, you know, talk to
young doctors about things, and medical students about things and so on and so forth. It would be a
more stimulating environment, less parochial, less excluding I suppose.
Cancer surgeon, interview
Teaching included junior doctors presenting patients to the MDT meeting and being questioned about
specific drugs or therapies, and individuals sharing knowledge from their particular specialty as a form of
interdisciplinary education:
This is just to show you a beautiful classical Reed–Sternberg cell you don’t often see that.
Cancer diagnostic doctor, observation
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There were also examples of team members being given advice on how to present cases to the rest of the team:
Just stop you there to give you feedback . . . so the problem is if you present history with all of that
then you forgotten the punch lines . . . so you know try to summarise.
Heart failure doctor to heart failure nurse, observation
However, concerns were raised about the practicalities of teaching in MDT meetings, particularly given
time constraints:
It’s always a bit of a challenge I think with MDT meetings . . . how much you use them as an
opportunity for learning.
Memory clinic doctor, interview
In addition, some MDT members also reported that students were not always able to keep up with the
pressurised pace of the meeting.
Peer-to-peer learning
For some members peer learning, particularly between different professions or specialties, was perceived to
be a valuable part of the meeting:
I actually think it, it was always an opportunity to learn from, from colleagues.
Mental health social worker, interview
Others argued that in reality there was little scope for professional development in MDT meetings:
‘I personally don’t feel that I benefit anything professionally from being there’ (cancer nurse, interview).
Theme 3: recruitment to trials in multidisciplinary team meetings
There was wide variation between MDT meetings in how frequently recruitment to clinical trials was considered.
Formal mechanisms for recruiting patients to clinical trials were evident in some teams, for example some cancer
and heart failure teams had dedicated research nurses or clinical trials practitioners at the MDT meeting. In other
teams reference to eligibility of a specific patient for a clinical or research trial was made on an ad hoc basis by
a member of the team, most commonly the lead consultant. Some mental health, heart failure and memory
teams occasionally had an external speaker attend the meeting to tell the team about a new study (either to
encourage the team to recruit patients or to disseminate findings), and in cancer teams members occasionally
gave brief reminders to the team about specific trials they were involved with to raise awareness within the
team: ‘people should know about the EuLITE [European Trial of Free Light Chain Removal by Extended
Haemodialysis in Cast Nephropathy] trial, it’s a real breakthrough’ (cancer doctor, observation).
Some members found it helpful to discuss trial recruitment in the MDT meeting to raise awareness of trials
and eligibility criteria, and to ensure that patients were identified at an early stage:
When you sit in the clinic talking to the patient, you don’t necessarily consider, or you may not be aware
of the trials that the patient might be eligible for and just discussing it at the meeting . . . have you
considered giving them the option of participating in this trial or that trial . . . all of these things are good.
Cancer surgeon, interview
One interviewee however cautioned that becoming overly research focused could be at the expense of the
individual patient under discussion, for example where there is conflict between clinical needs and
research needs:
So say for instance that the clinic has a research orientation but it is dealing with clinical cases. So
sometimes there are conflicts between clinical needs and research needs. So I guess that. Sometimes it
doesn’t work well, the clinical needs are outweighed by the research needs.
Memory clinic psychologist, interview
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The structure of multidisciplinary team meetings
Theme 4: attendance and participation in the multidisciplinary team meeting
Attendance
The MDT meetings for memory and mental health were usually attended by the whole team, and were
characterised by discussions in which most members participated. Those for cancer and one of the heart
failure teams tended to be larger and were often attended by additional people who were not part of the
core team. These included observers such as visiting members of staff and students, and professionals from
other clinical teams who had come to discuss specific patients.
It was common in cancer meetings for some members to attend only specific parts of the meeting:
One of the radiologists will quite often leave the meeting part way through, the pathologists don’t
turn up till near, till part way through the meeting, the oncologists’ attendance is flaky.
Cancer doctor, interview
Punctuality was also an issue in some teams, with delays occurring while waiting for all team members
to arrive. On several occasions mental health team members had to send someone back to the office to
‘round up’ the remaining team members and encourage them to attend. This indicated a certain
reluctance to attend the meetings among some members and resentment among those who felt the
meeting should be prioritised:
Social worker: Is this us? Four people? It’s pathetic!
[They discuss which staff are on annual leave and note that several team members had been seen in
the office.]
Psychologist: Did they look like they were moving?
Social worker: I don’t know, shall I go and –
Psychologist: Yes, give them a hard poke. You know the sooner we start the sooner it’s over.
Mental health team, observation
Team manager: I’m going to send out an e-mail [about attendance at meetings] because I think we’re
going to lose the sense of a team meeting if we don’t, I know it’s hard and everyone’s flat out, but it’s
just the only opportunity to think about, you know, the difficulties we have with work that we do
and if we don’t come together and really prioritise that time.
Doctor: That will make it worse.
Team manager: Yeah.
Mental health team, observation
In some teams, poor punctuality regularly delayed the start of the meeting and often a meeting would be
disrupted by latecomers because the layout of the room would need to be rearranged and chairs
retrieved from other rooms to accommodate them.
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Participants cited conflicting work commitments and practical difficulties getting to the location as reasons
for poor and late attendance:
It’s just other commitments, just busy-ness; generally we all work in various different places. On the
wards, here, in outpatient clinics, on other hospital sites.
Heart failure doctor, interview
We’re all pretty busy and for some of us, by the time we get to the meeting, have the meeting, that’s
a couple of hours out of the day.
Heart failure nurse, interview
Participation
As outlined in Theme 2: influence of multidisciplinarity on implementation, participants emphasised the
value of multidisciplinary participation in MDT meetings. However there was some dissatisfaction with how
this played out in practice.
There was also evidence that not all members found the meetings to be a valuable use of their time.
Though the very senior members tended to participate in all discussions, most attendees contributed only
when discussing patients directly under their care and many rarely spoke at all:
There were fifteen, sixteen, seventeen people are sitting doing nothing because other people’s
patients were being discussed. You’re actually using up about 14 personnel in one of those meetings,
that’s the equivalent of having another worker on the team and that felt like an enormous waste at
the time.
Memory clinic doctor, interview
Tedious . . . we are talking about people that, you haven’t got a clue what they look like, who
they are.
Mental health nurse, interview
In addition, some interviewees complained that the team lacked key professional groups; for example, two
of the mental health teams did not have a psychologist. Several mentioned that it would be useful to have
involvement from other disciplines such as general practice and palliative care.
Theme 5: administrative support and the role of the multidisciplinary team
co-ordinator
There was wide variation in how MDT meetings were organised in different specialties. All cancer
teams studied had dedicated MDT co-ordinators, while in heart failure, memory and mental health,
administrative duties were undertaken by managers, health-care professionals and general administrators.
Cancer MDT co-ordinator responsibilities included distributing lists of patients for discussion, operating IT
equipment for imaging and video-links, recording attendance, ensuring that medical records and test
results were available at the meeting, and monitoring patient review periods and compliance with waiting
time targets. Some MDT co-ordinators also recorded the outcome of each MDT discussion.
In teams without MDT co-ordinators, administrative support was more limited and MDT related
administration was largely undertaken by the professionals themselves. There was evidence that some
professionals resented having to perform administrative functions, as it detracted from their ability to
perform their professional roles:
It’s a bit stressful . . . doing an admin role as well as participating as a professional.
Mental health nurse, interview
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What is the manager’s role? Is it just to be the admin person who produces the minutes and sort of
chairs the meeting meekly on behalf of the psychiatrists so they don’t have to? Or is it to say no, this is
where we’re going with this team?
Mental health team manager, interview
In teams without MDT co-ordinators, meetings were often disrupted by people having to leave to get
documents which were necessary for the discussion (e.g. test results, medical records). There was
occasionally confusion about whether or not particular patients had already been discussed at
previous meetings:
We don’t have the form, what are we going to do? Isn’t it on a memory stick? . . . I’ll just go
quickly upstairs.
Memory clinic doctor 1, observation
I think I’ve already discussed him . . . I don’t know, I haven’t brought him, erm I am not sure . . . I can’t
remember . . . have I discussed him?
Memory clinic doctor 2, observation
In contrast, in cancer teams, MDT co-ordinators ensured that relevant documents were brought to the
meeting and kept track of which cases had been discussed previously and which were due for discussion.
Even in these teams, however, missing information was a relatively common problem, particularly when
the team was reliant on information being transferred from another hospital:
Diagnostic doctor: I don’t have the stains.
MDT co-ordinator: The histology’s not ready yet, do you want to leave it?
Doctor: Yep so we’ll have to move that to another week.
Cancer team, observation
It was clear from observations that, while there were similarities across teams in their administrative needs
(e.g. having access to relevant documents), there were also differences. For example, an important part of
the MDT co-ordinator role in cancer related to monitoring waiting times against national targets and
co-ordinating pathology and radiology results. However, not all MDTs in other disease specialties routinely
used radiology, pathology or other diagnostic information during their decision-making.
It is noteworthy that, among those teams which did not have dedicated co-ordinators, some managed
administration more effectively than others. For example, one of the memory teams brought a laptop to
the meeting which allowed them to access electronic medical records on demand. This meant that there
was rarely any missing information or disruption due to people leaving to retrieve documents. Conversely,
those teams with MDT co-ordinators were not immune to administrative and procedural problems
(e.g. raising patients for discussion before necessary test results were available and providing
out-of-date information):
We’re not good at updating the dialogue box about the patient which describes their history,
comorbidities, etc. and sometimes you’ll find that those comments relate to six months before and the
MDT co-ordinator has just cut and pasted them on to the sheet and I don’t think that’s good . . . if it’s
not accurate that’s very upsetting.
Cancer doctor, interview
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Multidisciplinary team meeting processes
Theme 6: chairing the multidisciplinary team meeting
The observation data showed that chairing varied considerably between teams. Most meetings were
formally chaired by a member of the team: in cancer teams, one memory clinic team and two mental
health teams, this was a designated person who chaired the meeting each week (either a consultant or the
team manager). In two mental health teams, the chairperson rotated between team members on a weekly
basis. The remaining three teams did not have a predefined chairing system and different senior members
took the lead on different occasions, sometimes changing during a meeting.
Some members argued that it was a significant responsibility for one person to chair the meeting every
week, and rotating between team members was seen as a way to reduce this burden. In addition, it was
suggested that rotating this role provided an opportunity for everyone in the team to acquire
chairing skills:
I liked the idea of having a rotating chair to give the others the opportunity to take on that skill.
Mental health doctor, interview
However, in teams with a rotating chairperson there were several occasions during the observation period
when members did not know who was due to chair specific meetings, resulting in delays to the start of
the meeting. In addition, some members acknowledged the specific skills needed to chair a meeting
effectively, and argued that not everyone had the necessary authority or training to keep presentations
succinct and discussions focused:
We rotate it, and some people chair better than others, and it depends on their sense of authority.
Mental health psychologist, interview
I think one of the weaknesses is everyone chairing and therefore everyone being lumbered two or
three times a year . . . [Senior members chairing] makes a little bit more sense because then that
person can deliver their control of the group a bit more. I think one of the reasons why they pass it
around . . . was the idea of having everyone as equals, but not everyone was as equals.
Mental health nurse, interview
Theme 7: agreeing which patients should be discussed in multidisciplinary
team meetings
Teams had different approaches to selecting patients to be discussed in MDT meetings. In the
cancer teams, for example, all new patients were routinely discussed to agree an initial treatment plan,
and patients tended to be discussed again only if a clinician had specific concerns. One mental health team
went through the whole team caseload at each meeting. In contrast, heart failure team meetings focused
only on specific groups of patients, for example all inpatients, and in most mental health and memory
clinic meetings team members were given the opportunity to discuss patients if, or as and when, they
thought it was necessary.
It became clear that there were different opinions among MDT members about which patients should be
discussed in MDT meetings. Some argued that only complex cases should be raised because in many cases
the same decision would be made even if that patient was not discussed in the meeting:
I think for most, the decision, the treatment decision is the treatment decision that most people would
have come to conclude just through their knowledge base or an informal chat in clinic.
Cancer doctor, interview
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There were also concerns about time constraints in the meeting, and prioritising patients according to
complexity was seen as one way of ensuring that there was sufficient time to discuss those patients who
would most benefit from multidisciplinary input:
Sometimes there are too many patients which means that some patients are not discussed or the
discussion might be a bit rushed about some patients.
Cancer diagnostic doctor, interview
Another member warned of the dangers of creating a ‘tick box exercise’ (cancer nurse, interview) if too
much emphasis was placed on discussing all new patients.
However, in spite of these concerns, many acknowledged the practical difficulties of stratifying patients
according to complexity, for example how to determine in advance which patients would benefit the most
from an MDT discussion. As one interviewee pointed out:
In the majority of cases you can pick up the ones that need more discussion, but there are always the
surprise patients who throw up something unusual, who you can’t identify beforehand, and that’s
the problem.
Cancer doctor, interview
It was also suggested that patients who were not discussed might miss out on the benefits of a
multidisciplinary discussion, including consideration of different options and a decision-making process that
was transparent and subject to scrutiny because ‘you have to robustly defend your decision in the MDT’
(cancer doctor, interview).
In teams which focused on complex cases, there was concern that devoting too much time to the most
anxiety-provoking or risky cases could lead to the neglect of others:
The quiet clients might not get discussed, the ones who aren’t causing worry . . . not being very tightly
looked after.
Mental health psychologist, interview
Some members also believed that patients could ‘only’ benefit from being discussed in an MDT:
‘it certainly can’t make anything worse I don’t think’ (heart failure doctor, interview).
It was suggested that one solution would be to prioritise patients in advance of the meeting to allow for
more time for complex patients, without necessarily excluding other patients completely:
I think we discuss a lot of follow ups that maybe don’t need to perhaps see the images or actually
formally discuss them. You could say, you know, ‘End of treatment scans show complete response,
you know, and treatment ended.’ You could save maybe a bit of time in that way.
Cancer nurse, interview
Finally, another perspective was provided by a patient, who pointed out that not all patients want to be
discussed in an MDT meeting, because they do not like the thought of being discussed by people they
have never met:
These are people who I’ve never met who are reading abbreviations and in my case I find that very
dangerous . . . I don’t really agree with some cases being a multidisciplinary discussion.
Memory clinic patient, interview
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Theme 8: preparing and presenting cases for discussion
Preparing patient lists for discussion
In order to determine which patients were to be discussed at the MDT meeting, cancer teams and one of
the heart failure teams had a patient list which was circulated to members in advance of the meeting
(either by an MDT co-ordinator or by a clinical member of the team). Any member of the MDT could add
to this list in advance of the meeting. In some cases, members also had to record the specific reason for
bringing each patient for discussion.
The observation data highlighted a number of benefits to using a formal structured approach to determine
which patients were discussed each week. This included the opportunity to collate all the necessary
material needed to discuss a patient before the meeting:
They [reference to another MDT] are so organised and you literally go from one patient to the next to
the next very smoothly, at a fair speed and still get all the information that you want.
Cancer nurse, interview
Patient lists were also used by some chairpersons to manage the meeting, because they knew in advance
how many patients needed to be discussed and could prioritise cases on this basis:
There are around seven cases left so if there were those that have to be presented before we end the
meeting we could talk about those.
Cancer team doctor, observation
Using a patient list also encouraged MDT members to define a specific query in advance of the meeting,
leading to improved focus during the presentation.
Most importantly, however, having a patient list agreed in advance of the meeting was a means of
ensuring that patients were not forgotten about. Teams which did not have a structured approach to
selecting cases for discussion in the MDT meeting relied on members presenting patients as and when
they thought it necessary. There was a risk with this approach that some patients would be
forgotten about:
Because you’re so busy you end up at that meeting and there probably are things but you haven’t
kind of thought about it and then you’re thinking at the end ‘oh no I wanted to talk about . . .’.
Mental health social worker, interview
This was also illustrated in a meeting where the chairperson asked if there were any Mental Health Act
assessments. Someone replied that there was one last week that ‘I completely forgot to mention’ (mental
health professional, observation).
However, there were a number of other arguments put forward that suggested that some flexibility in
determining which patients were to be discussed was a positive thing. One issue related to the resources
need to collate a patient list, because this relied on a member of the team co-ordinating this every week.
In addition, some felt that an informal approach where all team members were asked in the meeting if
there was anyone they wanted to discuss could be more inclusive, creating the expectation that all
individuals should participate in the discussions:
You would literally go round the table . . . which I think at least gives a sense of equal importance to
each member of the team.
Mental health social worker, interview
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It was also suggested that sticking too rigidly to a list can disadvantage some groups of patients, as the
order of patients on the list is likely to impact on the length of time available for their discussions:
Because of the time pressures on that meeting often what happens is . . . everyone else is rushed at
the end. So I would potentially either you have to curtail the cases a bit or you have to allow the
meeting to go on longer and maybe mix up the order a bit . . . maybe one week you start with a
different [patient group] just so that there’s, just more room for some other, some other cases.
Cancer nurse, interview
Presenting cases for discussion
Again, differences were apparent between teams in the way that patients were presented in the MDT
meeting. A relatively structured approach was used in the cancer and heart failure teams. This involved a
brief case presentation of predominantly clinical information, followed by review of any relevant imaging
or pathology results, and discussion and/or decision-making.
This contrasted with the approach taken in mental health and memory teams, where case presentations
were less structured but generally more holistic, and focused on the patient and their personal and social
circumstances as well as (and at times instead of) biomedical information. Specifically, some MDT meetings
were characterised by lengthy presentations in which information was not prioritised according to its
relevance for decision-making – ‘sometimes they go in unbelievable detail into incredibly irrelevant things’
(memory clinic doctor, interview) – and, in some cases, MDT members were unclear why a patient had
been presented because no queries were raised: ‘Thanks for sharing that story, why did we hear it?’
(Mental health doctor, observation.)
The need for more focus in presentations was raised by MDT members from all types of team (cancer,
mental health, memory and heart failure). A clearly structured presentation was seen as beneficial for a
number of reasons, including the fact that it could open up a discussion to all team members, by ensuring
that everyone had enough information to comment constructively on the case: ‘unless you know the
background to the case well it’s very difficult to disagree’ (cancer doctor, interview).
It was also argued that well-structured presentations kept the meetings focused and more interesting,
because otherwise:
People tend to dwell on cases and then everyone loses interest.
Cancer diagnostic doctor, interview
However, there were barriers to achieving focused and structured presentations, including the fact that
some members were unsure of the best way to do this, particularly for complex cases:
Because I find myself it’s hard to discuss inpatients in a meeting when they’re very complex and
there’s an awful lot going on with them . . . I did find it difficult at the beginning. And it’s also getting
to know how people work and how people like you to present things as well.
Heart failure nurse, interview
In addition, some members stated that they valued the flexible nature of case presentations to stimulate
more creative solutions to complex problems.
I’ve found a lot of times when I’m going to the doctors with my different opinion . . . you say what
you have to say quickly . . . whereas in the meeting . . . at least you have that time to go back and
forth and go back and forth.
Mental health nurse, interview
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It was also apparent that different members within teams prioritised different types of information as
important for discussion. This meant there was potential for certain types of information to be overlooked
if there was too much emphasis on presenting information in a structured format.
Theme 9: recording and reviewing multidisciplinary team decisions
Recording multidisciplinary team decisions
The process, completeness and accuracy of documentation varied widely across teams and specialties. In
some teams decisions or treatment plans were typed directly into patients’ electronic records, on a screen
visible to all members of the team. In other teams, handwritten records were made and subsequently filed
in the patient’s notes. In others, actions were noted as part of the minutes of the meeting, or recorded in
a notebook. In this last case, patient names were often misspelled or omitted, making it impossible to link
decisions and action points to particular patients (Table 18).
There was also variation in how easily accessible the minutes were to team members after the meeting, for
example whether the outcome of the MDT discussion was recorded in a patient’s notes or in a hardcopy
book kept by a single member of the team.
TABLE 18 Documentation of decisions across the 12 MDTs
Team
Recorded
electronically
Recorded
manually
Visible to others
during meeting
Systematically
recorded
in/transferred
to patient notes
Recorded
by clinician
Recorded by
administrator
Cancer 1 ✓ ✓ ✓ ✓
Cancer 2 ✓ ✓ ✓
Cancer 3 ✓ ✓ ✓ ✓
Cancer 4 ✓ ✓ ✓
Mental
health 1
✓ ✓
Mental
health 2
✓ ✓
Mental
health 3
✓ ✓
Mental
health 4
✓ ✓
Heart
failure 1
✓ ✓ ✓
Heart
failure 2
✓a ✓
Memory
clinic 1
✓ ✓ ✓
Memory
clinic 2
✓a ✓ ✓
a These teams did not formally record decisions but we observed professionals making notes during discussions.
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In one heart failure team, the lack of documentation was attributed to the fact that there was ‘no admin
support, no real guidelines’ (heart failure nurse 1, interview).
We don’t take official MDT meeting notes as such, I imagine that’s something we should do . . . it
would be a huge extra work load for us if we were to you know start typing up minutes and
everything . . . might be beneficial because we don’t keep a very accurate list of people who’ve been
discussed . . . if we were to be audited we probably wouldn’t do very well.
Heart failure nurse 2, interview
Review of multidisciplinary team decisions
Variation in the quality of documenting decisions has implications for the ability to undertake reviews and
audits. In most teams there was no formal audit of the outcomes of the MDT meeting, although some
MDT members stated that they would like to know how their MDT performed:
It would be interesting to audit the MDT decision against what happens . . . if the MDT decision is
consistently not the one that gets done, then that tells you that either people don’t listen to the MDT
in which case why are you doing it? Or they listen but the MDT’s missing something.
Cancer doctor, interview
MDT members overall thought it was a good idea to review the MDT outcomes, and, in one MDT, a
member stated that there were plans to audit outcomes but that this was not the case at the moment:
I think that there is a plan to try and audit outcomes of the first two hundred odd patients who were
discussed here to see whether it is possible to demonstrate improved care.
Heart failure doctor, interview
Members also suggested that MDT processes and discussions should be audited:
Perhaps record the discussions and some sort of audit to make sure that all the right things have been
discussed, the right course of treatment options have been considered and to work out if we are
doing things as we should be, according to best evidence based practice. And that would also have
the benefit of course of allowing audit of what we do rather than having to go back and
retrospectively audit everybody.
Heart failure doctor, interview
However, some were concerned that having too many audit procedures can be unhelpful:
Maybe [auditing outcomes] is something we should do, but then we keep other audits and it’s just
how many? Is it, would it be useful?
Heart failure nurse, interview
Content of discussion in multidisciplinary team meetings
Theme 10: the role of research and evidence in multidisciplinary
team meetings
There was variation across teams in how frequently they referred to scientific evidence and research in
MDT meetings. There were a number of contexts in which research was discussed. During specific patient
discussions, teams sometimes mentioned evidence in favour of particular treatment options or debated
whether or not it would be appropriate to recruit a patient to a particular trial:
Doctor: I was just thinking with the trial if he was encouraged.
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Nurse: Oh right, ok no I don’t think, I don’t think he’s somebody who’d be particularly suitable
for that.
Mental health team, observation
Doctor 1: Do we know from the [trial]? Has anyone published data on using stress echo to.
Doctor 2: We have, we are using, I mean there’s no publication but we are doing stress echoes on
many of such patients.
Doctor 1: And they’re following them up and seeing what . . . because I think it would be very useful
for this chap, obviously we’ll have a chat with him and see what he would like, but if he is agreeable
to going ahead for the assessment, we can . . . discuss him with one of the [trial] people.
Heart failure team, observation
Referencing evidence in relation to specific patient discussions was most common in cancer and heart
failure, followed by memory and then mental health meetings, where research and evidence were
mentioned only occasionally.
Research was also mentioned as a point of learning:
There’s an interesting paper in this week’s BMJ looking at the radiation risk from CT scans and you
know I think that’s something that’s going to be increasing topic of how we are following up patients.
Cancer doctor, observation
For some this was seen as an important function of the meeting:
I think it is educational because everybody keeps up to date with the latest research . . . it’s a
cascading way of information giving.
Cancer doctor, interview
Research was generally mentioned by consultant doctors. The reliance on senior consultants making the
decisions in cancer and heart failure teams was attributed to the fact that they have ‘the experience and
the evidence base’ (cancer doctor, interview). For non-medical team members, using research evidence was
seen as a way of capturing the attention of the rest of the team when they perceived that they were not
being listened to:
The times where you feel you just had to pull something from your ragbag of research knowledge,
you just go bat, bat and they go ‘oh, that’s very interesting’.
Cancer psychologist, interview
While evidence was sometimes used as a means of resolving disagreements, at other times discussions of
research turned into long debates that were not always relevant to the case under discussion.
There was also concern that an overzealous focus on research evidence could lead to neglect of the
specific needs of individual patients, and the more holistic aspects of care:
I think cardiologists are very focussed on treatment but they don’t always look at the whole person
and I suppose that’s where nurses step in and try and treat the patient holistically as well as all the
lovely evidence based practice and all the rest of it.
Heart failure nurse, interview
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Theme 11: discussing comorbidities at multidisciplinary team meetings
As described in Theme 5: roles that patient preference, health behaviours and other clinical factors may
have in explaining the socioeconomic variations in implementation, there was variation across teams in the
extent to which patient comorbidities were mentioned during case discussions. No team had a formal
process for discussing information on comorbidities, although some discussed this information regularly
(mental health, memory and one cancer MDT). Most, however, discussed this on an ad hoc basis, ‘not
routinely done, is done case by case depending on the circumstances’ (memory clinic manager, interview).
Overall, MDT members and patients considered discussion of comorbidities to be important. MDT
professionals highlighted the importance of considering how different conditions interact, and that
discussion of comorbidities helped to determine suitable management options and informed differential
diagnosis (e.g. cognitive impairment and depression):
Some of the cancers are, you’re at a higher risk if you’ve got a pre-existing comorbidity so
obesity, diabetes.
Cancer nurse, interview
Some of our service users smoke a lot, smoke too much so we have to be mindful of the fact that a
physical illness can impact on mental illness and vice versa . . . you can’t have one in isolation from the
other, it’s a human being we’re talking about.
Mental health social worker, interview
The majority of professional interviewees believed that comorbidities were appropriately considered
where relevant:
We send people off for exercise tolerance tests and you know think very carefully about, how best we
can manage their comorbidities.
Cancer nurse, interview
It was argued that the presentation of comorbidities encouraged a holistic approach to treatment,
for example, by highlighting issues relevant to patient engagement and adherence:
Comorbidities . . . they obviously impact on the whole treatment and particularly cognitive impairment
and how they [patients] co-operate and comply.
Heart failure nurse, interview
Patients also stated that they wanted their comorbidities to be considered and included in treatment plans,
as they were important for their quality of life.
However, MDT members also identified a number of barriers to the inclusion of comorbidities during MDT
meetings. They stated that information on comorbidities was not always available in advance of an MDT
meeting, for example when teams were discussing patients for the first time, ‘discussing people you’ve
never seen’ (cancer doctor, interview). Information on comorbidities could also be inaccurate or
incomplete (e.g. as a result of incomplete assessment): ‘often the letters you get give you no indication’
(cancer surgeon, interview). MDT members also stated that clinicians did not always capture this
information appropriately:
They’re clearly very important and the problem is these patients are normally seen by the surgeons . . .
as a rule surgeons don’t take detailed histories. So if you don’t take a history you can’t capture
a comorbidity.
Cancer doctor, interview
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Another issue identified in discussing comorbidities routinely was that it added to the volume of potentially
irrelevant information to be considered by the team, which could hamper decision-making: ‘we already
discuss things in sometimes in too great a detail’ (cancer doctor, interview). This was supported by analysis
of the observation data, where one team in particular allocated significant time to the presentation of
health behaviours, comorbidities and medical and family history, which were often irrelevant to the
presenting complaint: ‘It is just not relevant for somebody aged 75 if they had a normal delivery’ (memory
clinic doctor, interview).
Theme 12: discussing patients holistically
Our analysis revealed differences between specialties in the degree to which discussions focused on
psychosocial issues in addition to biomedical complaints.
Mental health and memory MDT members placed much more emphasis on describing the patient’s social
circumstances in depth:
He is in some respects a product of his environment. Very, very dysfunctional family. The mother is
regarded to be an inadequate parent, an inadequate person, not being derogatory . . . failed to
establish any boundaries whatsoever in the household . . . his sister was under children’s services under
child protection on the basis that mum was unable to keep her safe. There was lots of sibling rivalry
between himself and the sister, there was lots of antisocial behaviour from him and his lifestyle that
was taking place at the family home.
Mental health social worker, observation
Cancer and heart failure teams spent significantly less time on holistic discussions and focused instead on
the presenting biomedical complaint: ‘[patient name] came in [on date] with bilateral leg cellulitis and fluid
overload’ (heart failure nurse, observation).
These teams did mention psychosocial issues, but only briefly, usually as part of a structured
presentation – ‘he’s a 75 year old retired printer’ (heart failure doctor, observation) – or where particularly
relevant to a biomedical treatment:
She’ll be very concerned about hair loss I suspect. She’s a hairdresser, she’s, she’s, I had to write her a
letter to say it was ok for her to go for a botox injection and she’s quite into her aesthetics so she
wouldn’t be too keen to go for chemo from that perspective I’d imagine.
Cancer doctor, observation
Most MDT members believed that they included information on patients’ psychosocial circumstances
where relevant. However, some thought that discussions were overly focused on clinical factors to the
exclusion of important psychosocial factors:
I think one always has to be mindful not to forget the individual details of the individual patient that
one’s discussing. So when you come to consensus decision there is a danger of losing some of the
individual characteristics or comorbidities of that particular patient.
Cancer doctor, interview
It would be good to discuss the holistic patients – this is what I thought an MDT was supposed to
do – discuss the case as a whole . . . but that’s not discussed there.
Heart failure nurse, interview
STUDY 1 QUALITATIVE RESULTS
NIHR Journals Library www.journalslibrary.nihr.ac.uk
60
Patients also highlighted the need to be recognised as individuals, not as ‘presenting complaints’:
I would like them to, perhaps [name] the heart nurse there, to just describe what sort of a person I am
. . . When they are discussing me I would like someone, like [nurse] or someone like that, just to stand
up and say ‘Mr X is so and so . . .’ so they have got a picture of someone who they can then discuss.
Heart failure patient, interview
However, MDT members also highlighted a number of barriers to discussing patients in a holistic way. One
reason was the limited time available:
There are a lot of people to be discussed in it, that must be discussed in it and that’s always a
challenge between giving enough time to have a full discussion versus getting everyone discussed.
Cancer nurse, interview
In addition, some MDTs discussed patients who were based at different hospitals so it was not always
feasible to gather psychosocial information in time for the MDT meeting:
Because they’re discussing so many people that are not in this hospital, we don’t necessarily know the
social situation.
Heart failure nurse, interview
Theme 13: incorporating patient preferences about treatment into
multidisciplinary team discussions
As well as different perspectives on the most appropriate time to consider patient preferences (outlined in
Theme 5: roles that patient preference, health behaviours and other clinical factors may have in explaining
the socioeconomic variations in implementation), we found differences between disease specialties both in
terms of the frequency with which patient treatment preferences were mentioned, and in the nature of
the information that was discussed. This was most striking when comparing mental health and cancer
MDTs. In mental health, discussion of patient preferences often revolved around whether patients wanted
to avail themselves of services or not. Treatment options were often restricted by resource issues
(e.g. unavailability of psychologists), and discussions of choice tended to focus on practicalities such
as the timing and mode of delivery of care, rather than choices between different treatments:
Making sure that they have got a bit of choice about who, where, what, when that kind of thing.
Mental health social worker, interview
In contrast, discussions of patient preferences in cancer MDTs tended to focus on treatment alternatives, and
were most likely to be mentioned if the patient’s preference differed from the recommendation of the MDT:
I think the standard of care would be to assess his cardiac status to see if he was fit for
[chemotherapy] or if he wasn’t . . . consider other agents . . . but this man does not want intravenous
chemotherapy and this was something that he was adamant about 18 months ago and he has
reiterated, so I would like to consider for the patient [alternative treatment option,] he knows it is not
the standard of care . . . it’s against my better judgement but that is what he would like.
Cancer doctor, observation
Options around the practicalities of care were dealt with outside of the cancer MDT (e.g. through choice
of appointment time).
Across teams, certain professionals (clinical nurse specialists in cancer and heart failure, and care co-ordinators
in mental health) were perceived to be advocates for patients and best placed to know their preferences:
I mean as a nurse, you know, you should sort of represent the patients and their preferences.
Mental health nurse, interview
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However, other team members also acknowledged the benefits of taking patient preferences into account
when making decisions:
I mean I think it’s important for patients, it’s also important for teams because if you don’t take
patients’ views into account that does create a lot of problems for the team in the long run.
Memory clinic doctor, interview
Some felt that patient preferences were not adequately considered in the meetings:
Sometimes I think the patients’ understanding of the disease and their beliefs about treatment and
what not are swept under the carpet a little bit.
Heart failure doctor, interview
I think it may be that patients’ preferences aren’t systematically sort of brought into
decision-making enough.
Mental health social worker, interview
In contrast, others argued that, although patient preferences were important, the MDT meeting was not
always the best place to discuss them. One of the reasons given for this was that it was more appropriate
to have an informed discussion with the patient after the risks and benefits of different treatments had
been discussed at the MDT meeting:
I think one of the advantages of the MDT is it’s there to provide them with a degree of certainty about
their treatment, and wherever possible, I think if there are options they need to be put to the patient.
But at least having gone through the MDT they’re going to be realistic options.
Cancer doctor, member interview
It was argued that the patient was the final decision maker and could choose from the options identified
following the MDT meeting:
If all the options are equal, then you need to discuss with the patient and see what they wish to do,
I think that’s the right thing.
Cancer doctor, interview
Some patients agreed with the idea that clinical decisions should initially be independent of patient input:
What the teams ought to be doing is coming to the best clinical decisions . . . and then take my
preferences into consideration.
Cancer patient, interview
Other explanations given for not considering patient preferences in the MDT meeting were that patient
preferences could change over time, and that preferences are not always known, for example when a new
patient was being presented or when a patient was added to the list at very short notice.
It was also noted that it was not always appropriate to allow patient preferences to influence
decision-making (e.g. when considering compulsory admissions or preferences based on racist or
homophobic beliefs). Members also suggested that the ‘patient choice agenda’ could result in raised
expectations when resources were not available:
People’s expectations are sometimes such that what they want is not particularly what we can
provide necessarily.
Heart failure nurse, interview
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From a patient perspective, it was clear that different patients wanted different levels of choice. Many
patients did want their treatment preferences to be considered (including treatment type and location for
receipt of treatment):
I think it’s really important to have involvement in whatever treatment you’re offered.
Mental health patient, interview
The major decisions I think you should be consulted or be able to put your point of view forward.
Heart failure patient, interview
However, a desire for choice depended on, among other things, the severity of illness. For example, for
critical decisions, survival was paramount and patients did not always think that their treatment
preferences needed to be discussed:
Well I knew I had to have it [chemotherapy], I didn’t have much choice it was either that or die . . .
there does come a point where you don’t really have . . . perhaps at the stage my cancer was I didn’t
really have a choice.
Cancer patient, interview
Patients also acknowledged that the team could not always know all the factors that would influence their
personal choice in advance of the MDT meeting:
I suspect actually that most of, most of the real issues that would make me make a decision, you
know, based on what I’ve been given are things that the hospital couldn’t possibly really know about.
Cancer patient, interview
Finally, some patients believed that the doctor was the expert, and they should follow the advice they were given:
I think they know what they are doing and yes you know it is all very well saying ‘I could do this’ and
‘I could do that’ but I think if you’ve got faith in them then yes you go along with what they say.
Cancer patient, interview
I don’t try to interfere. First I know that they are doing what’s best for me . . . I’m confident they are
doing the right thing.
Heart failure patient, interview
This was quite common among cancer and heart failure patients who stated that they trusted their
clinicians and believed they would make the best decision: ‘it has got to be in my interest healthwise
rather than what I want’ (heart failure patient, interview). In contrast, some memory clinic and mental
health patients expressed a lack of trust in the decision-making process and felt that they had not
been involved:
They’re based too much on a very narrow erm, there’s no decision, if you have a problem, it’s a tablet,
that’s the answer.
Memory clinic patient, interview
I don’t really know how they’re [decisions] made to be honest. I don’t know, I don’t believe I have any
part in that.
Mental health patient, interview
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The role of the patient in multidisciplinary team meetings
Theme 14: patient awareness of multidisciplinary team meetings
Not all patients were aware that their cases were being discussed at MDT meetings. All cancer patients
interviewed were aware of the MDT meetings: ‘I knew there’d been a group of people discussing it’
(cancer patient, interview). In contrast, patients in other specialties were often unaware of the existence of
an MDT meeting:
The only person that makes that decision about my welfare and my state is Dr [name].
Heart failure patient, interview
[I] don’t know anything about any of that. Like behind the scenes stuff . . . I don’t know whether the
psychologist meets and discusses my case with the multidisciplinary team or whether she discusses my
case with an individual supervisor, I have no idea . . . I have no idea who I’m discussed with. I’d quite
like to know.
Mental health patient, interview
Patients who were aware of the MDT meeting reported that they felt more confident when a decision was
made by an MDT rather than one person:
When we’re in that kind of interim period like we are now and you see one of the less senior doctors,
you feel quite confident because you know it’s a team.
Cancer carer, interview
Although most patients did not object to being discussed by a team, a small number of mental health and
memory clinic patients were uncomfortable with the idea because of concerns about confidentiality and
how they would be portrayed. Some patients did not want people they did not know discussing their care:
I think it’s only a useful forum if it’s a multidisciplinary team meeting with team members who are
working with that client. But if you’ve just got lots of extra team members who have never met them,
got nothing to do with them then where’s the relevance in them even being there?
Mental health patient, interview
There was a concern that patients may be misrepresented at MDT meetings:
Come to my home address or have me in here or whatever rather than asking a member of a team
who you might not get on with that good, you might not have a good rapport with them.
Mental health patient, interview
Some patients also felt that the MDT meeting was not a good use of resources:
If they’re not working with you directly, it just seems like a waste of time and resources . . . these are
people who you’re potentially never going to meet, don’t even know the names of, are like just an
invisible team in the background, it’s like, they could be using those hours actually going out and
working with people and providing the care that people need instead of having so much discussion.
Mental health patient, interview
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Theme 15: patient attendance at multidisciplinary team meetings
The option of inviting patients to attend the meeting was not discussed in any of the MDT meetings we
observed. Patients’ views and experiences were fed into MDT discussions in an ad hoc rather than a
systematic manner. A small number of patients said that they would like to attend the meetings to ensure
that they were represented accurately, and to provide additional information:
I think the only way they can be represented is by the patients being there really isn’t it.
Memory clinic patient, interview
Overall, however, most patients stated that they would not want to attend MDT meetings as they felt it
would be confusing, impractical and potentially upsetting:
Well I don’t think I would like to go to the meeting because they talk in words I wouldn’t understand
and then I would come back here and I would sit and worry.
Heart failure patient, interview
It wouldn’t be very constructive to have to keep on stopping the meeting to ask well what does that
entail or what, you know that figure is that high, is it low or is it normal?
Cancer carer, interview
Most patients were happy to be represented by a professional who knew them:
People that we know like [doctor] and [nurse] it’s somehow easier than just sitting there hearing it . . .
discussed as a case.
Cancer patient, interview
Patients also suggested that they could be involved in other ways, such as adding to their own notes or
providing written or audio statements:
They were going to allow service users to add to their own notes, and like obviously not be able to
read what was written about them but they could actually update their notes and sort of like have a
little bit of input.
Mental health patient, interview
They could speak in the privacy of their home on maybe a phone and, and give a recording over of,
of what they, what they feel.
Heart failure patient, interview
Almost all MDT members felt that it would be inappropriate for patients to attend the meeting, citing the
reasons mentioned above, as well as the fact that the tone of discussions may be inappropriate for
patients to hear:
I think some of the decisions we take for granted . . . might seem quite bullish to people who are
just listening.
Cancer nurse, interview
They also argued that it would often be infeasible for patients to attend, as they are sometimes discussed
before they meet the clinician or key worker and in urgent cases there might be no time to arrange for
patients to attend.
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The observation analysis revealed a number of aspects of the meeting which would most likely have to
change were patients to attend. In mental health teams, discussions frequently centred around managing
relationships with patients, ethical dilemmas, challenging behaviours and peer support:
She denied stuff that we know to be the case. She denied the email, she denied the knocking on
neighbour’s door, she denied ringing police repeatedly.
Mental health doctor, observation
Manager: So how can we support [social worker] with [patient]?
Psychologist: I’d say that’s the only thing you can work with, feelings he generates. You know, your
role is to try and help him. And that’s the problem. You’ve got to try and stop helping him. ’Cause if
you take it in, then you just get completely crushed and feel rubbish yourself . . . you’re just gonna feel
crap the whole time, and that you’re somehow responsible for keeping this man alive and you’re not.
Mental health, observation
Discussions often involved criticising other services and the use of dark humour, which could be
problematic were patients to attend:
Doctor [reading GP referral letter]: ‘Please could you and your team take on this woman with whom
I’ve been fighting a losing battle’ [laughter] Well that’s encouraging . . . Why didn’t he start her
on [medication]?
Social worker: Because we’ve got magical powers! [laughter]
Doctor: At least we’ll be kept in work. So GPs don’t treat anyone any more.
Mental health, observation
It’s a combination of difficult patient and difficult GP.
Heart failure doctor, observation
Theme 16: providing feedback to patients on the outcome of
multidisciplinary team discussions
Patients’ experiences of feedback from MDT discussions varied, in terms of both the format and the level
of detail. Some were aware of when they were being discussed and expected that outcomes would be fed
back to them:
I know there was a discussion a couple of weeks ago at the, at the meeting to discuss whether the
stent should come out and I’m waiting to hear the results of that in fact.
Cancer patient, interview
Others did not receive any feedback on outcomes of the MDT discussions: ‘at the moment there’s no
information fed back to clients at all’ (mental health patient, interview).
Patients varied in the levels of detail they wanted fed back to them with some wanting minimal
information for various reasons:
I think sometimes ignorance is bliss, but not all patients feel that . . . I don’t think I need to know
every single detail.
Cancer patient, interview
The chances are I might not recognise what they’re talking about.
Heart failure patient, interview
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Others wanted to know about all treatment options discussed, including those that were ruled out by
the team:
There may be some wonderful treatment that actually stopped [dementia] in its tracks, but it costs
£20,000 a week and I’m sorry we can’t have it. And it would be interesting to know.
Memory clinic carer, interview
There were varied preferences even when it came to highly significant information:
Tell me when I’ve got like a month to live.
Heart failure patient 1, interview
If they say well maybe you’ve only got say six months to live or something like that, I don’t think I
would want to know that.
Heart failure patient 2, interview
Some MDT members emphasised that they use their professional judgement to decide the level and
content of feedback appropriate for each patient at a given time (e.g. according to patient anxiety levels
and comprehension). There were several occasions when the team decided not to disclose diagnoses to
patients if they felt it would make them unnecessarily anxious: ‘I don’t think there’s any point actually
giving her feedback and making her anxious’ (memory clinic doctor, observation). However, there were
mixed views from patients on the withholding of information by the team:
I mean some people can’t handle the situation and some people can.
Heart failure patient, interview
A person has a right to know everything no matter how ill they are.
Memory clinic patient, interview
Patients’ preferences regarding the mode of feedback also varied, with some saying they would prefer a
phone call and others preferring a written record.
Chapter summary
In this chapter we have provided an overview of the teams studied and their different contexts. We then
presented findings from our qualitative exploration of the quantitative findings, and from our investigation
of areas of diversity in beliefs and practice across the teams. In Chapter 5 we discuss the findings from
study 1, consider its limitations and draw conclusions.
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Chapter 5 Study 1 discussion
In this large study, the first to include MDTs for different conditions, we have identified specific team andpatient features which impact on decision implementation, and we have delineated 16 key areas where
there is substantial diversity in beliefs and practices across MDT meetings.
Identifying factors that influence decision implementation
Rates of implementation varied between specialties, with gynaecological cancer having the highest
implementation rate and CMHTs the lowest. Examining the policy context within which these teams
operate provides some insights into these differences. Mental health policy and guidance is much less
detailed than that in cancer, in terms of the expected attendance, structure and administrative support at
MDT meetings. Cancer teams use clear guidelines regarding the MDT purpose and processes, which
translated into clearly structured MDT meetings. These include guidelines on documentation,112
attendance,42 chairing113 and administrative support.1
The clearly structured, guideline-driven cancer MDT meetings are in no small part a consequence of the
historic priority given to cancer research, which has produced a robust evidence base for the care of cancer
patients. In contrast to mental health, which received 3.5% of Medical Research Council (MRC) funding
in 2008/9, cancer research received 14.6% of MRC funds.114 This is despite the fact that mental illness
accounts for 23% of the overall disease burden in the UK, while cancer accounts for 16%.48 There
have been recent efforts to redress this balance, with MRC spending in 2012/13 rising to 21.5% for
neurological and mental health research, and falling to 6.2% for cancer.115 In time, this shift is likely to
strengthen the evidence base for decision-making by mental health MDTs.
Another factor which could be argued to influence rates of implementation for teams focusing on
different conditions is the type of patient outcome which the teams focus on. The International
Classification of Functioning, Disability and Health (ICF) identifies three levels of human functioning:
functioning at the level of body or body part (body functions and structures), the whole person
(engagement in activities) and the whole person in a social context (participation in society).116 The clinical
conditions which we studied could be argued to vary with respect to the extent to which the MDT
meetings would focus on managing and treating diseases and on facilitating patients’ meaningful
participation in society. For those teams whose primary focus is to improve physical functioning, universally
relevant treatment guidelines are more commonly available. Teams which also place a heavy emphasis on
assisting patients’ participation in society may need to develop more individualised treatment plans.
Treatment plans relating to an individual’s participation in society may also be more inherently difficult to
implement, because they are more likely to rely on multiagency collaboration and complex social and
cultural factors.
Contrary to previous reports and expectations, greater multidisciplinarity was not necessarily associated
with more effective decision-making. This has important implications, as a major assumption underpinning
MDT meetings is that more multidisciplinary input leads to better and more informed decisions for
patients, with each team member bringing relevant information for the development of a cohesive care
plan.117 Our data suggest that the relationship between multidisciplinarity and MDT decision
implementation is mediated by other factors such as clarity of purpose and agreed processes. This is
supported by evidence which points to the benefits of shared objectives to guide and structure
communication,118 focused leadership119 and team reflexivity.21
It is also noteworthy that the teams which implemented the most decisions tended to be the most
medically dominated in terms of both attendance and participation. Higher implementation rates among
more homogeneous (medically qualified) groups are perhaps unsurprising given a higher likelihood of a
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shared biomedical perspective which drives the decisions made and implemented. However, the inclusion
of additional perspectives in the decision-making process may improve decision quality with respect to
patient experience, choice and patient-centred outcomes. It was beyond the scope of this study to examine
such components of decision-making, but it remains an important area for future investigation.
Effective teamwork is therefore necessary for the potential benefits of multidisciplinarity to be achieved.
MDT members identified difficulties in working across disciplinary boundaries, in terms of both status
differences and differing professional perspectives. In line with other research, we found that not all
professional groups participated equally in MDT discussions.120 Cancer and heart failure teams in particular
were characterised by a strong medical dominance which was manifest both in the degree of participation
and in the seating arrangements. We found some evidence that conflicting disciplinary perspectives made
multidisciplinary working a challenge, an issue that has been identified in previous research.21,121 For
example, mental health professionals identified differences in how social workers and nurses viewed their
roles (e.g. as healers or as human rights advocates), which sometimes made it difficult to collaborate.
In the absence of clear national guidance, team reflection on the assumptions underpinning each
disciplinary perspective and clarity regarding the role of each professional group may be necessary to
develop a shared perspective and agreement on the purpose of the meetings.
We also found that a positive team climate was an important predictor of treatment plan implementation
across teams. This finding corroborates previous research which has demonstrated that a good team
climate can translate to better decisions.23,122 It also adds to the body of evidence demonstrating the
effects of local context on team performance34 and supports research that has highlighted the importance
of positive relationships, teamwork and supportive systems to effectiveness.36 It was clear from our
qualitative data that local context, in this case restructuring in mental health teams, had a significant
impact on staff morale and many believed it hindered team performance. In examining the different team
structures and processes in the light of their varied national guidance and standards, our data also give an
indication of how the broader policy context impacts on effectiveness.
Patient preferences, comorbidities and socioeconomic variation
Despite clear policy commitments to promote equality in the NHS58 we found that there were variations in
treatment by patients’ socioeconomic circumstances. This was evident in all specialties and could not be
explained by consideration of patient preference, comorbidities or other health-related factors in team
meetings. Previous research reporting socioeconomic inequalities in use of adjuvant therapy for cancer
suggests that non-implementation is due to non-uptake of care for cancer patients.72 This is likely to partly
explain the continuing socioeconomic variations in cancer survival.123 There is little research on treatment
inequalities for people with dementia, although a small study indicates that these may occur124 and the
evidence in mental health has been mixed.65,67 Recent models have demonstrated equitable provision of
cardiovascular care which translated to similar proportions of deaths averted across deprivation quintiles.125
However, non-implementation may impact upon morbidity rather than mortality, which was not addressed
in these cardiovascular models.
Cancer policy states that patients’ comorbidities, preferences and circumstances are important for
decision-making and that MDTs should take these into consideration wherever possible.113 Guidelines for
mental health, memory and heart failure state that patient preferences should be taken into account when
managing their care, though they do not relate this specifically to the MDT meeting.49,77,126 Research in this
area has called for routine discussion of patient preferences and comorbidities, as evidence suggests that
MDT decisions are often not implemented because of a failure to consider patient preferences during the
meeting.127,128 Inadequate information on comorbidities in MDT meetings has also been associated with
failure to make decisions.129,130
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Contrary to these previous studies, we found no association between discussion of patient preferences
or comorbidities and treatment plan implementation. However, the qualitative results showed that
these were complex issues and there was diversity in how readily this information was available, and
that there were differing opinions regarding the most appropriate way of incorporating this information
into decision-making. Overall, both MDT members and patients stated that patient preferences and
comorbidities were very important for decision-making and that they should be included in MDT
discussions when possible. However, some suggested that treatment recommendations should initially be
independent of patients’ preferences, which was, in line with previous research,131 partly attributed to the
fact that patient preferences can change during the management journey. The belief that patients’ views
should be sought after the MDT meeting (to ensure clarity and feasibility of options) rather than
beforehand has also been highlighted in a previous study.120
Areas of diversity in beliefs and practices
We identified substantial diversity across teams in the purpose, structure, processes and content of MDT
meetings, and in levels of patient involvement. While such diversity may be appropriate to the various
needs of different teams, it may also indicate a lack of clarity regarding best practice and a need for
further guidance.
Meetings served a range of explicit and implicit functions, from decision-making to team bonding and
emotional support. Clarity of purpose has been identified as an essential to effective teamworking
and high quality patient care.132 In line with this previous research, we found that in mental health teams
the purpose of meetings was implicit rather than explicit and that there was rarely a written agenda.
Though almost all interviewees found the meetings valuable, several mental health interviewees noted the
need for greater clarity around the purpose of meetings. Previous research has also identified the potential
benefits of using the meeting for functions such as teaching and recruiting patients to trials.25,133
We identified mixed views regarding these functions. While generally these were considered beneficial,
there were practical issues relating to time constraints and resource issues that limited their potential.
The structure and processes of meetings varied widely between specialties. This partly reflects the different
policy contexts described above in which the teams operate. We also found wide variation within
specialties where there were no national guidelines for MDT meetings, particularly memory clinic and heart
failure teams. These variations highlighted the importance of certain team features, including the
availability of administrative support.
The importance of administrative support for MDT meetings was clear from both interviews and
observations. Previous research in cancer has emphasised the essential role of the MDT co-ordinator role in
MDT decision-making134,135 and they were resourced in the cancer teams we observed. In heart failure,
memory clinics and mental health, administrative duties were undertaken by managers, health-care
professionals and administrators. Many MDT members in these teams highlighted difficulties in having to
undertake administrative tasks while participating as professionals. This had an impact on how patients
were selected for discussion, and how decisions were documented, among other things. Previous research
has found that meeting processes are crucial to quality-monitoring and effectiveness, for example in terms
of the documentation and follow-up of meeting outcomes.31,113,136 Previous research has also identified
advantages in collating lists of patients for discussion in advance of the meeting. Registering patients for
MDT discussions can form part of a monitoring system that can reduce delays to treatment.137
The content of discussions also varied by specialty. There was diversity between teams in how much time
they spent discussing patients’ psychosocial issues and preferences. This was much more common in
memory clinic and mental health teams (both staffed by mental health professionals), while cancer and
heart failure meetings were more focused on biomedical information. This was despite the fact that
previous research in cancer has found that 98% of professionals surveyed believed that psychosocial care
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issues should always be considered in MDT meetings.25 Where patient preferences were mentioned, there
were differences between specialties in the kinds of preferences considered. For example, in cancer,
discussions of preferences focused on different treatment alternatives, while, in mental health, discussions
of choice tended to relate to the timing and delivery of treatment rather than choosing between
treatments. Again, this may reflect contextual differences, as lack of resources was a common issue in
mental health team discussions.
There was variation in the role of the patient in MDT meetings. While cancer patients are routinely
informed of MDT processes, several patient interviewees from other specialties were unaware of the MDT
meeting. Policy variations are also noteworthy here. Cancer policy states that patients should be given a
written description of the MDT meeting at which they are discussed,42 and should be informed of the
purpose of the MDT, when it meets,113 its membership and the responsibilities of each team member.41
It also states that patients should be informed of the outcome of discussions within a locally agreed
timeframe.113 In contrast, policy in mental health, heart failure and memory clinics does not specify
information that should be given to patients on MDT meetings. The idea that their treatment plans were
discussed by a team gave some patients confidence, while others were concerned that they might be
misrepresented at meetings. In line with previous research, most patients and staff believed it would be
impractical for patients to attend the meetings25 and patients varied in their preferences regarding the
format and content of the information they would like fed back to them after the meeting. While previous
research has found that clinicians tend to underestimate the amount of information that patients
require,138,139 it has also been found that these preferences vary at different stages of illness,140 meaning an
ongoing dialogue is required to determine a patient’s current informational needs.
Study limitations
The 12 participating teams were based in a single geographical area and, with the exception of one,
were all in London. This may limit the generalisability of our results. However, when designing this research,
we had to address the issue of feasibility. The researchers attended weekly MDT meetings and spent long
periods of time at hospital sites collecting interview and medical record data. They therefore needed to be
located within a reasonable distance of the study sites. It would have been difficult to provide close and
constructive supervision if researchers were based in geographically dispersed parts of the country. The
alternative would have been for the researchers to travel from London, but this would have impacted on
the time and cost of the study.
The use of decision implementation as an indicator of effectiveness raises several issues. Firstly, we
recognise that measuring treatment plan implementation does not address the issue of whether or not the
‘right’ decisions have been made. It is possible that poor decisions are implemented. In order to examine
whether or not implemented decisions are ‘good decisions’ that do indeed lead to patient benefit, it would
be necessary to analyse carefully identified disease-specific health outcomes that can be plausibly and
directly related to the MDT decision. Alternatively, a subset of decisions about which there are specific best
practice guidelines could be assessed according to whether or not they conform to this guidance.
Secondly, the factors we considered in our analyses were identified as potentially important based on
previous research. We appreciate that there may be other, unmeasured factors that could also have
influenced implementation.
Thirdly, we did not directly explore determinants of decision implementation or the extent to which ‘good’
decisions were made during our interviews with health professionals. This was because interviews took
place towards the end of the observation period for each team and making participants aware that
implementation was under investigation may have influenced their decision-making processes and practice.
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Fourthly, in our regression analysis, we combined decisions where implementation was ‘not documented’
with those decisions that were ‘not implemented’. This was because, on the basis of our clinical
experience, non-implementation is commonly not explicitly recorded in patients’ records. Our conclusions
are therefore limited by the accuracy of record-keeping.
Finally, multiple treatment plans recorded for the same patient over the observation period could not be
satisfactorily included in our models. Therefore, our main analysis considered only the first treatment plan
recorded for each patient. We examined the impact of this in our sensitivity analysis.
It is also possible that team members behaved differently when under observation. However, this was
mitigated by the 2 weeks of observation before data were collected. In addition, MDT members were
aware that decision-making was being studied, but not that implementation was being examined.
The field researchers were not clinicians, but there were several quality assurance procedures in place to
safeguard against this potential limitation, as described in Chapter 2, Quality assurance: clinician validation.
We did not achieve the target sample size of 3000 individual patients with treatment plans. This is because
fewer patients than expected had treatment plans formulated at each meeting. However, even with our
smaller sample, investigation into model overfitting did not raise concerns.
There is no consensus on the best measure of skill mix or team diversity.98 We therefore categorised
professionals into coherent groups on the basis of our clinical expertise. It was necessary to group allied
health professionals together as a result of low numbers. We did not account for the seniority or
qualifications of members in the different professional groups, which may have had a bearing on the
degree to which each profession participated in discussions.
We also used a well-established area-based measure of socioeconomic characteristics, commonly used
where individual level indicators are not available. This method rests on the assumption that individuals
conform to the socioeconomic profile of their residential area. We recognise that misclassifications can
cause under- or overestimates of the relation between socioeconomic circumstances and implementation.
Mental health patients are under-represented in the interview component of our research because, despite
strenuous attempts by the research team, we were able to recruit only two mental health patients. Their
experiences were distinct from the other patients we interviewed; for example, neither was aware that
their care was being discussed in MDT meetings. An in-depth comparison of our interview data from
cancer and heart failure patients with mental health and memory clinic patients further explores
patients’ experiences.141
Finally, we did not collect cost or waiting time data and so we cannot comment on the implications of
MDT diversity with respect to MDT cost-effectiveness or consequences for patients.
Conclusions
Multidisciplinary team meetings for the management of chronic diseases are widely established in the
NHS and internationally. This study builds on previous research in a number of important ways. It is the
first to include MDTs for a range of different conditions, generating findings with relevance across health
services for a diverse range of patients. We found that the effectiveness of MDT meetings (as indicated
by decision implementation) depends on a range of contextual factors, team features and patient
characteristics. Having a clear purpose, adequate administrative support and a team atmosphere that
facilitates involvement, task orientation and support for improvement is key to ensuring team decisions
are implemented. The benefits of multidisciplinarity per se should not be assumed; clear goals and
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procedures are crucial. These findings corroborate previous work which points to the benefits of shared
objectives to guide and structure communication,118 focused leadership119 and team reflexivity.21
We believe this is the first study to explore the influence of patients’ socioeconomic circumstances on MDT
decision implementation. We found that patients from more deprived areas are less likely to have their
MDT treatment plans implemented, highlighting continuing inequalities in NHS care provision. This
occurred despite the routine reference to treatment guidelines by cancer teams, and did not seem to be
explained by consideration of patient preference, comorbidities or other health-related factors. Further
research is necessary to understand this. Routine monitoring of decision implementation is one approach
that could be used to ensure the equitable provision of care.
We also found many areas in which there is a diversity of views and practices across MDT meetings. While
this diversity may reflect appropriate flexibility with respect to the purpose of meetings and their value for
team members, it may also indicate uncertainty regarding the most successful ways to conduct
MDT meetings.
Chapter summary
In this chapter we have discussed the findings from study 1 and related them to previous research. We
have also considered the limitations of the study. The next chapter describes how we used these data, in
combination with other research and policy documents, to derive a series of recommendations that would
be generalisable across MDTs for different chronic diseases.
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Chapter 6 Study 2: application of a formal
consensus method to develop recommendations to
improve the effectiveness of multidisciplinary
team meetings
Introduction
The aim of study 2 was to apply a modified formal consensus technique to derive a set of feasible
recommendations for improving the effectiveness of MDT meetings for patients with chronic diseases.
This chapter sets out how the research team, under the guidance of the steering group, used the
quantitative and qualitative findings from study 1 to derive a series of recommendations that would be
generalisable across MDTs for different disease types.
Formal consensus methods are structured facilitation techniques that explore levels of consensus among a
group of experts by synthesising their opinions.142 They are designed to minimise some of the limitations
associated with group decision-making. In contrast to informal decision-making groups such as
committees, they follow explicit methodological steps that can be replicated. They have been used to
formulate clinical practice guidelines143 and to establish national research priorities.144 They are particularly
useful in defining levels of agreement where there is an insufficient or contradictory evidence base,145 and
where there is uncertainty about the value of different options.146 These methods therefore constitute a
valuable tool for agreeing recommendations for improving MDT meetings, where the empirical evidence
informs but does not clearly stipulate the action to be taken to improve effectiveness.
The three consensus methods most commonly used in health-care research are the nominal group
technique (NGT), the Delphi method and the RAND/UCLA appropriateness method (RAM).147 In the NGT,
experts independently generate ideas, meet to discuss each of the ideas generated and then privately rank
them in order of preference.148 In contrast, the Delphi method does not require the participants to meet.
It involves two or more rounds of questionnaires and may start with the generation of ideas. Responses
from each round are aggregated and fed back, giving participants the opportunity to revise their answers
in the light of the responses of the other participants.149 The RAM was developed to determine the
appropriateness of particular health-care interventions by combining the best available evidence with
collective expert judgements.150 This method involves sending a literature review and list of possible
indications for intervention to participants, who independently rate each item. They then meet to discuss
areas of discrepancy, with the aid of a second-round questionnaire showing both their own initial rating
and the distribution of all first round ratings. Following this, they rerate the items privately and individually,
in the light of the discussion. In practice, formal consensus studies often adapt elements from each of
these methods to optimally address specific research objectives.146
Methods
We focused on those areas where the research evidence did not provide clear recommendations on
practice to improve effectiveness and where we identified diversity in both MDT practice and in beliefs
about best practice. We used a two-round process illustrated in Figure 3 and described in detail below.
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We use the term ‘recommendation’ throughout the report because this was the terminology used in
discussion with the expert panel members. We have therefore continued to use the term throughout
the methods and results sections of this report. However, for our final conclusions, we have named the
recommendations that were scored with strong agreement and low variation in agreement as ‘indications
of good practice’. This reflects the fact that they are designed to be helpful pointers, rather than
policy recommendations.
Generating statements for the expert panel to rate
We used the following sources to generate statements for the expert panel to rate.
Study 1: qualitative findings
We drew upon the 16 metathemes which described areas of diversity in beliefs or practices (see Chapter 4,
Qualitative investigation of areas of diversity in beliefs and practices) to generate a list of issues and
questions which could be turned into single-item statements. This took place during an analytic conference
attended by the field researchers, the chief investigator, two coapplicants and two patient representatives.
When exploring these issues we focused on:
l identifying specific practices or procedures that were considered effective in some teams but not used
in others
l identification of specific arguments for and against current MDT practices, issues relating to the
content of discussion, and reflections on team structure that were made by MDT professionals
and patients
l proposals made by MDT professionals and patients for improving MDT meetings and the experience
of patients
l suggestions made by MDT professionals and patients for incorporating patient preferences into
MDT discussions.
Other published research and guidance
We conducted a review of UK-based research literature published between 1995 and May 2013 and of
national policy and guidance (for cancer, heart failure, old age psychiatry and mental health MDT teams)
on issues related to the 16 metathemes.
Study 1: quantitative findings
We also drew upon information from our quantitative results, for example we found no association
between discussion of patient preferences and treatment plan implementation.
Study 1 results Research literature
National policy
and guidance
Questionnaire pack incorporating 68 statements describing potential
ways to improve the effectiveness of MDT meetings
Expert panellists rate statements in
two rounds
First round: postal, no interaction
Second round: expert panel meeting
The final recommendations are those that were rated highly and with a
high extent of agreement among the expert panellists
FIGURE 3 Overview of the consensus development method.
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Using these data sources we developed an initial series of statements describing potential ways to improve
the effectiveness of MDT meetings. These statements were refined in further analytic conferences, with all
members of the research team present to ensure that they were supported by the data. We also ensured
that each statement was clear and precise and included only one issue for consideration.
In total we generated 68 statements for the expert panel to rate and four open-ended questions where we
did not have enough evidence to propose a statement. In these cases we asked the panellists to provide
suggestions on feasible methods to improve effectiveness, for example how to incorporate teaching into
MDT meetings.
The questionnaire
The final questionnaire was divided into 16 sections, each relating to a theme (a sample theme is available
in Appendix 11; all questionnaire items are presented in the results tables in Appendices 12–15 and
the entire questionnaire pack is available from the authors on request). Each section summarised the
information outlined above, that is relevant policy and guidance, published research literature and our
results. This was followed by a series of statements. We instructed panellists to rate their level of support
for each statement by drawing on their own knowledge and experience in addition to the information
provided.151 Ratings were on a Likert scale, from 1 to 9, where a rating of 1 indicated that the panellist
strongly disagreed with the statement, a rating of 5 indicated neither agreement nor disagreement
(i.e. depends on circumstances), a rating of 9 indicated strong agreement, and ‘don’t know’ indicated that
participants did not think they were informed enough to answer the question. An example of a statement
is provided in Figure 4.
We piloted the questionnaire with a member of the steering group to ensure that the information was
presented coherently and clearly and to provide an estimate of the time required to complete it.
Identification and establishment of formal consensus panel
There is no agreed standard regarding the optimal size of consensus groups.150,152 Smaller groups provide
less reliable decision-making, while bigger groups tend to be more difficult to co-ordinate and have less
equal participation.153 Following guidance146 we aimed for a group of 12–16 participants to represent the
range of professional groups and disease specialties under study.
We purposively sampled health-care professionals, policy-makers and patient/carer representatives with
MDT experience of each of the different disease types under study. Potential participants were identified
by consulting the project’s steering group and relevant professional organisations (e.g. the British Society
for Heart Failure). This approach helped to ensure that participants had credibility as experts in their field
and were representative of their profession.146 Three patient representatives were included to bring an
additional perspective to the discussion and to ensure that any recommendations reflected what patients
value in their care. We did not invite members of any of the MDTs observed in study 1 or members of the
project’s steering group to participate.
The chief investigator contacted potential panellists by e-mail to introduce the study, explain the process
and likely workload that it would entail, and invite them to participate. Of 22 individuals invited, 16 agreed
to participate. The professional background of panellists is shown in Appendix 16.
The main objectives of MDT meetings should be
the same across all chronic diseases
Strongly   …………………………   Strongly
disagree                                          agree 
Don’t
know
1      2      3      4      5      6      7      8      9
FIGURE 4 A questionnaire item from round 1.
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Formal consensus development process
Expert panel round 1: consensus development questionnaire
Ten weeks before the consensus meeting, all members of the panel were sent the first round
questionnaire pack with instructions and a stamped addressed envelope. They were asked to return the
completed questionnaire within 1 month (see Appendix 17 for the invitation and instructions).
We contacted panellists who returned questionnaires with missing data and asked them to complete the
remaining questions.
Expert panel round 2: consensus development meeting
The ratings from round 1 were used to develop a personalised version of the questionnaire for each panel
member (Figure 5). These showed the participant’s own responses (in green) and the distribution of
responses for all panellists for each item (in italics above the Likert scale).
We grouped together all the responses from the four open-ended questions, and included a summary of
these in the second-round questionnaire. For one of the questions, we used the suggestions to amend an
existing statement, and flagged this up to participants so they could rate it during the consensus
development group meeting.
This information was distributed to the panellists when they attended the consensus meeting in central
London, chaired by the chief investigator, who is experienced at facilitating formal consensus meetings.
The purpose of the meeting was to discuss those statements where there was a lack of consensus, to
explore causes of divergent responses and to identify any statements where lack of consensus was
secondary to different interpretations of the statements. Therefore, statements were ordered for discussion
so that those with the least consensus (defined using RAND guidelines, see Data entry and analysis below)
were discussed first, and those which had strong consensus were considered last. Thus, during the
meeting, priority was given to discussing the statements where there was most variation in scoring among
expert panel members. For these statements, panellists were encouraged by the facilitator to discuss
reasons for differences in ratings before rerating each item privately. The facilitator ensured that all
participants had an opportunity to contribute during the meeting, and made it clear that participants did
not need to conform to the group view.145
Where it became apparent that differences in first-round ratings had resulted partly from ambiguity in the
wording of the statement, the group agreed a revised wording before making their second-round rating.
Where there was consensus in the first-round ratings, statements were not discussed individually, although
the broader discussion usually touched on the themes in these statements and panellists were given the
opportunity to comment on any of these statements before rerating.
With the consent of all the panellists, the meeting was audiotaped and field notes were taken to ensure
we could correctly identify the specialty associated with each justification for variations in agreement
with statements.
The main objectives of MDT meetings should be the
same across all chronic diseases
Strongly   ………………………  Strongly
disagree                                      agree  
Don’t
know 
1     2     3     4     5     6     7     8     9 
2 1 7 1 2 2
FIGURE 5 A questionnaire item from round 2 showing the distribution of round 1 responses in italics above the
Likert scale, and the respondent’s own round 1 rating in green.
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The meeting lasted 3.5 hours. At the end of the meeting, we ensured that panellists had completed the
entire questionnaire.
Data entry and analysis
Data entry
Ratings were entered into a database using IBM SPSS V21. At each round, we double-checked 25% of the
data entered against the original paper questionnaires to ensure accuracy. No errors were detected.
Analysis of round 1 ratings
We prioritised statements for discussion at the meeting using RAND guidelines for a panel of
16 members.150 ‘Consensus’ was defined as four or fewer panellists rating outside the three-point region
containing the median (1–3.5, 4–6.5, 7–9). These statements were grouped together, and were not
discussed individually at the meeting. We ordered the remaining statements according to the number of
panellists rating in each extreme (1–3 and 7–9). The RAND guidelines define ‘lack of consensus’ as five or
more panellists rating in each extreme (1–3 and 7–9) so statements meeting this criterion were ranked
first, followed by those where four or more panellists rated in each extreme, and so on.
Analysis of round 2 ratings: quantitative analysis
For each item, we examined:
l the strength of agreement with each recommendation and
l the variation in extent of agreement among panellists.
The strength of the group’s agreement with each item was indicated by the median.147 Medians between
7 and 9 indicated agreement with the statement, medians between 4 and 6.5 indicated uncertainty,
and medians between 1 and 3.5 indicated disagreement. These ranges cover all possible medians for a
16-member panel.
The group’s variation in extent of agreement was indicated by the mean absolute deviation from the
median (MADM).147 This was categorised into low, moderate and high variation according to thirds
of the observed MADM scores (low < 1.11, moderate 1.11–1.75 and high > 1.75).
We defined a statement as a final ‘recommendation’ for improving the effectiveness of MDT meetings
when both strong agreement (median between 7–9) and low variation in extent of agreement
(MADM < 1.11) were present.
Where recommendations were rated ‘uncertain’ (medians 4–6.5) or ‘disagree’ (medians 1–3.5), we
categorised the panellists into cancer, mental health and heart failure groups and calculated the median
score for each group. This allowed us to assess whether uncertainty or disagreement might be a result of
differences in the nature of MDT meetings for different diseases. However, these results are limited by the
small numbers represented within each specialist category.
Analysis of round 2 ratings: qualitative analysis
We transcribed the meeting in full. We conducted a thematic analysis of the meeting transcript, coding the
panellists’ comments regarding each statement to highlight the range of views about each item discussed
and to identify possible explanations for differences in ratings.
Feedback of ratings
The final list of recommendations was shared with the expert panel and the steering group for
final comments.
DOI: 10.3310/hsdr02370 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 37
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Raine et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
79
Patient and public involvement
Our PPI representatives assisted in identifying and recruiting patients to participate in the consensus
development meeting.
Results
Results from the second round of ratings are summarised here and presented in full in Appendices 12–15,
18 and 19. Of the 68 potential modifications to improve the effectiveness of MDT meetings, only one
needed to be reworded before rerating.
There were 21 statements for which there was both strong agreement (median ≥ 7) and low variation in
the extent of agreement (MADM score of < 1.11). This included six recommendations relating to the
purpose of the meetings, ten relating to meeting processes, two relating to content of the discussion and
three relating to the role of the patient. Panellists from all specialties agreed that these recommendations
were desirable and feasible. The list of these final indications of good practice is provided in Box 5.
Recommendations that the expert panel agreed with
In total, there were 38 recommendations that panellists agreed with (median ≥ 7). This included the
21 final recommendations (see Appendix 12) as well as recommendations where there was agreement
(i.e. medians between 7 and 9) but high or moderate variation in the extent of the agreement
(see Appendix 13). Of these 38 recommendations, 14 related to MDT meeting processes, including the
role of the chairperson, the need for agreed objectives which are reviewed and audited annually, and
the formal documentation of decisions made. Seven recommendations were about the purpose of MDT
meetings, three were about the structure of the team, six were about the content of MDT discussions
and eight were about the role of the patient in the MDT meeting.
Where there were differences in opinion, the main concern among panellists was feasibility: ‘that’s going
to be tricky’ (doctor, cancer: recommendation 34, Appendix 13), ‘it would be nice in an ideal world’
(doctor, cancer: recommendation 24, Appendix 13) or ‘I disagree . . . we can’t actually commit to sending
everyone written feedback . . . because of time constraints’ (team manager, mental health:
recommendation 38, Appendix 13).
Recommendations rated as ‘uncertain’ (see Appendix 14)
There were 17 recommendations where the strength of agreement was ‘uncertain’ (i.e. the median rating
was between 4 and 6.5). Most of these related to ensuring patient-centred care, such as how information
on patients’ comorbidities and psychosocial issues should be managed and the best ways of facilitating
patient input into discussions.
There were also uncertainties regarding who should be required to attend MDT meetings and whether or not
patients should be discussed even where a standard protocol for treatment exists. Panellists from different
specialties expressed strong differences of opinion with respect to the creation of local (as opposed to
nationally) prescribed attendance lists (recommendation 44, Appendix 14). However there were opposing
views within the same disease specialty and professional group with respect to patient discussions.
For example, one oncologist stated that ‘all patients should be discussed . . . it’s a way of ensuring that
absolutely every patient has that safety net of quality assurance’ while another argued that ‘I think that if
you’ve got a clear protocol I’m not quite sure of the benefit of going through the protocol again’
(recommendation 42, Appendix 14).
Recommendation 39 (Appendix 14), about whether or not the objectives of team meetings should be the
same across all chronic diseases, was rated as ‘uncertain’. Panellists pointed out that MDTs for different
diseases ‘are very, very different animals’ (policy-maker, cancer).
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BOX 5 Indications of good practice: improving the effectiveness of multidisciplinary team meetings for patients
with chronic diseases
We applied the RAM to determine consensus on 68 statements derived from a mixed-methods study of
12 MDTs, a review of other research evidence and key national policies and guidance. Sixteen expert panellists
rated the statements individually, met to discuss their ratings and then rerated them. Statements for which
there was strong agreement and low variation in extent of agreement form the basis of the following
21 indications of good practice.
The purpose and functions of multidisciplinary team meetings
1. The primary objective of MDT meetings should be to agree treatment plans for patients. Other functions
are important but they should not take precedence.
2. MDT discussions should result in a documented treatment plan for each patient discussed.
3. MDT meeting objectives should include locally (as well as nationally) determined goals.
4. The objectives of MDT meetings should be explicitly agreed, reviewed and documented by each team.
5. Explaining the function of the MDT meeting should be a formal part of induction for new staff.
6. There should be a formal mechanism for discussing recruitment to trials in MDT meetings (e.g. having
clinical trials as an agenda item).
Multidisciplinary team meeting processes
7. All new patients should be discussed in an MDT meeting even if a clear protocol exists.
8. All chairpersons should be trained in chairing skills.
9. Teams should agree what information should be presented for patients brought for discussion in an
MDT meeting.
10. All new team members should be told what information they are expected to present on patients they
bring for discussion in an MDT meeting.
11. The objectives of the MDT meeting should be reviewed yearly.
12. Once a team has established a set of objectives for the meeting, the MDT should be audited against these
goals (e.g. every 2 years).
13. All action points should be recorded electronically.
14. Implementation of MDT decisions should be audited annually.
15. Where an MDT meeting decision is changed, the reason for changing this should always be documented.
16. There should be a named implementer documented with each decision.
Content of discussion in multidisciplinary team meetings
17. Comorbidities should be routinely discussed at MDT meetings.
18. Patients’ past medical history should routinely be available at the MDT meeting.
The role of the patient in multidisciplinary team meetings
19. The MDT should actively seek all possible treatment options, and discuss these with the patient after
the meeting.
20. Patients should be given verbal feedback about the outcome of the MDT meeting.
21. Where it would be potentially inappropriate to share the content of an MDT discussion with the patient
(e.g. where it may lead to unnecessary anxiety or disengagement from services), the decision not to
feedback should be formally agreed and noted at the meeting by the team.
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When we calculated the median score for each group of panellists with expertise in cancer, mental health
or heart failure, we found that, although 17 recommendations were rated ‘uncertain’ by the group overall,
every one of these was rated ‘agree’ or ‘disagree’ by at least one disease group (see Appendix 18). For
seven of the recommendations, at least one disease group disagreed, while another agreed with the
proposal (recommendations 39, 42, 44, 48, 51, 53, and 55, Appendix 18). For example, the cancer and
heart failure participants did not think that patients should be given the option to provide audio-recorded
input to the meeting (recommendation 55, Appendix 18), while the mental health panellists agreed with
the proposal. Mental health participants also agreed that patients should be discussed only when their
psychosocial characteristics could be presented (recommendation 48, Appendix 18). Heart failure panellists
disagreed with this proposal and cancer panellists were uncertain.
Recommendations the expert panel disagreed with (see Appendix 15)
There were 13 recommendations that the panellists disagreed with (median < 4). Most disagreements
centred on the role of the patient in MDT decision-making. For example panellists argued that it was
unfeasible to always obtain patients’ treatment preferences before discussing their case: ‘we have to make
a diagnosis . . . so . . . before the MDT it’s almost irrelevant because we don’t know what we’re actually
going to be talking to her about’ (doctor, cancer: recommendation 61, Appendix 15). They also pointed to
practical and cognitive barriers to asking patients before the MDT about how much they wish to be
involved in decision-making (recommendation 63, Appendix 15): ‘if you are the tertiary centre . . . you
don’t know the patient’ (policy representative, cancer); ‘I’m not sure it’s a question that many patients
might necessarily be able to deal with . . . especially . . . if you are presenting with something that you
don’t suspect, you’ve got so many things to think about’ (patient representative, cancer). However, one
patient representative did point out that: ‘I’ve had those conversations at various stages of my own
treatment, including from the very earliest stages . . . It’s not always going to be relevant but I think it can
be done’ (patient representative, heart failure and cancer).
Panellists also disagreed with proposed recommendations about the purpose and structure of MDT
meetings (recommendations 56, 57, 58 and 60, Appendix 15).
For eight of the 13 potential recommendations that the panel as a whole disagreed with, at least one of
the disease group medians fell into the ‘uncertain’ range (recommendations 58, 59, 61, 62, 64, 66, 67
and 68; Appendix 19). For example, although the panel as a whole did not think that there should be time
within MDT meetings to discuss current and emerging research and evidence which is not specifically
related to an individual case (recommendation 59, Appendix 19), the mental health panellists were
uncertain about this. Both the mental health and cancer panellists were uncertain whether or not patients
should be discussed only if their treatment preferences were known (recommendation 61, Appendix 19),
something that the heart failure panellists strongly disagreed with.
Discussion
We used formal consensus development methods to produce a list of indications of good practice for
ensuring the effectiveness of MDT meetings, which expert panellists agreed were both feasible and
desirable. Of 68 potential modifications proposed, almost one-third (31%), were rated with ‘strong
agreement’ by experts from all three disease types (cancer, heart failure and mental health). While the
research to date on improving the effectiveness of MDT meetings has focused on teams within one
disease type,9,17,154 our findings illustrate that there is scope for learning between specialties and the
potential to determine a significant number of indications of good practice that are applicable in the varied
contexts within which MDTs operate. Our group-level findings with respect to those 17 potential
recommendations with an overall panel rating of ‘uncertain’ suggest that, in these areas, disease-specific
recommendations may be more appropriate.
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The largest category of indications of good practice where there was cross-specialty agreement related to
MDT processes (10 of the 21 recommendations). Our findings concur with other studies that have
demonstrated the importance of clear documentation of meeting outcomes (recommendations 13, 15 and
16, Box 5)113,136 and regular review of meeting objectives (recommendations 11 and 12, Box 5).21,118 While
cancer MDTs already follow, and are audited against, national guidelines that explicitly address these issues
by requiring, for example, recording of patients’ treatment plans, other MDTs do not.10,42 This clarity of
structure and processes is reflected in our findings from study 1, with similarities between the cancer
teams but greater variation between teams in other disease specialties. Our findings from study 2
demonstrate agreement that it is feasible and desirable for other chronic disease MDTs to adhere to a
number of these processes too. Notably, many of these indications of good practice require minimal
additional financial resources, indicating that improvement is possible even in resource-stretched teams.
Our findings from study 1 highlighted clarity of purpose as an important area of diversity in MDT practices.
Clarity of purpose has also been identified in previous research as a key feature of effective teamworking
in health care.21,154 In study 2 we showed that, while consensus was achieved about the primary objective
of MDT meetings, and about the need to include both locally and nationally determined goals, there was
uncertainty or disagreement about other functions such as teaching.
Previous research has also emphasised the importance of considering patient preferences, arguing that
they are associated with MDT decision implementation rates.120,127,128 The expert panel discussed the
importance of knowing patient preferences before MDT meetings and of shared decision-making. Much of
the discussion highlighted the complexity of these issues in terms of the most appropriate and sensitive
times to involve patients, practical constraints (such as urgent, last-minute inclusion of patients in MDT
discussions where there has been no time to obtain their preferences) and disease-specific concerns (such
as difficulties faced by some mental health patients in making decisions about their treatment). The panel
therefore recommended that, when making a decision, the MDT should actively seek all possible treatment
options and discuss these with the patient after the meeting.
The feasibility and acceptability of giving patients the option to attend MDT meetings has been explored
in the Australian healthcare system.155,156 However the consensus panel rejected this proposal because of
logistical difficulties and because these meetings were not considered to be an appropriate forum for
breaking bad news.
The calculation of condition-specific medians highlighted 17 areas where disease-specific recommendations
may be required. For example, while the cancer panellists argued strongly for national agreement on at
least a common core of required professionals at every MDT meeting, the heart failure panellists suggested
that it was more appropriate for their MDT attendees to reflect the flexibility inherent in the variable
composition of MDTs across the country. Similarly, mental health panellists considered it to be imperative
for someone with personal knowledge of a patient be present when that patient is discussed by the MDT,
but this was believed to be unnecessary in cancer and heart failure MDT meetings.
Study limitations and strengths
Important strengths of our study include our calculation of both the strength and extent of agreement for
each recommendation and our ability to understand the reasons given for each rating by conducting a
thematic analysis of the panel discussions. Our consideration of results by disease group allowed us to
distinguish between recommendations which might be applied generically across conditions and those
which might be more appropriately dealt with on a disease-specific basis. However, these results should be
treated with caution, as they represent the views of small numbers of disease-specific participants.
The three consensus methods most commonly used in health-care research are the Delphi method, the
NGT and the RAM. In practice, formal consensus studies often adapt elements from each of these
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methods to optimally address their specific research objectives.146 In the Delphi method, participants rate
recommendations over a series of rounds using questionnaires. They do not meet to discuss their
responses, but a summary of previous ratings is provided in each successive round to allow them to take
them into consideration into their ratings. In contrast, the NGT convenes a panel of participants who list
their ideas on a particular subject and then share them with the group in a structured meeting. After
discussion, participants individually rank-order each topic.146,148 We chose to use the RAM because the
forum for detailed discussion allowed us to gain valuable data on panellists’ reasoning, and their ratings
allowed us to statistically summarise both the strength and extent of agreement for each
recommendation discussed.
Another strength of our study was the size and diversity of our consensus group. The inclusion of
16 participants meant that we were able to include a range of representatives from each disease speciality.
Had we convened a larger panel, it is likely that the ability of every panellist to contribute fully to the
discussion of each recommendation would have been diminished. However, we recognise that a
consensus panel of this size raises questions around the reliability of the results. Another group of different
experts might have produced different recommendations.150 This is particularly relevant for mental health
and heart failure MDTs, which, unlike cancer MDTs, are not required to follow guidance about core
membership.41,42 We therefore aimed to achieve a balance between including as many stakeholders as
possible (including patient and policy representatives) and ensuring that the size of the panel allowed
all participants sufficient opportunities to be heard. In the event, not all the professionals whom we
approached accepted our invitation to participate, which meant that we were unable to represent all
relevant professional groups (e.g. psychologists). We could have improved within- and between-group
reliability by using the results of this study as the basis for a large-scale Delphi survey.157 However, we did
not have the resources to do this.
In terms of patient representatives (of which there were three), the larger proportion of health-care
professionals in attendance may have acted as a barrier and prevented the views of patient representatives
from being heard. Given the practical challenges described above relating to the size and diversity of the
panel, the chairperson sought to overcome this limitation by actively involving all panellists in discussion.
It was also made clear throughout the meeting that there were no ‘right’ or ‘wrong’ answers. In addition,
by reporting variation in agreement as well as strength of agreement, we were able to take account of
differences between panellists, and our final 21 indications of good practice included only those where
there was agreement and low variation in agreement.
It is also possible that the framing of the evidence and recommendations could influence judgements.158
We attempted to address this by using the meeting to identify any differing interpretations of the evidence
and recommendations. This resulted in the rewording of just one of the recommendations to clarify its
meaning (recommendation 19, see Box 5).
Finally, the 68 recommendations were derived from research evidence and policy guidance. Had we
chosen the NGT, in which panellists begin by listing their ideas, additional and perhaps more innovative
potential recommendations might have been discussed. However, this approach might also have led to
less consensus.
Conclusions
Multidisciplinary team meetings for patients with chronic diseases are well established across the NHS.
However, evidence for their effectiveness is mixed and their structures and processes vary widely. Given
that MDT meetings are resource-intensive their value to the NHS and patients should be maximised.
Previous research on improving MDT meetings has examined specific diseases in isolation,9,17,154 limiting the
potential for learning across different specialties. In addition, much of the evidence regarding features of
effective teamworking in health care has not been translated into practical recommendations. We used
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consensus development methods to build on our findings from study 1, and our expert panel identified
21 feasible and desirable indications of good practice to improve the effectiveness of MDT meetings
which are applicable to a range of chronic diseases. These can be directly applied in NHS practice and
quality-monitoring initiatives. The fact that no single team from the 12 teams that we observed in study 1
met all of the indications agreed suggests that there is room for improvement in all specialties, even those
that already have clear policies and procedures. We also identified uncertainty and disagreement regarding
a number of issues, including the best ways to involve patients, which patients should be discussed and
meeting membership. These issues require further investigation, and disease-specific or locally determined
guidance may be necessary.
Chapter summary
This chapter has presented study 2 in its entirety, describing how we used a formal consensus
development method to derive a set of feasible recommendations for improving the effectiveness of MDT
meetings for chronic diseases. In Chapter 7 we discuss the project as a whole, bringing studies 1 and 2
together to consider the key findings and implications for future research.
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Chapter 7 Overall conclusions and future
research directions
This research is innovative and important in examining and comparing MDT meetings for differentchronic diseases. Examining decision implementation, a proxy measure of effectiveness, allowed us to
identify determinants of effectiveness applicable across disease types. A qualitative investigation of
differences between disease types highlighted the potential for learning across specialties.
The use of a formal consensus development method allowed us to build on these data to identify
indications of good practice that are applicable across chronic diseases. We have also identified areas
where disease-specific or locally determined guidance may be required, in particular regarding the best
ways to involve patients in multidisciplinary decision-making.
Our key results are summarised below. These findings raise a number of issues which merit further
investigation. Many of these issues can be investigated through further in-depth analyses of our rich
data sets, some of which is under way. Others will require the collection and analysis of additional data.
Having summarised our key findings below, we discuss possible avenues for future research to enhance
our understanding of MDT processes and thereby promote improved care.
Finally, we have included a reflexive discussion of key challenges and learning points from our experience
of conducting this large multisite mixed-methods study (see Appendix 20). We hope that this will provide
valuable lessons for researchers embarking on studies of a similar nature.
Summary of key findings
l We found that greater multidisciplinarity is not necessarily associated with more effective
decision-making; rather it is mediated by having a clear purpose, agreed processes and a team
atmosphere that facilitates inclusion and improvement.
l Overall, 78% of MDT decisions across the 12 chronic disease MDTs under study were implemented.
l CMHTs implemented fewer decisions than did other teams. Staff in these teams reported a wide array
of functions of MDT meetings in addition to decision-making; however, some reported that meetings
lacked clarity of purpose.
l Teams differed widely in relation to the format and structure of meetings, documentation and audit
procedures, choice of patients for discussion, the content of discussions and the use of technology.
l While team members reported that they valued hearing a range of disciplinary perspectives, not all
disciplines were perceived to have an equal ‘voice’.
l Some teams were characterised by a strong medical dominance in terms of attendance and
participation. While these teams typically made and implemented high numbers of treatment plans,
those plans were less likely to have incorporated the full range of disciplinary perspectives.
l Patients from more deprived areas were less likely to have their treatment plans implemented and this
occurred despite the routine reference to treatment guidelines by cancer teams. Consideration of
patient preference, comorbidities or other health-related factors did not seem to explain this, and we
were unable to account for these findings.
l Stakeholders with expertise in cancer, mental health and heart failure agreed on 21 indications of good
practice, which were applicable to all the chronic diseases considered. They included recommendations
relating to the purpose of the meetings (e.g. that agreeing treatment plans should take precedence
over other objectives); meeting processes (e.g. that MDT decision implementation should be audited
annually); content of the discussion (e.g. that information on comorbidities and past medical history
should be routinely available); and the role of the patient (e.g. concerning the most appropriate time to
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discuss treatment options). Panellists from all specialties agreed that these recommendations were both
desirable and feasible.
l No single team from the 12 teams that we observed in study 1 met all of the recommendations agreed
on by the expert panel. Our findings illustrate that there is scope for learning between specialties and
the potential to agree a significant number of indications of good practice that are applicable in the
varied contexts within which MDTs operate.
Future research priorities
Our results highlight the following areas for further study.
The effectiveness of a modified multidisciplinary team
Further research is needed to examine whether or not the 21 indications of good practice identified in this
study will lead to better decision-making (in terms of decision implementation or appropriate outcomes).
This requires the incorporation of the indications into a modified MDT. Effectiveness and cost-effectiveness
in comparison with ‘usual care’ can then be experimentally tested in a pragmatic randomised controlled trial.
Although there was agreement that the most appropriate time to discuss treatment options with patients
is after the meeting, we did not achieve clarity on the most appropriate methods for ensuring that patient
preferences are accurately and systematically incorporated into the decisions made during the various
stages of treatment. Our findings suggest that disease-specific approaches are needed. It is crucial for
patients to be integrally involved in the design of interventions to improve their role in decision-making.
The value of multidisciplinarity
Although the principle of multidisciplinary input was highly valued by professionals across all disease
specialties, considerable shortcomings existed with respect to the extent of effective multidisciplinary
input into discussions. This may be important if it results in relevant determinants of decision-making
(e.g. patient preferences) being omitted from discussions, or alternative perspectives being lost.
We are therefore planning further analysis of our qualitative data to explore why multidisciplinarity is
valued and by whom. We will also explore ways in which different professional groups share information
and contribute to decision-making, possible determinants of these different approaches and the
ways in which genuine multidisciplinary contributions add value to MDT decision-making.
Reasons for low implementation in community mental health teams
Community mental health teams had the lowest implementation rates. Our results suggest that this may,
in part, be because members of these teams believe that MDT meetings fulfil a range of functions, but
that these functions are not always clear. This opacity may be compounded by a tendency for these teams
to lack administrative support, and to be hampered by variable chairing skills and a lack of a structured
approach to presentations of patient cases. Taken together, our results suggest that these factors impede
the ability to focus on treatment plan formulation. We are embarking on additional analysis of our
qualitative data to further explore CMHT members’ beliefs about what the functions and benefits of MDT
meetings are and should be; the rationale for these beliefs and how these may vary among different
professional groups; and the levers and barriers to achieving key goals.
Inequalities in treatment plan implementation
We were unable to elucidate the reasons for our finding that patients from more deprived areas were less
likely to have their treatment plans implemented than those from the least deprived areas. Given the
continuing commitment of the NHS to provide care solely on the basis of clinical need, it is vital that
further research be conducted in this area. Issues for further study include the extent to which there are
systematic socioeconomic differences in choices made by patients and their carers. Certain groups of
patients may have systematic variation in their preferences159 and in their capacity to articulate them.160
There may also be systematic differences in the ways that clinical uncertainty and risk/benefit ratios are
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discussed with patients. Such variations may be influenced by the professional background of the patient’s
key worker and the patient–key worker relationship. The possible influence of these and other factors on
patient preferences and their association with treatment received needs further study.
Examination of the most appropriate composition of multidisciplinary
team meetings
Although we identified examples of teams that did not meet best practice recommendations (e.g. two of
the mental health teams lacked a permanent psychologist), it was beyond the scope of our study to address
the issue of whether or not the professional composition of each team influenced decision-making.
Further research in this area would entail a quantitative comparison of a large number of MDTs
for one condition (e.g. heart failure) to assess the association between professional composition and
decision-making (or implementation).
Examination of the association between multidisciplinary team decision
implementation and improvements in patient outcomes
We have explained our rationale for using decision implementation as a proxy measure of effectiveness.
In order to examine whether or not implemented decisions are ‘good decisions’ that do indeed lead to
patient health benefits, one approach would be to identify disease-specific measures of patient benefit
that have a plausible direct relationship with defined decisions (within specified time intervals for each
disease) and ideally which can be extracted from medical records. For example, for cancer patients,
there are widely accepted international definitions of response of the tumour to the chosen therapy
(complete/partial remission, stable/progressive disease) and of adverse events which are readily measurable
within 6 months from the start of therapy. For the other conditions, outcomes may need to be measured
at 3–6 months (as appropriate). In heart failure, data are routinely collected on New York Heart
Association Functional Classification and on weight; in psychiatry of old age clinics, mini mental state
assessments are routinely undertaken; and, in mental health, the Health of the Nation Outcome Scales
(which are being introduced by some mental health teams) could be used. These would, however, be
relevant to only a subset of MDT decisions (i.e. major decisions about treatment, rather than more ‘minor’
decisions, e.g. regarding the best time or method to contact a particular patient, or decisions to raise
particular issues for discussion with patients or carers. These ‘minor’ decisions may also influence patient
outcomes, e.g. they influence the extent to which patients engage with their care.).
The role of technology in supporting multidisciplinary team meetings
Our research focused on current practice in MDT meetings. While it was not a focus of our study,
we found considerable variation in the use of technology (e.g. electronic presentations and
documentation, and the use of video-conferencing) across teams. Further investigation of the role of
technology in supporting MDT meetings is warranted.161 Future studies may investigate whether possible
limitations associated with using technologies such as video-conferencing (e.g. the need for IT support, less
naturalistic participation, difficulties in turn-taking) are offset by potential advantages such as convenience and
cost savings associated with less travel. Such research could also examine the scope for existing and emerging
technologies and ways of working (e.g. those used in design technology or the aviation industry)162,163
to transform the way that MDTs work together to achieve better outcomes.
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Appendix 1 Participant consent forms
Participant consent form to observe
 
[Hospital logo] 
 
 
 
 
 
UCL Project ID number: 10/071             Participant ID number for this study:  
 
Title of study: Improving the effectiveness of Multi-Disciplinary Team Meetings (MDMs) for patients  
with chronic diseases: Non-participant observation 
 
Chief investigator: Professor Rosalind Raine 
Principal Investigator at [Hospital]:  
Researchers: Dr Penny Xanthopoulou, Isla Wallace, Caoimhe Nic a’ Bhaird 
 
 
INFORMED CONSENT FORM 
                                                                                                             Please initial box 
1. I confirm that I have read and understand the participant information sheet 
dated 03/08/10 (version 2) for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily.      
 
2.  I understand that my participation is voluntary and that I am free to withdraw at any time, 
without giving any reason and without my medical care or legal rights being affected.      
 
3.  I understand that all the information I provide for the purposes of this study will be kept 
strictly confidential.  
 
4.  I consent to the multidisciplinary meetings being taped and understand that these 
recordings will be stored securely and destroyed after analysis is complete. 
 
5.  I agree to being quoted anonymously in the results. 
 
 
6.  I agree to take part in this study. 
 
 
 
 
____________________ ________________ ____________________ 
Name of Participant (PRINT) Date Signature 
 
_________________________ ________________ ____________________ 
Name of person taking consent Date Signature 
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Participant information leaflet
[hospital logo]
VERSION 2, 3 AUGUST 2010
PARTICIPANT information leaflet
Improving the effectiveness of Multi-Disciplinary Team
Meetings (MDMs) for patients with chronic diseases
We would like to invite you to take part in a research study. Please read this leaflet which tells you about
the study and what it involves and ask one of our team if there is anything that is not clear. Take time
to decide whether or not you wish to take part.
What is the purpose of the study?
Multi-Disciplinary Team Meetings (MDMs) are widely used across the NHS for managing chronic diseases.
We want to find out more about the factors that influence clinical decision-making at MDMs. The findings
will be used to improve treatment decisions in your MDM and in other MDMs across the NHS by
recommending possible improvements in the way that MDMs work.
Why have I been chosen?
We wish to examine a number of MDMs covering a wide range of clinical conditions affecting a diverse
range of patients. All members of your multi-disciplinary team have been provided with this information
sheet because we wish to observe your MDM and to invite some MDM members to participate in an
interview. We will invite MDM members from each core professional group represented on the MDM,
including both regular and infrequent attenders, to be interviewed.
What does the research involve?
If all multi-disciplinary team members consent, a researcher will attend and observe a number of
consecutive MDMs. She will not be an active participant in these meetings, but will both audiotape the
meeting and take notes, using a structured form. She will collect information on the structure of the
meeting (including the number of patients discussed, the professional mix of members attending);
processes (including the roles of each of the members); patient related factors that are discussed and the
clinical decision made. We expect to attend and observe between 22 and 41 meetings, depending on
the number of patients discussed. The first eight meetings will be audiotaped. In this part of the study,
you will not be required to do anything outside of, or in addition to your normal day to day activities.
Patients discussed at each MDM will be given the opportunity to ‘opt out’ of having their
medical information included in the study. We will ask each patient’s key worker/treating
clinician to give their patients an ‘opt out’ form at the earliest appropriate and feasible
opportunity. These forms will be available at every MDM where patients eligible for inclusion in
this research are discussed.
In addition, the researcher will conduct face-to-face interviews with a selection of multi-disciplinary team
members. The purpose of these interviews is to explore members’ perceptions of MDM strengths and
weaknesses; factors influencing MDM decisions; their professional role and value to the MDM. The
questions will be flexible and open-ended, to allow you the chance to raise the issues that you feel
are important. If you are approached to be interviewed, we will ask you to sign a further consent form.
APPENDIX 1
NIHR Journals Library www.journalslibrary.nihr.ac.uk
104
All information given during these interviews will be kept strictly confidential and no names will be attached
to the information provided. The interview will be conducted at a convenient time and place of your
choosing. The interview will last between 30 minutes and one hour and may be ended by you at any time.
It will be tape-recorded, if you consent, but the tapes will be destroyed after analysis has been completed.
Do I have to take part?
It will be entirely up to you to decide whether or not to take part in the study and you can withdraw from
the study at any time without having to give a reason. If you decide to participate, you will be asked to
sign a consent form, and given a copy to keep. A decision not to take part or a decision to withdraw from
the study will not affect your work in any way.
What are the possible disadvantages of being interviewed?
It is expected that this study does not have any disadvantages, but the interview will take between thirty
and sixty minutes of your time.
What are the possible benefits of being interviewed?
The information we get from this study will improve the MDM decision-making process by highlighting
areas of excellence and possible weaknesses. If you take part in an interview, your anonymised views will
contribute to our findings and any resulting recommendations for change.
Will what I say be confidential?
Yes. We will follow ethical and legal practice and all information about you will be handled in confidence.
If you are interviewed, this will take place in private, and the recording will not contain your name or any
personal information, only a study identification number. Recordings will be encrypted and held in a
computer in the Department of Epidemiology and Public Health, UCL. Only those members of the research
team who are directly involved in analysing the information will have access to the recordings. In
publications and reports, the identity of participating MDMs will not be revealed, only basic descriptive
information on the conditions covered and regional location of the MDM will be given. Professor Rosalind
Raine is the Chief Investigator and she has overall responsibility for confidentiality and data security.
What will happen to the results of the study?
Once the study has finished the results will be analysed and conclusions drawn about how treatment
decisions are reached, and how this process might be improved. Findings will be published in scientific
journals, but the MDM and all individuals will be referred to in anonymised form. Quotes from the
interviews may be used, but again will be anonymised. Any quotes where the individual concerned could
be identified by another team member, or anyone else, will not be used. We will also visit your MDM and
provide a summary of our findings. Again, interview quotes will only be used as long as the speaker’s
anonymity can be preserved. MDM members will have the opportunity to discuss the findings and give
their views on the recommendations.
Who is organising and funding the research
Professor Rosalind Raine is the Chief Investigator and the study is funded by the National Institute of
Health Research. No payments are made to the researchers conducting this study.
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Who has reviewed this study?
All research in the NHS is looked at by an independent group of people, called a Research Ethics
Committee, to protect your interests. This study has been reviewed and given a favourable opinion by
East London Research Ethics Committee.
What do I do if I wish to make a complaint about the research?
If you wish to complain about any aspect of the research, you should contact the Chief Investigator,
Professor Rosalind Raine or the researcher. If you feel you do not receive a satisfactory response and you
wish to take the matter further you should contact the Complaints Manager (see below) giving the project
title and the Principal Investigator’s contact details.
Contact details
Please contact [researcher] if you would like to ask questions about the study or for any other reason:
By telephone:
By email:
By post:
You can also contact:
Professor Rosalind Raine on [telephone] or by email [email address]
Contact details for the Complaints Manager are:
[local service address and telephone]
Thank you very much for taking the time to read this information about the study.
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Appendix 2 Observation proforma
Quantitative data collection
 
 
 
 
 
 
 
Study ID       
 
MDT Date   
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6. Decision 1 
8. Factors impacting on team ability to make a decision (free text) 
5. Actions discussed 
7. Decision 2  
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Appendix 3 Models from sensitivity analyses
Sensitivity analysis 1
Sensitivity analysis
Final model: adjusted
model 3 (n= 2431)
Sensitivity analysis 1: adjusting for number of
decisions making up first treatment plan (n= 2431)
Odds ratio (95% CI) p-value Odds ratio: (95% CI) p-value
IMD quintile
Least deprived 1 1
2 0.80 (0.52 to 1.25) 0.80 (0.51 to 1.24)
3 0.87 (0.56 to 1.34) 0.86 (0.56 to 1.32)
4 0.64 (0.42 to 0.97) 0.64 (0.42 to 0.96)
Most deprived 0.60 (0.39 to 0.91) 0.05 0.59 (0.38 to 0.90) 0.05
TCI (0.1 increase) 1.07 (1.01 to 1.13) 0.01 1.89 (1.12 to 3.22) 0.02
Type of disease
Haematological cancer 1 1
Gynaecological cancer 2.48 (1.48 to 4.15) 2.36 (1.40 to 3.95)
Skin cancer 0.97 (0.67 to 1.39) 0.94 (0.65 to 1.36)
Memory clinic 1.05 (0.76 to 1.45) 1.07 (0.78 to 1.48)
Mental health 0.57 (0.39 to 0.82) 0.56 (0.39 to 0.81)
Heart failure 0.75 (0.50 to 1.14) < 0.001 0.83 (0.55 to 1.26) < 0.001
No. of professional groups 0.75 (0.66 to 0.87) < 0.001 0.76 (0.66 to 0.87) < 0.001
No. decisions in first plan 0.87 (0.78 to 0.98) 0.02
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Sensitivity analysis 2
Sensitivity analysis
Final model: adjusted
model 3 (n= 2431)
Sensitivity analysis 2: model based on randomly
chosen treatment plan for each patient (n= 2433)
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
IMD quintile
Least deprived 1 1
2 0.80 (0.52 to 1.25) 0.77 (0.50 to 1.20)
3 0.87 (0.56 to 1.34) 0.83 (0.54 to 1.27)
4 0.64 (0.42 to 0.97) 0.66 (0.44 to 0.99)
Most deprived 0.60 (0.39 to 0.91) 0.05 0.59 (0.39 to 0.91) 0.09
TCI (0.1 increase) 1.07 (1.01 to 1.13) 0.01 1.05 (1.00 to 1.11) 0.05
Type of disease
Haematological cancer 1 1
Gynaecological cancer 2.48 (1.48 to 4.15) 2.39 (1.41 to 4.01)
Skin cancer 0.97 (0.67 to 1.39) 0.88 (0.62 to 1.26)
Memory clinic 1.05 (0.76 to 1.45) 1.08 (0.78 to 1.49)
Mental health 0.57 (0.39 to 0.82) 0.54 (0.38 to 0.78)
Heart failure 0.75 (0.50 to 1.14) < 0.001 0.81 (0.54 to 1.21) < 0.001
No. of professional groups 0.75 (0.66 to 0.87) < 0.001 0.80 (0.70 to 0.92) < 0.001
Sensitivity analysis 3
Sensitivity analysis
Final model: adjusted
model 3 (n= 2431)
Sensitivity analysis 3: model with 5 IMD quintiles
collapsed to 2 groups
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
IMD quintile
Least deprived 1 Group 1–3:
2 0.80 (0.52 to 1.25) 1
3 0.87 (0.56 to 1.34)
4 0.64 (0.42 to 0.97) Group 4–5:
Most deprived 0.60 (0.39 to 0.91) 0.05 0.72 (0.57 to 0.90) 0.004
TCI (0.1 increase) 1.07 (1.01 to 1.13) 0.01 1.95 (0.15 to 3.31) 0.01
Type of disease
Haematological cancer 1 1
Gynaecological cancer 2.48 (1.48 to 4.15) 2.50 (1.49 to 4.18)
Skin cancer 0.97 (0.67 to 1.39) 0.98 (0.68 to 1.41)
Memory clinic 1.05 (0.76 to 1.45) 1.05 (0.76 to 1.45)
Mental health 0.57 (0.39 to 0.82) 0.56 (0.39 to 0.81)
Heart failure 0.75 (0.50 to 1.14) < 0.001 0.76 (0.50 to 1.14) 0.004
No. of professional groups 0.75 (0.66 to 0.87) < 0.001 0.75 (0.65 to 0.86) < 0.001
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Sensitivity analysis 4
Sensitivity analysis
Final model: adjusted
model 3 (n= 2431)
Sensitivity analysis 4: alternative definition for
implemented treatment plan: > 80% of component
decisions implemented (n= 2425)
Odds ratio (95% CI) p-value Odds ratio (95% CI) p-value
IMD quintile
Least deprived 1 1
2 0.80 (0.52 to 1.25) 0.99 (0.67 to 1.49)
3 0.87 (0.56 to 1.34) 1.07 (0.72 to 1.58)
4 0.64 (0.42 to 0.97) 0.74 (0.51 to 1.07)
Most deprived 0.60 (0.39 to 0.91) 0.05 0.74 (0.50 to 1.08) 0.05
TCI (0.1 increase) 1.07 (1.01 to 1.13) 0.01 1.07 (1.02 to 1.13) 0.006
Type of disease
Haematological cancer 1 1
Gynaecological cancer 2.48 (1.48 to 4.15) 2.87 (1.74 to 4.72)
Skin cancer 0.97 (0.67 to 1.39) 1.05 (0.74 to 1.50)
Memory clinic 1.05 (0.76 to 1.45) 0.93 (0.69 to 1.26)
Mental health 0.57 (0.39 to 0.82) 0.51 (0.36 to 0.73)
Heart failure 0.75 (0.50 to 1.14) < 0.001 0.40 (0.28 to 0.58) < 0.001
No. of professional groups 0.75 (0.66 to 0.87) < 0.001 0.71 (0.63 to 0.81) < 0.001
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Appendix 4 Observation coding sheet
Qualitative data collection
INPUTS – Systems, organisational
1. Mention of national policy directives or guidelines:
2. Mention of local guidelines/rules/regulations:
3. Mention of resource issues (staff, time, money). How do these factors impact on decision making?
4. Mention of other individuals/services/teams within organisation that impact on options/decision made:
5. Other broader contextual factors influencing decision making:
INPUTS – Team and task
6. What information is shared in advance? How does this influence decision-making?
7. Meeting environment (size of room/seating arrangement/light/acoustics):
8. What use is made of technology? e.g. access to test results, patient notes, virtual team. How does this
influence decision making?
9. How structured is the meeting process? (e.g. following agenda, protocol):
10. Who presents cases? How? Use of structured proforma? Framing of decisions to be made:
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11. Patient factors: who mentions patient preferences? Who, if anyone, mentions carer or family
preferences? How do attendees react? Any variation by patient characteristics:
l Socio-demographic (age, gender)
l Socioeconomic (education, poverty)
l Social (marital status, employment, family)
l Health literacy (understanding about condition and navigation of healthcare services)
12. Mention of missing information? (test results, attendees) Impact on decision making:
13. Other team, task and patient inputs influencing decision making:
MEDIATORS – Team processes, emergent states
14. Participation/Communication: who dominates? Who has least involvement? Is there a hierarchical
pattern of participation or a relatively even distribution?
15. Any misunderstandings/lack of clarity – between whom? Who asks questions? To whom? Is there
dissent or conflict? Who disagrees? How is it dealt with?
16. Leadership style: clear role or several competing leaders? Does the leader dominate discussion or
decision making, or take a back seat? Do they encourage involvement or limit contributions
(e.g. because of time)? Do they checking understanding or proceed at their own pace?
17. Cohesion: Any social conversation immediately pre/post meeting? Is everyone focused on the
task – anyone chatting/disinterested? Mood/affect – Relaxed? Pressured? Formal? Focused on task?
18. Decision mechanisms: Is consensus sought? How? (Verbal, eye contact) Are decisions made in the
absence of consensus?
19. Other mediators, processes influencing decision making:
OUTCOMES
20. OUTCOME: Clarity of recommendations; Who records the decision? Is there a verbal summary and
rationale? Is responsibility for implementation discussed?
Other:
APPENDIX 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
116
Appendix 5 Multidisciplinary team member
interview topic guide
UCL DEPARTMENT OF APPLIED HEALTH 
RESEARCH 
MDT STUDY: Participant interview TOPIC GUIDE
Version 1, 28.3.12
INTRODUCTION FOR PARTICIPANTS
The purpose of this interview is to explore your views on the multidisciplinary team meetings that you
attend for [team name], and to discuss some of the factors influencing MDM decision-making.
The questions will be flexible and open-ended, to allow you the chance to raise the issues that you feel are
important. Your responses will be confidential, and anonymised in any findings we publish. They will not
be shared with your team. There are no ‘right’ or ‘wrong’ answers and I stress that this is not about
individuals, but about the system. There is conflicting evidence in the literature about whether MDTs are
effective or not, and this is what we would like to explore.
Interviewer will then talk through patient information sheet if needed and answer any questions
Warm Up
1. This interview is about your experience of the MDT meeting, in general, how do you find working in
this way?
¢ What do you think works well about your MDT meeting?
¢ Is there anything you would change about your MDT meeting?
¢ If there was no MDT meeting, what difference would it make?
¢ Is the MDT a good use of your time? What is most/least valuable?
¢ What would you describe as the primary role of the MDM? Does it have any other functions?
2. What factors are most important to the success of an MDT meeting?
Team Processes – I’d like to focus now on the wider team
1. What is the atmosphere like in the team meetings? What do you think creates this atmosphere?
¢ What would make it better?
¢ Do you think people are able to speak freely during the meetings? Why?
¢ How do different professional groups interact in the team?
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¢ Are some professions more or less relevant to the meeting than others?
¢ What do you see as your role in the meeting?
¢ What kind of issues do you bring to the meeting? Do you think the MDM is the best way to do this?
2. What happens when people disagree?
¢ Can you give example of time you disagreed?
Decision-making: can I get you to think about decision making in the MDM?
1. How does the team come to a decision about a case/patient?
¢ What information do you need to make a decision?
¢ Probe re barriers to accessing information?
¢ Are there times when the team doesn’t come to a decision? Why is this?
2. Can you talk a bit about patient preferences in relation to decision making?
¢ How much do you tend to know about patient’s preferences? To what extent do they influence
decision making?
¢ How could patient preferences be incorporated into decision making?
¢ What about other factors, for example, other illnesses or conditions: how do these influence
decision making?
3. Is there anything you think doesn’t get discussed enough during the meeting?
¢ Is there anything you think less time should be spent on?
¢ Can changes happen (realistically) to improve it? How (how can x or y happen)?
4. How do MDT meetings affect the quality of clinical decisions?
¢ Do you think MDT meetings lead to better clinical decisions for patients?
¢ Prompt for a specific example
¢ Are there times when poor/sub-optimal decisions are made? Why do you think this happens?
¢ Prompt for a specific example
5. Can you describe a time when a decision made at the meeting was changed? Why did this happen?
6. How much of decision-making happens outside the meeting? How does the quality of these
decisions compare?
7. To conclude this section, could you reflect on what could be improved about the way decisions
are made?
External influences
1. How is decision-making influenced by resourcing issues? (e.g. time-constraints, funding, staff shortages)
2. Thinking about the physical environment, are there any aspects of the room or layout that influence
the way the team interacts?
3. At the moment, there are a lot of changes going on in the NHS . . .
¢ How would you describe the impact of this on your organisation?
¢ And do you think this has impacted on the team?
4. Finally, is there anything else you think is relevant?
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Appendix 6 Patient interview topic guide
UCL DEPARTMENT OF APPLIED HEALTH 
RESEARCH 
MDT STUDY: Patient interview TOPIC GUIDE
VERSION 1, 28.3.12
INTRODUCTION FOR PATIENTS
This research aims to understand clinical decision-making processes through the eyes of the patient. There
will be three sections to the interview. First, we’d like to hear about your experience of your care so far.
Then we’ll move on to how you and your healthcare team make decisions about your care. Finally, we’ll
discuss more generally how you feel patients should be involved in these kinds of decisions.
We would like to emphasise that the study is being conducted by UCL and we are not employed by your
Trust or the NHS.
We wish to reassure you that you do not have to answer any question you feel uncomfortable with and
you can stop the interview at any time. This will in no way affect your care.
This is about getting your views across. Your responses will be confidential: they will not be shared with
your healthcare team. Quotes from the interviews may be used in our findings, but it will not be possible
to identify you or your healthcare team from these.
Interviewer will then talk through patient information sheet if patient/carer wishes
Warm up - I’d like to start by asking you about your condition and your care
1. Could you briefly tell me about your [condition] and the most important ways that it affects you?
Encourage focus on main condition (focus of MDM) & impact on quality of life
2. What types of care do you currently have for your [condition]?
Encourage brevity & focus on major health (+/– social care) interventions
3. Can you describe how decisions were/are made about your care?
¢ Who are the main people involved in making decisions about your care? i.e. are respondents aware
of multidisciplinary team (MDM) vs. individual consultant making decision?
¢ What involvement did you have in making decisions/planning care?
¢ What were your preferences/wishes regarding your care?
¢ Can you describe any times when you were invited to discuss or choose any aspects of your care?
¢ Did you want to make choices? Does it depend on the type of decision?
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4. Please can we talk in more detail about a particularly important decision that was made about your
care? This may include a treatment, diagnostic procedure, something about the timing, setting
(inpatient/outpatient) or anything else such as a second opinion.
5. Can you describe how you made your decision to/not to receive this care? Can you tell us the factors
that influenced the decision?
¢ Any perceived concerns/benefits e.g. side effects; time in hospital; convalescence time; enormity of
procedure; quality of life etc.
¢ Where they received information from (e.g. family, friends, reading, clinical staff)
¢ Which of these factors made a difference to the decision made? Why?
¢ Extent to which their choice/decision was influenced by personal characteristics e.g. belief systems
(fatalism, faith, ‘willing to try anything’, autonomy [want to retain personal control], delegation
[want their Dr to make important decisions] etc.)
¢ Extent to which personal characteristics interacted/were mediated by context e.g. their relationship
with key health professionals / the importance of the decision/uncertainty surrounding management
options etc.
6. Is there anything about your care that you know now, that you would like to have known before?
¢ Side effects, time in hospital, recuperation issues, specified risks etc.
¢ How might this information have changed your care preferences/decision?
MDT meetings - increasingly in the NHS, patient care is managed by a team of professionals with
different skills, rather than one person. For example, [insert relevant mix of professionals] may
meet together once a week to discuss different cases. Patient care decisions are often made in
these in ‘multidisciplinary team meetings’, by the whole (multidisciplinary) team.
1. What do you know about these meetings?
¢ Do you know that your care is discussed?
¢ Were decisions fed back to you?
¢ What do you think about this way of working?
¢ How do you feel about your care being discussed in these meetings?
2. What were/are the important things about you that you would want the multidisciplinary team to
consider when they meet to discuss your care/management?
3. What were/are the important things about your care that you would want the multidisciplinary team to
consider when they meet to discuss your care/management?
¢ Defined benefits and concerns e.g. side effects; time in hospital; convalescence time; enormity of
procedure; quality of life etc.; importance of short versus long term effects
¢ Timing; setting etc.
4. When is the most appropriate time to discuss this information with you?
¢ How should it be done & how often? e.g. before or after the MDT
¢ Who would you want to represent your views at a multidisciplinary meeting (key health
professional; patient advocate; patient/carer)?
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5. Are there issues that you would wish to remain confidential (not to be shared) when the team is
discussing management options for you?
As appropriate, probe, with sensitivity:
¢ Comorbidities; risky behaviours; personal circumstances (do NOT press to define these if the patient
does not volunteer the information).
In this final section, I’d like to talk more generally about how you think multidisciplinary teams
should work
1. Do you think it is important for multidisciplinary teams to always consider patients’ views when making
a decision about care?
As appropriate, probe the influence of:
¢ Context e.g. major decisions (to have a major intervention or not etc.) versus decisions about
process (scheduling, setting etc.);
¢ Intervention specific issues e.g. where there is clinical uncertainty about options; quality of life
(pain, impact on mobility/independence etc.)
2. What information should be fed back to patients about the multidisciplinary team meeting
decision-making process about their care?
As appropriate, probe:
¢ How the MDT decided what to recommend e.g. whether it was protocol/evidence based;
the specialties involved in making the decision; options discussed; factors which influenced the
decision etc.
3. Do you have any suggestions for ways for patients’ views to be represented at the multidisciplinary
team meeting?
As appropriate, probe:
¢ Some suggestions include: staff known to patient attend; patient advocate attends; preparatory
meeting with patient; patient preferences written down in advance; patient submits a written
statement; patient/carer attends meeting; formalised feedback after the meeting; decision options
discussed with patient after meeting etc.
¢ How would this work in practice? e.g. would they find it upsetting, would they understand the
discussion, would it be intimidating; is it feasible (work & family commitments)?
¢ What about for patients who feel unable to express their view/ask questions?
Finally, is there anything else about how patients are involved in decisions about their
healthcare that you would like to add?
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Appendix 7 Observation code definitions
Code Code name Definition
1 Administration
1a Admin support as enabling factor in
decision-making
Demonstrates where administrative support, including the MDT
co-ordinator role, is instrumental in facilitating decision-making
(e.g. by providing information or reminders of previous discussions)
1b Use of IT as an enabling factor Examples of members of the team using IT to access information to
help them make a decision
1c Administrative/IT problems Illustrates how administrative (including IT/technical issues) problems can
impact on decision-making
2 Role of carers
2a Carer preferences Mention of carer preferences in relation to a patient’s care
2b Carer well-being Team discussing the well-being of the carer
2c Negative carer influence Discussing concerns that carers are negatively influencing patients, for
example by interfering in their treatment or colluding in their illnesses
2ci obstructive carer interference
2cii Obstructive carer collusion
2d Positive carer influence Examples of carer influence being described in a positive light by the
team (e.g. supportive of patient)
3 Patient experience of services When team acknowledges the impact of services/treatment
on patient(s)
4 Empathy toward patient/carer Examples of the team showing empathy towards the patient or carer
because of their symptoms or social situation
5 Positive comments about patients Where staff make positive comments about patients, or positive
judgements about patient personality
6 Casual talk Staff expressing opinions or sharing information that does not appear
to be relevant or helpful to the discussion
7 Advocacy/Patient centred care Where staff consider the perspective of patients and advocate on
their behalf
8 Labels and stigma Discussion of stigma around illness and the effects of ‘labelling’ patients
9 Comorbidities Discussion of comorbidities
10 Treatment decisions based on impact
of symptoms on patient
When the members report patient and carer complaints about their
condition to decide whether to treat or not
11 Withholding information or treatment
from pt in “pt’s best interest”
When the team decide it is best for the patient not to know certain
information, e.g. a diagnosis or treatment alternative
12 Attendance/punctuality Reference to a member of the team being absent or late to the meeting
13 Awareness of researcher Where reference is made by someone in the team to the fact that the
meeting is being recorded
14 Challenging an earlier decision Discussions where someone questions the rationale for or challenges a
decision made previously by the team
15 Challenging or difficult cases
15a Complex diagnoses Cases where there are complexities in diagnosing a patient, also when
the ‘set’ criteria do not fit but teams ‘have’ to diagnose within
specific codes
15b Lack of clear options for patient Discussions where clinicians express that they do not feel they have any
more treatment options to try or are unsure of what to do with
the patient
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Code Code name Definition
15c Challenging behaviour Discussion of patient behaving in a way that the team finds challenging
(e.g. non-compliance, violence, etc.)
15d Patient disputing illness When the patient denies/does not agree that they are unwell
15e Questioning pt truthfulness Discussions of patients being deliberately untruthful to staff
15f Conflict between information by
patient and other sources
Discussion of patient/carer giving inaccurate information (but no
suspicion of deliberate deception)
15h Opportunistic or inappropriate
service use
Where clinicians question the patient’s motives for seeking care,
e.g. to claim benefits or to garner mitigating circumstances for
criminal behaviour
16 Cohesion: humour Highlights examples of the group using humour
17 Cohesion: personal and
social communication
Personal/social exchanges between team members
18 Consensus Clear examples of team making a decision by explicit
consensus agreement
19 Criticising other services Negative perceptions or comments about other teams or services
20 Content of discussion
20a Decision framing Examples of discussions culminating in a decision
20b Information giving – presenting
patient information
Presenting patient characteristics or clinical history before discussion
and/or a decision is made
20c Information giving – imaging Radiology/imaging presentation of information to shape discussion
and/or decision
20d Information giving – pathology Pathology or histology review feeding into discussion and/or decision
20e Ownership of case in MDT Establishing responsibility for presenting the case/‘ownership’ of case
in MDT
20f Implementation responsibility Discussing who will implement the decision – or whether this is not
discussed but assumed, etc.
21 Decision making outside of meeting Explicit acknowledgement from the team that a decision has been or
will be made outside the meeting, e.g. in clinic or in the
operating theatre
22 Directives/Requests One person instructing or asking another to do something
23 Discharge Examples of team deciding to discharge a patient
24 Ethical dilemmas Using the meeting to discuss ethical dilemmas or issues
25 Distinction between “illness” and
“behaviour/personality”
Discussions where members distinguish between issues attributed to
patient’s ‘illness’ and those attributed to their ‘behaviour’
or ‘personality’
26 Divided responsibility between patient
and safety of staff
Discussions highlighting conflicting responsibilities towards patient
and staff
27 Divided responsibility between patient
and family
Discussions highlighting conflicting responsibilities towards the patient
and the patient’s family
28 Divided responsibility between patient
and society
Discussions highlighting conflicting responsibilities towards patient and
society at large
29 Documentation/audit function Explicit reference to something being done in order to create an
audit trail
30 Emotional expression function Members expressing emotions during meeting (e.g. in relation to
patient or occupational stressors) or acknowledgement of emotional
burden related to work. This is separate from ‘Empathy towards
patient’, which focuses on acknowledging how the patient feels, rather
than how members of the team feel. Some quotes may be coded
as both
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Code Code name Definition
30a Resignation/failure Expressions of resignation regarding a failed treatment attempt
30b Positive emotion Expressions of positive emotions relating to work, e.g. successful
treatment or engagement
31 Feedback function Making the team aware of an issue without seeking to make a decision
or seeking input
32 Hierarchy Evidence of status differentials between professionals
33 Holistic discussion of patients Consideration of a patient’s psychosocial situation
34 Dominance of clinical information Focus on clinical information without considering patient’s psychosocial
situation or preferences
35 Multidisciplinary participation and
multidisciplinary decision-making
Where people from different professions contribute to a decision
or discussion
36 Legalities and professional
safeguarding
Mention of legal issues or potential for legal action
37 Links with other services Examples of interaction between team members and other services
38 Local policy/guidance Reference to policy or guidance at a local level (i.e. not national or
international; usually trust policies)
39 Meeting disruption Examples of meeting disruption, e.g. answering mobile phones,
responding to pagers
40 Meeting management Examples illustrating how the meeting is conducted and procedural
issues regarding the meeting, e.g. discussions being moved along
quickly, clarifications of who has the final say in decision-making, or
decisions regarding whether a patient is discussed or not
40a Selection of patients for discussion Demonstrates how the team decides which patients are discussed
during or before the meeting
41 Missing information Relates to both missing team members and missing information,
e.g. scans, pathology results
42 National policy/guidance Any reference to external policy or guidance which influences the
discussion, e.g. waiting times
43 Non-clinical disagreement Disagreements or sharp exchanges between members of the team that
are not clinical in nature
44 Pathways of care Mention of pathways into or out of the service – demonstrates
complexity and ‘bigger picture’ within which the teams are
making decisions
45 Patient awareness of MDT Reference to a patient being aware that the ‘team’ are making a
decision, rather than an individual clinician
47 Patient treatment preferences Mention of patient preferences regarding treatment
48 Patient persuasion, negotiation
and management
Mention of trying to persuade or negotiate with patients
49 Questioning/clarifying Members of the MDT asking a specific question to another member
50 Reflecting on therapeutic alliance Acknowledgement of the quality of the patient/team
member relationship
51 Research/evidence Explicit reference to research or evidence during the meeting
52 Resources: funding Mention of money or funding
53 Resources: system capacity Mention of capacity within the team or system (e.g. waiting lists and
theatre slots)
54 Resources: time Comments reflecting the impact of a lack of time on team behaviour
55 Responding to errors Team response to errors – clinical or administrative
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Code Code name Definition
56 Searching for information Delays in discussion while the team look for information or wait for
someone to respond (after meeting has started, so different from
punctuality/attendance)
57 Seeking opinions or advice Examples of team members explicitly asking the rest of the group
for advice
58 Sense of team responsibility Where a sense of joint responsibility for the patient is evident
59 Service improvement Examples of the team using the meeting as a place to recommend
wider improvements to the service or to raise concerns about
existing processes
60 Service restructuring/
higher management
Discussions of management issues at levels higher than the team
manager, e.g. service-restructuring
61 Sharing local knowledge of
organisational systems (function)
Sharing information regarding the organisation, e.g. policies,
services, trials
62 Sharing local knowledge of
patients (function)
Someone with previous knowledge of a patient sharing information
relevant to that specific patient with someone who is now working with
him or her
63 Support or guidance (function)
amongst team members
Expressions of support and/or encouragement between team members,
including continuing professional development or reflective practice
63a Teaching function Examples of the meeting being used to educate or teach other
team members
64 Team management (function) Using the meeting for management duties or management queries,
e.g. manager instructing team to update their paperwork, or doctor
asking manager for details of the policy on information-sharing
65 Validation Relates to the team acting as a ‘check’ on individual members,
e.g. correcting errors or misconceptions, or attempting to rectify a
mistake made by a member of the team
66 Meeting environment Describes the physical space where the meeting takes place
67 Team Characteristics Descriptions of features of the team, i.e. what professions attend
usually, etc.
68 Clinical conflict Exchanges between members of the team that demonstrate a clinical or
professional disagreement or challenge
69 Collateral Verifying patient’s account with third party
x Recommendations Potential recommendations noted by the observing researchers
APPENDIX 7
NIHR Journals Library www.journalslibrary.nihr.ac.uk
126
Appendix 8 Observation codes clustered for
qualitative exploration of quantitative results
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Appendix 9 Collaborators and steering group
members
Name Profession
Coapplicants
Professor Gill Livingston Professor of Psychiatry of Older People
Professor Susan Michie Professor of Health Psychology
Dr Julie Barber Lecturer in Statistical Science
Dr Archie Prentice President of the Royal College of Pathologists
Dr Alex Clarke Consultant Clinical Psychologist and Nurse
Dr Anne Lanceley Senior Lecturer, Women’s Cancer Research
Professor Jane Blazeby Professor of Surgery
Dr Simon Gibbs Reader in Pulmonary Hypertension
Professor Ewan Ferlie Professor of Public Services Management
Professor Michael King Professor of Primary Care Psychiatry
Expert advisory panel
Dr Simon Woldman Consultant Cardiologist
Dr Mark Exworthy Reader in Public Management and Policy
Professor Michael West Professor of Organizational Psychology
Miriam Harris PPI representative
Professor Adrian Newland Professor of Haematology
David Ardron PPI representative and carer representative
James Green Consultant Urological Surgeon
Charles Vincent Professor of Clinical Safety Research
Nick Sevdalis Senior Lecturer, Faculty of Medicine, Department of Surgery and Cancer
Sarah Harvey Assistant Professor, Department of Management Science and Innovation
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Appendix 10 Summary of the 12
multidisciplinary teams
We aimed to include a diverse range of teams in this study to highlight important issues about MDTdecision-making and implementation. The 12 MDTs we observed included four cancer teams,
four mental health teams, two heart failure teams and two memory clinic teams. A brief description of
each of the teams is provided below.
Cancer team 1
This team meeting was one of the longest MDT meetings we observed, often running for almost 3 hours.
Between 35 and 50 patients were discussed each week. It was a large team, with over 30 core members,
including surgeons, oncologists, psychologists, palliative care specialists, pathologists, radiologists, research
nurses, a clinical trials manager, a physiotherapist and an MDT co-ordinator. There were also often a
number of observers present each week who did not participate in discussion, for example medical
students or visiting academics.
The meeting was chaired by the MDT lead, who was a surgeon. On occasion, other surgeons would be
asked to chair the meeting on their behalf.
A full list of patients to be discussed was provided at the start of the meeting by the MDT co-ordinator.
The list was divided into different groups for discussion:
¢ radiology and integrated pathology patients (these tended to be lengthy discussions)
¢ complex cases (these tended to be a small number of lengthy discussions)
¢ new patients referred to the centre (these were brief updates, often feedback only)
¢ pathology cases (this tended to be a long list but covered quickly).
During the meeting, the chairperson updated an ‘MDT sheet’ for each patient discussed. This recorded the
findings presented by the radiologist and/or pathologist, and captured the plan agreed for each patient.
These records were stored on a team shared drive, and were also subsequently uploaded to individual
electronic patient files.
Cancer team 2
There were 17 members in this team, including haematologists, an oncologist, a pathologist, a radiologist,
clinical nurse specialists, chemotherapy nurses, specialist registrars, clinical trials practitioners and an MDT
co-ordinator. Most team members attended the weekly MDT meeting regularly. Three or four members of
the team were connected via video link from a second hospital site. The meeting lasted for 1 hour, with
between 10 and 20 patients discussed each week. A consultant haematologist chaired the meeting.
A patient list was circulated to all team members a day or two in advance of the meeting. This was used
as an agenda to structure the meeting.
Decisions were clearly summarised for the MDT co-ordinator, who made notes of the treatment plan
agreed for each patient. These notes were subsequently checked by the MDT lead before being uploaded
onto the electronic records system.
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At the start of each meeting an IT representative set up the equipment for the video link. However, there
were frequent problems with IT, which disrupted the meeting or delayed the start time.
Cancer team 3
This was the largest team we observed, with as many as 35 to 40 people attending some meetings. There
was wide input from a number of those present, although many people attending did not contribute at all.
Attendees included haematologists, clinical oncologists, pathologists, radiologists, specialists in nuclear
medicine, cytogenetics and molecular biology, research nurses, trials co-ordinators, pharmacists, specialists
registrars and an MDT co-ordinator. A consultant haematologist chaired the meeting.
The meeting was clearly structured and a patient list was circulated in advance which grouped patients by
disease subtype (e.g. lymphoma, myeloma). This was used as an agenda to guide the meeting.
Decisions were recorded for each patient directly into an electronic patient record, which was projected
onto a screen for other team members to see. The decision was usually recorded by a specialist registrar or
a junior doctor and checked by the chairperson.
Cancer team 4
This team included both medical and clinical oncologists, dermatologists, plastic surgeons, a clinical nurse
specialist, pathologists, a radiologist, a nuclear medicine specialist and a research nurse. The pathologists
and the radiologist were more actively involved in discussion and decision-making than in the other
cancer teams.
A patient list was circulated by e-mail to the team in advance of each meeting. This included information
on patient’s sociodemographic characteristics; the consultant responsible for their care; imaging or
histology to be reviewed; and a note of the issue for discussion.
There was a clear structure to the meeting, during which between 35 and 50 patients were discussed,
in the following order:
¢ melanoma cases (radiology done first, allowing the radiologist to leave afterwards)
¢ patients from another hospital (done via video link)
¢ squamous cell carcinoma cases
¢ basal cell carcinoma cases.
The meeting was chaired by a consultant oncologist, with a surgeon taking the lead in their absence.
There was a wide pattern of participation during this meeting, as the focus shifted between different
specialties depending on the cases being discussed. Most people attending presented at least one case
(with the exception of the clinical nurse specialist, who rarely presented cases), although the consultants
usually made the decisions.
Clinical decisions were recorded on a paper proforma by the presenting clinician. They were subsequently
photocopied by the MDT co-ordinator at the end of the meeting and filed in both the paper and electronic
notes. During the observation period the team began to complete this information electronically.
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Heart failure team 1
This was a large team which included cardiologists, surgeons, palliative care specialists, specialist registrars
and junior doctors, heart failure specialist nurses, research nurses and imaging consultants. In addition,
a small number of observers often attended, but they did not participate in discussion.
There was a patient list, distributed before the meeting, which consisted of inpatients and any other
patients flagged by a member of the team as needing discussion. This list was collated by a Senior House
Officer (SHO) and included the patient’s name and hospital number, and sometimes included the reason
for discussion, for example ‘review of echo’. Each patient was presented to the meeting by the SHO using
a PowerPoint presentation (Microsoft Corporation, Redmond, WA, USA). The electrocardiogram, echo and
other test results were also projected on a large screen.
These presentations provided the structure for the meeting. While the matter of chairing was not
explicitly discussed, discussions tended to be moved along by one of the consultant cardiologists or a
specialist registrar.
A specialist registrar made hand-written notes on each case and wrote up a summary of each patient
discussion, including a list of named members who had contributed to the discussion. After the meeting
this was given to an administrator, who added it to the patient’s electronic record.
Heart failure team 2
This was a new team and attendance changed over the period of observation when additional
professionals were asked to join the team. Initially the meeting was attended by six to eight members;
however, after the fourth week of observation the team was regularly attended by just three to five
members. This coincided with the MDT meeting moving from its initial location to a different building. The
meeting was attended by cardiology consultants, specialist registrars and heart failure nurses regardless of
the number of attendees. On some occasions meetings were cancelled because the consultant was unable
to attend. In response to this the lead consultant suggested that other consultants should attend
the meetings.
The meeting ran for approximately 1 hour with an average of six patients discussed each week. The heart
failure nurses decided which patients to bring to the meeting, and presented these, sometimes in
conjunction with a specialist registrar. Patients’ cases were presented on a computer screen and the
discussion focused mainly on the echo findings.
Decisions were not always clear, but when they were made they tended to be very specific, for example
medication or surgery. Usually the nurses presented their suggestions and then confirmed with the doctor
that the treatment they had chosen was correct.
Memory clinic team 1
Between 8 and 12 staff attended every meeting. Attendance was regarded as compulsory for all members
unless there was a good reason for not attending. Team members included nurses, psychiatrists,
psychologists, a specialist registrar, a team manager, social worker, an occupational therapist and a
dementia support worker. The meeting was chaired by the team manager, who was a senior nurse.
At the beginning of the meeting all new referrals received that week were allocated to team members.
Following this, between five and eight existing patients were discussed in the hour-long meeting, during
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which the results of an assessment were fed back to the team, specific queries were raised or patient
updates were provided.
There was no predetermined patient list for this meeting. Instead, all team members were given the
opportunity to raise cases on an ad hoc basis. Decisions made by the team were typed directly into
electronic patient records during the meeting by the chairperson.
Memory clinic team 2
This team consisted of psychiatrists, psychologists, specialist registrars and a memory specialist nurse. It was
a relatively small team with three to eight people attending each week to discuss three or four patients.
Specialist registrars would usually attend only if they had a case to present. Not all cases were discussed
during the meeting, in which case they were either brought back the following week or discussed outside
the meeting by one of the consultants and another member of the team. The meeting was chaired by a
consultant psychiatrist.
As with the other memory team, there was no predetermined patient list for the meeting, and team
members were given the opportunity to raise patients they had seen most recently. The structure of
discussion was uniform, with full presentation of test results, including cognitive assessments and a
medical assessment made by a specialist registrar. Discussions would then focus on making a diagnosis
based on these assessments. Decisions were recorded informally by the team member who raised the case.
Community mental health team 1
This team was observed for 14 weeks, before it disbanded. It included a consultant psychiatrist, specialist
registrar, nurses and social workers, and a team manager. A locum psychologist joined the team for the
last few weeks before the team disbanded. The meeting lasted for between 2.5 and 3 hours, during
which approximately 30 patients were discussed. The meeting was chaired by the team manager
(a social worker).
The structure of the meeting was usually not made explicit, but tended to cover:
¢ discussion and allocation of new referrals
¢ feedback from assessments (outpatient or community assessments)
¢ discussion of patients shared with other teams, if the inpatient/home treatment consultant was
in attendance
¢ ongoing cases, where the team was given the opportunity to discuss any issues they wanted to raise.
A patient list was not distributed in advance of the meetings. Instead, team members raised patients as
they remembered them. They fed back assessments from memory, and did not use IT or patient notes
during the meeting.
At the start of the observation period, the team began recording handwritten notes into a hard-backed A4
copybook to capture team discussions and decisions made during the meeting.
Community mental health team 2
The team included nurses, social workers (one of whom was the team manager), a psychologist, a
psychiatrist (who did not always attend), a specialist registrar and a junior doctor. Other occasional
attendees included a rotating specialist registrar, an SHO, an administrator, who took minutes but did not
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contribute to discussions, and a representative from the crisis team. The nurses, social workers and
psychologists took turns to chair the meeting. The meeting lasted 1 to 1.5 hours, with the team discussing
around 25 patients.
The rotating chairperson tended to go through a format of:
¢ matters arising from the minutes of the last meeting
¢ crisis team liaison
¢ feedback from assessments
¢ clinical liaison (taking turns to raise issues of concern)
¢ any other business (e.g. new staff arriving or updates on the service-restructuring plan).
In common with CMHT 1, a patient list was not distributed in advance of the meetings; instead, team
members raised patients as they remembered them. In addition, they did not use IT or patient records
during the meeting and fed back assessments from memory.
During the observation period there was considerable anxiety within the team due to service
line-restructuring, and many of the team were being re-interviewed for their jobs. There were
sometimes extended discussions about this restructuring during MDT meetings, when people spoke about
their anxieties. These discussions often ended with a reminder that restructuring issues should be
discussed at the weekly ‘business meeting’ held on a different day of the week.
Minutes of the meeting were hand-written by the team administrator (or another team member, if the
administrator was absent), who later typed them up. Details of discussions were not systematically entered
into patients’ electronic medical notes, although some team members occasionally mentioned the MDT
discussion in the notes (e.g. ‘discussed with the team and decided to discharge’). Members did not usually
bring paper with them or write their own action points down during the meeting.
Community mental health team 3
This team included a consultant psychiatrist, community psychiatric nurses, social workers (including the
team manager) and a clinical psychologist. Other attendees at the meeting included a rotating specialist
registrar and/or SHO, an administrator, who took minutes but did not contribute to discussions, a
representative from the crisis team and occasionally trainee psychologists or student nurses. The nurses,
social workers and psychologists took turns to chair the meeting.
The weekly meeting lasted approximately 1 hour, though this ranged from 30–90 minutes. The team
discussed around 25 clients per week. Because the job of chairperson rotated, the style of chairing varied
from week to week, though it loosely followed the structure:
¢ apologies
¢ minutes of last meeting
¢ Mental Health Act assessments (mention of any patients sectioned or plans to do so this week)
¢ feedback from new assessments
¢ crisis team liaison
¢ clinical liaison (taking turns to raise any issues of concern).
Like the other CMHTs, there was no patient list made in advance of the meeting. Instead, team members
raised patients about whom they had concerns (due, for example, to relapse, crisis or risky behaviour).
They also brought up specific medical queries (e.g. asking the psychiatrist about medication dosages). In
addition, when the chairperson went through the previous week’s minutes, senior members occasionally
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asked for feedback (e.g. ‘how did that appointment go?’, team manager, observation). Mental Health Act
assessments planned for the following week were mentioned.
Minutes of the meeting were hand-written by the team administrator, who later typed them up. Details of
the discussions were not systematically entered into the patient’s electronic medical notes, although some
team members occasionally mentioned the MDT discussion in the notes (e.g. ‘discussed with the team and
decided to discharge’). Members did not usually bring paper with them or write their own action points
down during the meeting.
Community mental health team 4
The team consisted of a consultant psychiatrist and specialist registrar, social workers (including the team
manager), community psychiatric nurses and occupational therapists. In addition, a forensic psychiatrist
and a forensic nurse attended on a monthly basis and there were other occasional attendees including
student nurses and student psychologists. Approximately 16 team members met each week for between
2 and 3 hours, during which approximately 49 patients were discussed. Discussions were guided by a list
distributed at the start of meetings by the manager, which listed all patients currently on the team’s
caseload. Most team members attended every week, although a small number did not attend for the full
duration of the meeting.
The meeting was usually chaired by the team manager (a social worker with no caseload) or the deputy
manager (a social worker with a reduced caseload), and was structured around the following categories:
¢ inpatients
¢ new assessments (discussion of patients in their initial 6-week assessment period while the team
decided whether or not to ‘take them on’)
¢ clients of concern (each team member read through their list of patients and commented on anyone
they were concerned about).
On one occasion the team went through a team member’s whole caseload. They made reference to the
fact that they had intended to go through a team member’s whole caseload each week but there was
rarely time for this.
During the ‘clients of concern’ session, the team members used their discretion to decide whom to
mention, although sometimes the manager asked them about particular clients whom they had not
mentioned of their own accord.
There was a computer in one corner, where one member of the team typed notes directly into the patient
electronic records system or into a Word (Microsoft Corporation, Redmond, WA, USA) document to be
uploaded later. This was usually done by the deputy manager or a nurse.
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Appendix 11 Example of a theme from the
consensus development group questionnaire pack
Theme: Discussing comorbidities at MDT meetings
Key points from policy and guidance
¢ Cancer policy states that patients’ demographic profiles and comorbidities should always be considered
at MDT meetings.113
¢ Guidelines for Mental Health, Memory Clinic and Heart Failure MDTs all emphasise the importance
of identifying and managing comorbidities but there are no specific references to whether or how this
information should be incorporated into MDT discussions.77,164–166
Key points from the research literature
¢ 99% of MDT members responding to an online survey agreed that patient comorbidities should always
be considered when making a decision in the MDT meeting.25
¢ Inadequate information on comorbidities has been associated with failure to make decisions in
MDT meetings.129,130
¢ Having insufficient information on comorbidities has been reported to be an important cause of MDT
decision non-implementation.127
Our research findings
Quantitative findings
¢ Our study found no association between discussion of comorbidities and decision implementation.
Qualitative findings
¢ There was diversity within and between specialties with respect to the extent to which comorbidities
were discussed. No team discussed this information routinely.
¢ Team members considered discussion of comorbidities to be valuable.
Arguments in favour of including comorbidities in multidisciplinary
team discussions
¢ Discussion of comorbidities helps to determine suitable treatment options and informs differential
diagnosis (e.g. cognitive impairment and depression).
¢ Presentation of comorbidities encourages a holistic approach to treatment, for example, by highlighting
the need to consider both physical and mental health issues, and issues relevant to patient
engagement and adherence.
¢ Patients wanted their comorbidities to be considered and included in treatment plans.
Arguments against including comorbidities in multidisciplinary
team discussions
¢ Information on comorbidities is not always available (e.g. when discussing patients for the first time),
and not always accurate (e.g. as a result of incomplete assessment).
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¢ When comorbidities are discussed routinely this can add to the volume of potentially irrelevant
information to be considered by the team, which can hamper decision-making.
¢ Patients may be stigmatised or stereotyped because of their comorbidity (e.g. obesity).
¢ It is not always possible to identify in advance of an MDT meeting, and therefore to have the
information available on, comorbidities which might be relevant to decision-making.
Questions
Approaches to incorporate information on comorbidities in the MDT meeting:
Do you have any other suggestions about how to incorporate comorbidities into MDT
meeting discussions?
A designated MDT member should speak to
the patient about comorbidities before the patient
is discussed at an MDT meeting
Strongly   ………………………… Strongly
disagree                                        agree  
Don’t
know 
654321 7 8      9 
There should be a structured discussion on
each patient with a section on comorbidities
(e.g. using a checklist)
Strongly   ………………………… Strongly
disagree                                        agree  
Don’t
know 
654321 7 8      9 
Patients’ past medical history should
routinely be available at the MDT meeting
Strongly   ………………………… Strongly
disagree                                        agree  
Don’t
know 
654321 7 8      9 
Comorbidities should be routinely discussed
at MDT meetings 
Strongly   ………………………… Strongly 
disagree                                        agree  
Don’t
know
654321 7 8       9 
A patient should only be discussed at the
MDT meeting when information on comorbidity
is available 
Strongly   ………………………… Strongly
disagree                                        agree
Don’t
know 
654321 7 8       9 
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Appendix 12 Consensus development results
from round 2: recommendations for which strength
of agreement was strongly agree (median ≥ 7) and
variation in extent of agreement was low
The 68 recommendations are grouped into four tables by strength of agreement. Appendix 12 showsthose recommendations where there was strong agreement (median ≥ 7) and low variation in the
extent of agreement (the 21 final recommendations). Appendix 13 shows recommendations where there
was strong agreement (median ≥ 7) and moderate or high variation in extent of agreement. Appendix 14
shows those where there was uncertainty (median ≥ 4 and ≤ 6.5) and Appendix 15 shows those
recommendations where there was disagreement (median < 4). The quotes in the final column of the
tables reflect each of the distinct points made by panellists in order to explain the causes of variation in
extent of agreement.
No participant used the ‘don’t know’ option in the second round of ratings.
Item Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating
variability in agreement
(when discussed)c
Recommendations relating to the purpose and functions of MDT meetings
1 MDT meeting objectives
should include locally
(as well as nationally)
determined goals
8 0.63 Low Not discussed
2 The primary objective of
MDT meetings should be
to agree treatment plans
for patients. Other
functions are important
but they should not
take precedence
8 0.88 Low
3 The objectives of MDT
meetings should be
explicitly agreed, reviewed
and documented by
each team
8 0.94 Low
4 Explaining the function of
the MDT meeting should
be a formal part of
induction for new staff
9 0.44 Low
5 MDT discussions should
result in a documented
treatment plan for each
patient discussed
9 0.56 Low
6 There should be a formal
mechanism for discussing
recruitment to trials in MDT
meetings (e.g. having
clinical trials as an
agenda item)
8 0.81 Low
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Item Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating
variability in agreement
(when discussed)c
Recommendations relating to MDT meeting processes
7 All chairpersons should be
trained in chairing skills
7 0.81 Low Not discussed
8 All new patients should be
discussed in an MDT
meeting even if a clear
protocol exists
8.5 0.94 Low
9 Teams should agree what
information should be
presented for patients
brought for discussion in
an MDT meeting
9 0.56 Low
10 All new team members
should be told what
information they are
expected to present on
patients they bring for
discussion in an
MDT meeting
9 0.38 Low
11 The objectives of the MDT
meeting should be
reviewed yearly
9 1 Low
12 Once a team has
established a set of
objectives for the meeting,
the MDT should be audited
against these goals
(e.g. every 2 years)
7.5 0.94 Low Probably in an ideal world it
probably should be
Nurse (heart failure)
I’m not sure what we
would audit
Doctor (heart failure)
13 All action points should be
recorded electronically
9 0.81 Low Not discussed
14 Implementation of MDT
decisions should be
audited annually
8 1 Low Discussed and rated together
with the recommendation:
‘Once a team has established a
set of objectives for the
meeting, the MDT should be
audited against these goals
(e.g. every 2 years)’
15 Where an MDT meeting
decision is changed, the
reason for changing this
should always
be documented
9 0.19 Low Not discussed
16 There should be a named
implementer documented
with each decision
9 0.38 Low
Recommendations relating to the content of discussion in MDT meetings
17 Comorbidities should be
routinely discussed at
MDT meetings
8 0.94 Low Not discussed
18 Patients’ past medical
history should routinely
be available at the
MDT meeting
8.5 0.56 Low
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Item Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating
variability in agreement
(when discussed)c
Recommendations relating to the role of the patient in MDT meetings
19 The MDT should actively
seek all possible treatment
options, and discuss these
with the patient after
the meeting
9 0.44 Low This question was reworded.
It initially read as: ‘Patient
preferences should not be
routinely discussed, but when
making a decision, the MDT
should actively seek all possible
treatment options, and discuss
these with the patient after
the meeting.’ The panel
agreed to reword so it was a
single-issue recommendation
20 Patients should be given
verbal feedback about
the outcome of the
MDT meeting
8.5 0.94 Low Not discussed
21 Where it would be
potentially inappropriate to
share the content of an
MDT discussion with the
patient (e.g. where it may
lead to unnecessary anxiety
or disengagement from
services), the decision not
to feedback should be
formally agreed and noted
at the meeting by the team
9 0.63 Low
a Strength of agreement with the statement is indicated by the median: medians between 7 and 9 indicated agreement,
medians between 4 and 6.5 indicated uncertainty, and medians between 1 and 3.5 indicated disagreement.
b Variation in extent of agreement among panellists is indicated by the mean absolute deviation from the median:
> 1.75 high, 1.11–1.75 moderate, < 1.11 low.
c Note: only recommendations with a lack of consensus in round 1 were discussed.
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Appendix 13 Consensus development results
from round 2: recommendations for which strength
of agreement was agree (median ≥ 7) and variation
in extent of agreement was moderate or high
Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability
in agreement (when discussed)c
Recommendations relating to the purpose and functions of MDT meetings
22 MDT meetings
should be a forum
for recruiting
patients to
clinical trials
8 1.19 Moderate Not discussed
Recommendations relating to the structure of MDT meetings
23 All MDTs should
have a designated
(rather than a
rotating)
chairperson for
MDT meetings
7 1.75 Moderate It’s quite a difficult skill to
necessarily chair an MDT well
. . . the MDT becomes
temporarily dysfunctional for
three months whilst someone is
thrown into the position of chair
who doesn’t really want to be
doing it, and doesn’t necessarily
have the skills to do it. So I
think it’s quite liberating actually
for there to be an appointed
position
Doctor (cancer)
Having a designated chair and
some sort of succession plan
Patient representative (heart
failure and cancer)
Perhaps you don’t want to be
considered heavily reliant on
one . . . so it would be nice to
have two or three people that
are taken through
Doctor (heart failure)
I don’t think it has to be
designated, ours rotates and it
works fine. I think we should
learn and have those skills
Team manager (mental health)
24 All teams should
have a designated
person at each
MDT meeting to
help identify
suitable patients
for clinical trials
7 1.88 High I would believe that the entire
MDT should be doing that. But
we would always have . . . trials
nurses are always seen in the
MDT, and you know, so every
patient who was a potential
candidate on the basis of their
pathology for a clinical trial
should be identified as
a candidate
Doctor (cancer) 1
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Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability
in agreement (when discussed)c
It’s not necessary to have it a
designated person but it would
be nice in an ideal world
Doctor (cancer) 2
It’s impractical, the number of
people that would potentially be
identified for trials across the
whole of the mental health
service
Doctor (mental health)
25 All MDTs should
have a dedicated
MDT co-ordinator/
administrator
9 1.31 Moderate I don’t think there are many
oncology MDTs that don’t
have it
Doctor (cancer)
I think it would be great to have
one actually, because certainly
we struggle sometimes getting
people to the MDT, and
struggle to get things moving
when everybody’s quite busy.
So actually having a dedicated
person who co-ordinates and
makes sure everything is in the
right place would actually be
really beneficial. But certainly in
my experience that role doesn’t
exist in cardiac care
Nurse (heart failure)
I suppose I think clinicians end
up doing a lot of work which
could easily be done by
someone else, and free up their
time to do [other things]
Nurse (mental health)
If a service has a manager then
you’d expect the manager to be
co-ordinating and gathering the
team and addressing the
members of their team . . . I see
that as my role in my service
Team manager (mental health)
Well I don’t know, I’m not sure
that we need them . . . because
we’re talking about people who
we know . . . the person who’s
seen them needs to be able to
pull all that together succinctly
and report back to the team,
why do you need someone to
co-ordinate that?
Doctor (mental health)
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Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability
in agreement (when discussed)c
Recommendations relating to MDT meeting processes
26 MDT chairpersons
should attend at
least one other
MDT meeting
to identify
approaches to
improve their
chairing skills
8 1.56 Moderate
27 A patient list
should be available
for all team
members to view
in advance of an
MDT meeting
8.5 1.31 Moderate
28 Presentations
should be explicitly
framed in the light
of a specific query
or issue to
be discussed
8 1.13 Moderate
29 All MDTs should
be audited
through external
peer-review
8.5 1.13 Moderate
Recommendations relating to the content of discussion in MDT meetings
30 There should be
time within MDT
meetings to
discuss current and
emerging research
and evidence only
in relation to the
case discussed
7.5 1.25 Moderate Discussed and rated together with
recommendation: ‘There should be
time within MDT meetings to
discuss current and emerging
research and evidence which is not
specifically related to an
individual case’
31 Relevant
psychosocial issues
for patients
presented to each
type of MDT
should be
identified and
agreed by
the MDT
7.5 1.44 Moderate
32 The MDT member
who presents the
case should
routinely consider
psychosocial
factors and ensure
that relevant
information is
available at
the meeting
8 1.19 Moderate
DOI: 10.3310/hsdr02370 HEALTH SERVICES AND DELIVERY RESEARCH 2014 VOL. 2 NO. 37
© Queen’s Printer and Controller of HMSO 2014. This work was produced by Raine et al. under the terms of a commissioning contract issued by the Secretary of State for Health.
This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that
suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should be addressed to: NIHR
Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton
SO16 7NS, UK.
145
Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability
in agreement (when discussed)c
33 Teams should be
explicit about the
research evidence
that they are
drawing on when
making a decision
in the MDT
meeting
7 1.25 Moderate
Recommendations relating to the role of the patient in MDT meetings
34 Patients should be
given feedback on
which professional
groups were
present when they
were discussed at
the MDT meeting
7.5 1.69 Moderate It’s good practice to let people
know, and again it’s an
opportunity to explain that care is
multidisciplinary and what that
might mean
Doctor (mental health)
We’re able to tell them if they wish
to know, but we wouldn’t routinely
necessarily tell them
Doctor (cancer) 1
On the hand-out it will say you
were discussed in MDT which will
involve pathologist, gynaecologist,
clinical oncologist, so there’s that,
but each individual, that’s going to
be tricky
Doctor (cancer) 2
They should be aware that the
radiotherapist wasn’t there on that
day, is that what it means, that’s
the problem for me
Doctor (cancer) 3
35 Patients should be
given feedback
every time they are
discussed at an
MDT meeting
8 1.25 Moderate Not discussed
36 Patients should be
given feedback on
all treatment
options, even
those rejected by
the MDT
7 2.25 High I think in cancer . . . where there’s
sort of three or four options; surgery,
radiotherapy, chemotherapy,
endocrine therapy . . . there’s such a
high profile that the patients are all
very aware of the options, they very
much want to know, you know,
why in my case am I not being
recommended chemotherapy. But
that was almost as important as the
why you are being recommended
radiotherapy etc
Doctor (cancer)
I just thought it was impractical.
There may be a number of
treatment options for, you know,
schizophrenia that are impractical
because of the person’s
engagement with treatment or
ability to use some of those
interventions . . . if you were to
have to write that down and
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Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability
in agreement (when discussed)c
explain that to your patient, I think
you would be entering into very
very very long conversation creating
a lot of conflict, instead of it being
the treatment you think is practical
and will hopefully work
Doctor (mental health)
37 Patients should be
given written
feedback about
the outcome of
the MDT meeting
7 1.63 Moderate If it’s practical to do so for every
single person then you can do . . . if
you’ve got a co-ordinator and it’s
an extra job . . . verbal is the more
effective way of doing it
Nurse (heart failure)
Written feedback, that’s pretty
much our model
Doctor (cancer) 1
It’s impractical, and I think it’s
different in different trusts. But we
will see the patient, tell them of the
MDT, do a letter at the outpatient
Doctor (cancer) 2
38 Patients should be
able to choose the
mode of MDT
meeting feedback
(e.g. written,
phone call,
in clinic)
7.5 2.19 High In our situation this is not an issue
at all, and yet all the other issues
would have been pressed with time
constraints. That’s not a challenge
at all for us
Doctor (cancer)
It’s just whether this is aspirational
or pragmatic isn’t it, so of course in
an ideal world of course, but
there’s 10,000 heart failure
patients . . . this is pragmatic real
world MDTs rather than aspirational
Doctor (heart failure)
People always have an identified
care co-ordinator meeting with
them regularly, if there is a decision
or not out of an MDT meeting that
feedback should be done in the
usual way at their meeting
Doctor (mental health)
I disagree because I thought we
can’t actually commit to sending
everyone written feedback about
what’s happened in the meeting,
because of time constraints. So
as long as we give feedback that
they understand, I thought that
was okay
Team manager (mental health)
a Strength of agreement with the statement is indicated by the median: medians between 7 and 9 indicated agreement,
medians between 4 and 6.5 indicated uncertainty, and medians between 1 and 3.5 indicated disagreement.
b Variation in extent of agreement among panellists is indicated by the mean absolute deviation from the median:
>1.75 high, 1.11–1.75 moderate, <1.11 low.
c Note: only recommendations with a lack of consensus in round 1 were discussed.
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Appendix 14 Consensus development results
from round 2: recommendations for which strength of
agreement was uncertain (median ≥ 4 and ≤ 6.5)
Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
Recommendations relating to the purpose and functions of MDT meetings
39 The main
objectives of MDT
meetings should
be the same across
all chronic diseases
6.5 1.88 High In a mental health MDT, there
might well be more discussion
about the complexity of a case and
the fact that er, people need some
emotional support in managing a
patient who’s quite risky. That
might be very different to er, a
more clinically orientated team
who are really checking that an
algorithm has been followed
Doctor (mental health)
There are different forms of MDTs,
which are very, very different
animals . . . and for that reason I
don’t think all those different animals
can have the same objectives
Policy (cancer)
Generically they should all have the
same purpose, which is better care
for patients
Doctor (heart failure)
40 Teaching should
be a function of
MDT meetings
provided it does
not add to the
length of meetings
6.5 2.31 High Discussed and rated together with
question: ‘Teaching should be a
function of MDT meetings even if it
means meetings will be longer’
41 Teaching should
be a function of
MDT meetings
even if it means
meetings will
be longer
5 1.94 High I think teaching should happen
somewhere else where people can
attend to being taught, with the
exception of . . . you know, there is
something very pertinent to an
individual case that’s being
discussed, you might well mention
that in your team meeting because
it relates directly to their treatment.
I don’t think the MDT meeting is
a teaching forum
Doctor (mental health)
I felt very strongly, because it’s
probably more to do with the fact
that for our trainees it’s inherent
within the MDT. These are going
to be the . . . future consultants,
and there is a teaching/learning
process in there, irrespective.
And if it means you have to extend
your MDT slightly, that’s fine
Doctor (cancer)
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Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
42 All treatment plans
for existing
patients should be
agreed in an MDT
meeting even
if a clear
protocol exists
5 2.06 High All patients should be discussed.
Some of our patients can be
discussed quite quickly once we
talk about the diagnostic process;
it’s a way of ensuring that
absolutely every patient has that
safety net of quality assurance
Doctor (cancer) 1
I think that if you’ve got a clear
protocol I’m not quite sure of the
benefit of going through the
protocol again for the patient
Doctor (cancer) 2
There’s no need to bring every
patient to an MDT meeting, we
would only bring patients we’re
struggling to make progress with
Doctor (mental health)
It would be impossible for us to
discuss every recurrence
Doctor (cancer)
Recommendations relating to the structure of MDT meetings
43 Members should
be allowed to not
attend as long as
someone from
their discipline is
attending and the
member does not
have a case
to present
5 1.75 Moderate Not discussed
44 A list of people
who are required
to attend the MDT
meeting should be
decided locally by
the team
5 2.44 High I agree strongly with this because I
think every department, every
trust, different parts of the country,
they have different make-ups and
that needs to be reflected in
the teams
Nurse (heart failure)
I strongly disagreed with this. I
think that to have a consensus,
and again, coming from the cancer
world, we need certain people
there as at least a skeleton, and if
you leave it locally, what’ll happen
then is the Chief Executive will
have an MDT with one person in it
if they can get their way to
save money
Doctor (cancer)
Recommendations relating to the content of discussion in MDT meetings
45 A patient should
only be discussed at
the MDT meeting
when information
on comorbidity
is available
4.5 2.19 High
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Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
46 A designated MDT
member should
speak to the
patient about
comorbidities
before the patient
is discussed at an
MDT meeting
4 2.38 High If it had said information about
comorbidities should be available
for the MDT then that would
be a definite yes, you have to
incorporate processes into our
systems so that we have that
information when the patients are
discussed. But having a designated
member of the team discussing it
with the patient is a different
question
Doctor (cancer)
I want that, you know, my, a
discussion about my comorbidities
to be in there and brought to
the MDT
Patient representative
(mental health)
Somebody speaks to the patient
before the patient is discussed at
the MDT, again, practically very
difficult to do
Doctor (heart failure)
47 Each MDT should
identify the most
appropriate
methods for
presenting
complete
information
on comorbidities
5 1.13 Moderate We have usually a PowerPoint
presentation of the history of the
patient, and their other medical
conditions listed fairly standardly
Doctor (heart failure)
It’s an aspirational counsel of
perfection, which is difficult to
define, and I don’t think has very
much value. Sounds fantastic but I
don’t think . . . it’s just not
something you can put into a
protocol or a methodology I
don’t think
Policy (cancer)
Assessment and measurement of
comorbidities, it remains a massive
challenge, and there are various
ways of trying to get proxy
measures . . . but it’s incredibly
difficult to get right
Doctor (cancer)
48 Case presentation
should routinely
include a brief
introduction of the
patient and
relevant
psychosocial
characteristics,
otherwise the case
should not
be discussed
6 2.38 High You can’t discount a case just
because you’re not looking at
every single characteristic and
every single issue for that patient
Nurse (heart failure)
Only a relatively small proportion
of our cases would it be relevant
and appropriate . . . to have a
multidisciplinary discussion on the
psychosocial aspects
Doctor (cancer)
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Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
Patients are people, and I think it’s
relevant as to whether their
treatment is likely to impact on their
social life erm, their quality of life
and in the other direction whether
or not their context is having an
impact on their treatment
Doctor (mental health)
Recommendations relating to the role of the patient in MDT meetings
49 Any MDT member
who presents a
case should discuss
treatment
preferences with
the patient before
the MDT meeting
5.5 2.00 High Not discussed
50 Patient preferences
regarding available
treatment options
should be
discussed with the
patient after
(rather than
before) the
MDT meeting
5.5 1.63 Moderate Not discussed
51 Patients should not
be presented at the
MDT meeting
unless there is
someone present
who has met with
them at least once
before the meeting,
even if this
postpones
discussion of
that patient
5 2.63 High The MDT should function
automatically anyway, irrespective of
whether the person is there or not
Doctor (cancer)
It’s different [in mental health] You
can’t say anything before you’ve
met the patient
Doctor (mental health)
52 Patients should be
given the
opportunity to
provide information
in advance of the
MDT meeting to
ensure the
information
presented is
accurate and
7comprehensive
5 2.13 High Not discussed
53 Patients should be
able to provide
information by
having direct
access and the
ability to modify
their medical
records
5 2.69 High Strongly disagreed with this,
it struck to me of potential for
falsifying information
Doctor (heart failure)
Having the record that represents
what the patient’s perspective is, is
very helpful
Doctor (mental health)
I think access is one thing, but the
ability to modify your records is a
horrendous concept
Doctor (cancer)
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Recommendation Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
54 Patients should be
given the option to
provide a written
summary for
the meeting
5 1.88 High In a practical sense . . . a patient
comes in and is told she’s got
cancer, I’m going to tell her about
the MDT, would you like to
provide me with a summary, the
meeting’s on Friday, today is
Thursday. I’m struggling, I
understand the principle of it but
it’s the practicalities of it as well
Doctor (cancer)
Allowing them the opportunity to
present their viewpoints . . . it will
be further evidence of their state
of mind at the time
Patient representative
(mental health)
55 Patients should be
given the option
to provide
audio-recorded
input to the
meeting
4.5 2.50 High It would be . . . it just wouldn’t be
relevant to the discussions in what
is largely a diagnostic . . .
Doctor (cancer)
I strongly disagreed with it as well
for practical purposes
Policy (cancer)
The opportunity to maybe record
something that would then be
used in the meeting would be er,
very welcome
Nurse (mental health)
From a mental health point of
view, to have the service user’s
view on the situation I think would
reduce the time in terms of making
decisions about the treatment of
the person with a mental health
problem, just to hear what their
. . . their choices are, their voice
Team manager (mental health)
It shouldn’t require audio input if
you’re being a good doctor or a
good nurse
Doctor (heart failure)
We maybe need to change the
system . . . to allow the person to
feature in some way . . . then maybe
that is something that that we need
to think about. Sometimes just
because we’ve always done it that
way, it doesn’t make it right
Nurse (cancer)
a Strength of agreement with the statement is indicated by the median: medians between 7 and 9 indicated agreement,
medians between 4 and 6.5 indicated uncertainty, and medians between 1 and 3.5 indicated disagreement.
b Variation in extent of agreement among panellists is indicated by the mean absolute deviation from the median:
>1.75 high, 1.11–1.75 moderate, <1.11 low.
c Note: only recommendations with a lack of consensus in round 1 were discussed.
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Appendix 15 Consensus development results
from round 2: recommendations for which strength
of agreement was disagree (median < 4)
Question Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
Recommendations relating to the purpose and function of MDT meetings
56 MDT meetings
should be a forum
for brainstorming
and giving advice
without necessarily
reaching a decision
3 1.25 Moderate There are other forums for
brainstorming and I don’t think
the multidisciplinary meeting is
that forum
Doctor (heart failure)
It seems to open the possibility
that you can brainstorm and
give each other advice, but then
it’s fine not to reach a decision
about the patient, which just
seems . . . what’s the thing [the
MDT meeting] for then?
Policy (cancer)
Sometimes the decisions are not
that clear, so having to say a
range of options that come out
of that discussion – I’d call it a
discussion rather than
a brainstorm
Doctor (mental health)
It’s important teams have a
space on an occasional basis
where there’s a possibly to
perhaps brainstorm, explore
wider issues about how the
team’s working and stuff, not
on a routine basis
Nurse (mental health)
I slightly sat on the fence . . . if
that’s the only forum, which it
quite often would be, where
you might be able to bring
something where it isn’t
appropriate to make a decision
at that time, then it might be
that that’s the place because
that’s where you’ve got the
expertise, so it might happen
Nurse (cancer)
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Question Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
57 Only complex
cases should be
discussed in the
MDT meetings
(regardless of
whether they
are new or
existing patients)
3 1.31 Moderate Some of our patients can be
discussed quite quickly once we
talk about the diagnostic
process, it’s a way of ensuring
that absolutely every patient has
that safety net of quality
assurance. So I really believe
we should
Doctor (cancer)
I think there’s a lot of
straightforward cardiology that
really doesn’t need discussing,
where you’d ask, you’d have
100 MDTs you’d always get the
same decision, you’d always
follow the protocols
Doctor (heart failure)
58 It is more
important to
discuss all patients,
even if superficially,
than it is to discuss
a smaller number
of patients in
more depth
3.5 1.69 Moderate I think there’s a lot of
straightforward cardiology that
really doesn’t need discussing
Doctor (heart failure)
I actually agree that all patients
should be discussed, even if
they are what we consider to be
a relatively low-risk cancer
or whatever
Doctor (cancer)
Recommendations relating to the content of discussion in MDT meetings
59 There should be
time within MDT
meetings to
discuss current and
emerging research
and evidence
which is not
specifically
related to an
individual case
3.5 2.38 High It’s just not really the forum unless
it’s pertinent to the patient care
Doctor (cancer) 1
It’s not a CPD [continuing
professional development]
forum
Doctor (heart failure)
Knowing what’s up to date,
current, and changing the
thinking on care is actually
really, really important for me to
help make decisions with the
patients about the way forward
Nurse (heart failure)
That’s useful to be brought to
the meeting . . . may not always
be relevant to a specific case,
but just . . . [being] aware that
this [research] has come out
Doctor (cancer) 2
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Question Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
Recommendations relating to the structure of MDT meetings
60 Members should
be allowed to join
the meeting for
cases that are
relevant to them
and leave after the
discussion of these
3 1.19 Moderate There’s nothing worse than
seeing people coming and
going through an MDT
Doctor (cancer)
You have your core team and
then you can invite other people
in to discuss one particular case,
maybe a dietitian or
physiotherapist. To make them
sit through two hours of the
rest of the cases that are
irrelevant seems a bit harsh
Doctor (heart failure)
Recommendations relating to the role of the patient in MDT meetings
61 Patients’ treatment
preferences should
be routinely
discussed at the
MDT meeting and
if not available the
case should not
be discussed
3 1.94 High The horrifying bit is this case
should not be discussed . . . we
have a defined timeframe in
which we have to make a
diagnosis and . . .
recommendations . . . so the
MDT for us, the large part of
the MDT is a diagnostic process
getting the diagnosis, stage,
treatment options correct, and
then we sit down with the
patient and go through it. And,
you know, the patient can say
look, I don’t want any of that.
That’s fine but before the MDT
it’s almost irrelevant because we
don’t know what we’re actually
going to be talking to her about
Doctor (cancer) 1
Trying to do that in a practical
sense is not really going
to happen
Doctor (cancer) 2
I think a better model is you
decide it’s medically the right
treatment and then you spend
half an hour with the patient
discussing it. Why put them
through the worry then go back
and say, we’re not going to
do that?
Doctor (heart failure)
People with mental health
problems don’t always have a
strong preference
Doctor (mental health)
It depends a little bit on
whether you’ve got someone
who’s totally new to the
condition or new to the
treatment, they may have
already had certain treatments
and have quite strong views
Nurse (mental health)
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Question Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
62 Patient preferences
regarding available
management
options should be
reported to the
MDT meeting only
if the clinician
responsible for their
care thinks it will
alter the decision
3 2 High Not discussed
63 Patients should be
asked before the
MDT how much
they want to be
involved in
decision-making
about their
treatment
3 1.88 High I’m not sure it’s a question that
many patients might necessarily
be able to deal with . . .
especially . . . if you are
presenting with something that
you don’t suspect, you’ve got so
many things to think about
Patient representative (cancer)
If you are the tertiary centre . . .
you don’t know the patient
either . . . you don’t have that
link with the patient, so I think
probably quite difficult
Policy (cancer)
The nature of many heart failure
MDTs is you’re discussing
complex patients much further
down the pathway when you
know them well and you’ve had
many conversations with them.
Therefore, it didn’t seem relevant.
They’re already involved in the
decision-making before then
Doctor (heart failure)
In mental health, a lot of service
users have difficulties making
decisions, so it’s much easier to
take it to the MDT, discuss the
different options and then go
back, as opposed to asking
them to kind of make decisions
before the options have been
discussed in the MDT
Team manager (mental health)
What are you going to do with
the answer, unless they say no,
nothing at all, in which case
you’ll persuade them that they
should be. You know, it’s
just . . . I don’t think it’s a
practical question
Policy (cancer)
I’ve had those conversations at
various stages of my own
treatment, including from the
very earliest stages . . . It’s not
always going to be relevant
but I think it can be done
Patient representative (heart
failure and cancer)
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Question Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
64 All patients should
be told if they are
going to be
discussed at an
MDT meeting
before the meeting
otherwise they
should not
be discussed
2 1.88 High I just think it’s good practice to
explain that you’re working as
part of a multidisciplinary team
and that their case will be
discussed in that setting . . . it’s
not giving people the option to
say well, I don’t want you to . . .
if people express a concern then
you can explain why
it’s necessary
Nurse (mental health)
In the cancer world . . . there
will be an explanation that the
MDT is routine practice. It’s kind
of covered
Doctor (cancer)
65 All patients should
be explicitly given
the choice of
whether or not to
be discussed at the
MDT meeting
1.5 1.19 Moderate We have a lot of ‘at risk’ clients
and if there are risks that they
may harm someone else . . .
then there’s actually . . . there
isn’t an option
Doctor (mental health)
If they’re going to be under our
care then this is an integral part
of our process
Doctor (cancer)
66 Patients should not
be given an explicit
choice, but if they
express concern
about being
discussed at the
MDT meeting they
should be allowed
to opt out
2 1.25 Moderate We couldn’t do our jobs if
patients could opt out. It’s not
uncommon for patients to not
want anything to do with us
Doctor (mental health)
If then, once you’ve explained it
fully to them, they then say they
don’t really want to be involved,
then that’s a different matter,
but I think you need to make
sure they fully understand what
you’re talking about first
Nurse (heart failure)
67 Patients should be
given the option of
attending
MDT meetings
1 1.19 Moderate The logistics of it wouldn’t work
Policy (cancer)
It’s not the forum for breaking
bad news
Doctor (cancer)
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Question Mediana
Mean absolute
deviation from
the median
Variation in
extent of
agreementb
Quotes illustrating variability in
agreement (when discussed)c
68 Patients should be
given MDT meeting
feedback only
when decisions are
made about
their care
3 1.06 Low Accepting that there is a
scenario where an MDT may
meet and not apparently made
a decision, feedback, you know,
feedback would be harmless
wouldn’t it?
Policy (cancer)
Maybe it’s important to
acknowledge to that patient
that they were discussed, but
decisions weren’t reached, so
that they know that they
weren’t left out
Team manager (mental health)
Why have an MDT and not have
a decision?
Doctor (cancer)
a Strength of agreement with the statement is indicated by the median: medians between 7 and 9 indicated agreement,
medians between 4 and 6.5 indicated uncertainty, and medians between 1 and 3.5 indicated disagreement.
b Variation in extent of agreement among panellists is indicated by the mean absolute deviation from the median:
>1.75 High, 1.11–1.75 Moderate, <1.11 Low.
c Note: only recommendations with a lack of consensus in round 1 were discussed.
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Appendix 16 Consensus development
group panellists
Profession Area of expertise Location
Nurse Heart failure London
Nurse Heart failure London
Doctor Heart failure London
Doctor Heart failure London
Patient/carer representative Heart failure and cancer Hertfordshire
Nurse Mental health Sheffield
Nurse Mental health London
Occupational therapist Mental health London
Doctor Mental health London
Patient/carer representativea Mental health West Yorkshire
Nurse Cancer London
Nurse/policy Cancer London
Doctor/policy Cancer Sheffield
Doctor Cancer Birmingham
Doctor Cancer Kent
Patient/carer representative Cancer East Sussex
a Recruited as a mental health carer but also has experience as a cancer patient.
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Appendix 17 Consensus development group
information for panellists
 
 
 
1. Completing the questions in the booklet  
· 
· 
· 
· 
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Appendix 18 Consensus development results
from round 2: medians for each disease group –
recommendations rated as ‘uncertain’ overall
Recommendation
Overall
median
Median among
mental health
panellists (n= 5)
Median among
cancer panellists
(n= 6)
Median among
heart failure
panellists (n= 5)
39 The main objectives of MDT
meetings should be the same
across all chronic diseases
6.5 3 7 7
40 Teaching should be a function of
MDT meetings provided it does
not add to the length
of meetings
6.5 8 6 5
41 Teaching should be a function of
MDT meetings even if it means
meetings will be longer
5 7 6 4
42 All treatment plans for existing
patients should be agreed in an
MDT meeting even if a clear
protocol exists
5 7 5 2
43 Members should be allowed to
not attend as long as someone
from their discipline is attending
and the member does not have
a case to present
5 7 4.5 6
44 A list of people who are required
to attend the MDT meeting
should be decided locally by
the team
5 6 2 7
45 A patient should only be
discussed at the MDT meeting
when information on
comorbidity is available
4.5 2 6 6
46 A designated MDT member
should speak to the patient
about comorbidities before the
patient is discussed at an
MDT meeting
4 6 3.5 3
47 Each MDT should identify the
most appropriate methods for
presenting complete information
on comorbidities
5 7 5 5
48 Case presentation should
routinely include a brief
introduction of the patient and
relevant psychosocial
characteristics, otherwise the
case should not be discussed
6 7 4 3
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Recommendation
Overall
median
Median among
mental health
panellists (n= 5)
Median among
cancer panellists
(n= 6)
Median among
heart failure
panellists (n= 5)
49 Any MDT member who presents
a case should discuss treatment
preferences with the patient
before the MDT meeting
5.5 7 4.5 7
50 Patient preferences regarding
available treatment options
should be discussed with the
patient after (rather than before)
the MDT meeting
5.5 5 6 8
51 Patients should not be presented
at the MDT meeting unless there
is someone present who has met
with them at least once before
the meeting, even if this
postpones discussion of
that patient
5 8 2 3
52 Patients should be given the
opportunity to provide
information in advance of the
MDT meeting to ensure the
information presented is
accurate and comprehensive
5 7 4.5 6
53 Patients should be able to
provide information by having
direct access and the ability to
modify their medical records
5 7 2 5
54 Patients should be given the
option to provide a written
summary for the meeting
5 6 3.5 3
55 Patients should be given the
option to provide audio-recorded
input to the meeting
4.5 7 1.5 3
In order to illustrate differences, numbers in bold indicate agreement; and numbers in italics indicate disagreement.
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Appendix 19 Consensus development results
from round 2: medians for each disease group –
recommendations rated ‘disagree’ overall
Question
Overall
median
Median among
mental health
panellists (n= 5)
Median among
cancer panellists
(n= 6)
Median among
heart failure
panellists (n= 5)
56 MDT meetings should be a
forum for brainstorming and
giving advice without necessarily
reaching a decision
3 3 3 2
57 Only complex cases should be
discussed in the MDT meetings
(regardless of whether they are
new or existing patients)
3 3 2 3
58 It is more important to discuss all
patients, even if superficially,
than it is to discuss a smaller
number of patients in
more depth
3.5 2 5 2
59 There should be time within
MDT meetings to discuss current
and emerging research and
evidence which is not specifically
related to an individual case
3.5 6 3.5 3
60 Members should be allowed to
join the meeting for cases that
are relevant to them and leave
after the discussion of these
3 3 3 3
61 Patients’ treatment preferences
should be routinely discussed at
the MDT meeting and if not
available the case should not
be discussed
3 5 4 2
62 Patient preferences regarding
available management options
should be reported to the MDT
meeting only if the clinician
responsible for their care thinks
it will alter the decision
3 5 3.5 2
63 Patients should be asked before
the MDT how much they want
to be involved in
decision-making about
their treatment
3 3 2.5 3
64 All patients should be told if
they are going to be discussed at
an MDT meeting before the
meeting otherwise they should
not be discussed
2 5 1 2
65 All patients should be explicitly
given the choice of whether or
not to be discussed at the
MDT meeting
1.5 2 1 1
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Question
Overall
median
Median among
mental health
panellists (n= 5)
Median among
cancer panellists
(n= 6)
Median among
heart failure
panellists (n= 5)
66 Patients should not be given an
explicit choice, but if they
express concern about being
discussed at the MDT meeting
they should be allowed to
opt out
2 2 2 5
67 Patients should be given the
option of attending
MDT meetings
1 5 1 1
68 Patients should be given MDT
meeting feedback only when
decisions are made about
their care
3 3 3 5
In order to illustrate differences between specialties, numbers in bold indicate uncertainty.
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Appendix 20 Challenges and learning points:
reflections on conducting a large multisite
mixed-methods study
Throughout the 3 years of this project we faced a number of unforeseen challenges. This is inevitable inany prospectively conducted health services research project. These difficulties required us to be flexible
in our approach and derive innovative solutions. Here we describe some of the challenges and share
learning points that may be helpful for researchers embarking on studies of a similar nature.
Conducting a study across different NHS organisations
Conducting the study across eight NHS trusts was not a streamlined process. The hurdles we describe are
familiar to every researcher undertaking multisite research in the NHS. Though the field researchers had
NHS Research Passports, trusts varied in the approvals they required (e.g. honorary contracts, letters of
access, licences to attend) and in the procedures for obtaining them. One site required a site-specific
agreement to be drawn up which involved extensive liaison between the researchers, representatives of
the study’s sponsoring organisation (University College London) and the contracts team of the trust
in question.
Similarly, it was time-consuming to find and follow the local procedures for acquiring the necessary
security passes and IT access privileges at each trust. Some trusts required that the researchers go on
specific training before granting access to certain computer programs used to access parts of medical
records (e.g. software for viewing magnetic resonance imaging scans). This occurred even where the
training was not relevant to the researcher’s role – for example, in order to gain access to certain
medication records, one of our researchers was obliged to undergo training on electronic prescribing, even
though this was clearly not a task she was going to undertake.
Difficulties in reaching the planned sample size for the
quantitative analysis
We originally recruited 10 MDTs in eight NHS trusts. The necessary ethical and R&D approvals were
obtained by the chief investigator before the project start date to allow us to begin data collection
immediately. For a number of reasons, however, it became apparent that these teams would not provide
sufficient data for us to reach our target sample size of 3300 patients. Although we drew on the experience
of all our clinical coapplicants, the idiosyncratic nature of MDT meetings soon became apparent: there were
extensive differences in the number of patients discussed both within and between teams concerned with
different chronic conditions. We encountered particular problems in identifying heart failure teams with
sufficient patient throughput to allow us to achieve the necessary sample size in the required time frame.
Having met with heart failure consultant leads across London we identified two teams, but with low patient
throughput. We therefore identified a third heart failure team, which agreed to participate in the study.
Unfortunately, despite our efforts and timely production of all relevant documentation, delays in the R&D
procedures at the site meant that after 6 months of liaison it was no longer going to be possible to recruit
the required number from that site. Instead, we compensated for the small numbers discussed in some
teams by observing these teams for longer than originally planned and we also observed extra meetings at
the three MDTs discussing the highest numbers of patients.
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One of the mental health teams disbanded shortly into the data collection phase because of
service-restructuring within their trust. We were unaware of any plans to disband when we started data
collection. We therefore recruited another team. As there was not enough time to go through the process
of acquiring R&D approval from a new NHS trust, we recruited a new team from a trust which had already
approved the study in relation to another team. This allowed us to recruit the new team and
begin data collection relatively quickly.
Another challenge related to the nature of discussions in different teams. In our clinical coapplicants’
experience, each patient discussion resulted in a management decision. This information was used to
calculate the sample size required. While this did occur in some teams, in practice several teams did not
make decisions in every patient discussion, particularly in mental health teams. This meant that, even
where teams were discussing sufficient patients, they were not making enough decisions to allow us to
reach the target sample size. We therefore recruited a fourth mental health team to compensate for this.
Another unanticipated and time-consuming task related to quality assurance of our data. We originally
planned to audiotape the first six meetings observed for each team. However, because meetings often
involved team members talking simultaneously, we found that it was necessary to listen to the recordings
of all meetings observed to ensure accurate completion of the observation proformas (i.e. to make sure we
had captured all decisions and other relevant information). This meant listening to all 370 meetings at least
twice (once in person and once on the recording). We amended the participant information sheet to
reflect this.
Because of the recruitment of additional teams, we needed to employ an additional research assistant to
attend and collect data from these teams. We applied for and were awarded service support costs from
the Central and East London Comprehensive Local Research Network to fund this.
The NHS National Research Ethics Service granted approval for these minor amendments to the study.
Challenges relating to the interviews
The need to extend the data collection period in order to achieve a sufficient sample size had
consequences in terms of our ability to undertake the planned number of interviews. We considered
focusing only on the professional interviews; however, on the advice of our funders and members of our
steering group, we proceeded with both professional and patient interviews as planned, though with a
smaller sample and with carefully targeted recruitment to retain a diversity of disciplinary perspectives in
the professional interviews.
We were assisted in the conduct of some of the interviews with mental health patients by a medical
student and two specialist registrar psychiatrists (currently under the supervision of one of our
coapplicants). The specialist registrar psychiatrists performed additional analyses of these interviews, and
these have resulted in a research article which is currently under review. We invested considerable time to
ensure that the medical student and trainee psychiatrists were fully cognisant of the study. Crucially, we
trained them in qualitative interview techniques and observed their technique in pilot interviews with
volunteer patients identified by our coapplicant PPI representatives before they began data collection.
We also helped them to obtain the necessary approvals and submitted a substantial amendment
(concerning the additional researchers) to the Research Ethics Committee.
Recruitment of mental health service users for interviews proved very challenging for a number of reasons.
We recruited patients who had been recently discussed at MDT meetings, purposively sampling for a
diversity of age, sex and ethnicity. For each selected patient, we asked their key worker to contact the
patient and, if the patient agreed, we then made direct contact with the patient to explain the study,
respond to their questions and arrange the interview. We agreed exclusion criteria with MDT members.
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These were patients who were acutely unwell, who had been discharged and were no longer contactable,
and who were in prison.
The MDT teams from which these mental health patients were drawn were undergoing restructuring.
Though only one team disbanded during the observation period (no patients from this team were
interviewed), the others were preparing for staff changes and morale was very low because many staff
members were concerned about losing their jobs. Thus, the research was understandably not a high
priority for them. The key workers were also very busy and did not always have time to speak to the
patients they had agreed to contact about the study. Several key workers did not respond to our e-mail
and voicemail reminders.
Even where patients had been approved as appropriate by their key workers, by the time they had
contacted them to explain the study and let us know, many patients had experienced deterioration in their
health or had moved address and were no longer contactable.
Several patients agreed to be interviewed during our initial conversation but we were subsequently unable
to contact them. One patient agreed to participate but then rescheduled the date of the interview and
subsequently changed their mind and declined. One patient did not attend two appointments that we had
agreed for the interview and so we decided not to pursue them for a third appointment. Both of the
mental health patients we did interview had rescheduled at least once.
Managing large qualitative data sets
The qualitative aspect of the study involved 73 interviews and observation of 370 meetings (6053 patient
discussions and approximately 530 hours of audiotape). Managing this volume of data was challenging,
in terms of confidential storage, data reduction, ensuring consistency of data analysis across researchers
and reporting the results concisely. At one point we unexpectedly ran out of electronic storage space and
had to reduce the size of our audio files. This had a detrimental effect on the sound quality. The large
volume of data also significantly slowed the running of the analytic software.
We adopted a number of strategies to facilitate the processing and analysis of the data. We outsourced
transcription of the interviews to an external company that was recommended by qualitative researcher
colleagues and that signed a confidentiality contract. We did not outsource transcription of the audio
recordings of the meetings because they were too complex, with large numbers of speakers and variable
audio quality.
Ensuring that each of the three field researchers coded the data reliably was a learning process
necessitating close and regular communication between the researchers. Each researcher had different
expectations regarding a ‘normal’ number of codes, how broadly or narrowly to interpret the research
question, how to divide the task between them and which data management software to use, if any. Each
code is open to different interpretations and it was a slow and laborious process to agree unambiguous
definitions which coders could use consistently.
However, we found that the benefits of performing the analysis as a group far outweighed the costs. We
believe it improved the robustness of the analysis because we needed to scrutinise, challenge and defend
our ideas throughout. It led to more accurate and standardised coding and gave us insights into the
assumptions underlying our interpretations of events. It allowed us to learn from each other and provided
more ideas for a richer conceptualisation. Finally, it allowed us to analyse far more data than an individual
could have managed alone.
We began to code data from the different sources as they became available, rather than waiting for the
data collection phase to be complete before beginning the analysis. Observation of the different teams
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finished at different times. Thus we began the basic inductive coding and selective transcription of
the observational data for the first team when it was ready, rather than waiting until observation of all the
teams had finished. This meant that one field researcher could work on the coding framework and feed
back to the team before the next researcher used it on the next ‘batch’ of data. This avoided the potential
problem of researchers simultaneously coding different sections of the data and then meeting to find
that their coding frames were incommensurable or redundant. This phased approach also meant that we
were already very familiar with many of the data by the time data collection was finished and we could
proceed relatively quickly to the integration stages.
Conclusions
Studies of this nature, involving collaboration across multiple sites, are inevitably subject to factors that are
beyond the control of the research team. Responding to these challenges requires a willingness to be
flexible and responsive to unanticipated events. Maintaining an open dialogue with our funders
throughout and proactively seeking the advice of our steering committee were also essential to successfully
navigating these challenges.
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